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ABSTRACT
Development and Validation of a Diabetes-specific Health State Classification
System and Valuation Function Based on the Multi-attribute Theory
Murali Sundaram
Preference-Based Measures of Health (PBMH) provide ‘preference’ or ‘utility’ weights
that enable the calculation of quality-adjusted life years for the economic evaluations of
interventions. The Diabetes Utility Index (DUI) was developed as a two-page, selfadministered diabetes-specific PBMH that can replace expensive time-consuming
interviews with patients to estimate their health state utilities. Inputs from theory, an
existing diabetes-specific measure of quality of life, and statistical analyses were
submitted to a clinical expert panel. After three rounds of pilot surveys (n1=52, n2=65,
n3=111) at primary care clinics in Morgantown, WV, five attributes and severity
categories for each attribute were finalized on the basis of the results of Rasch Analysis
and consultations with the panel. The final attributes were: ‘Physical Ability & Energy’,
‘Relationships’, ‘Mood & Feelings’, ‘Enjoyment of Diet’, and ‘Satisfaction with
Management of diabetes’. The next step involved obtaining preferences for health states
based on combinations of DUI attributes and severity levels from 100 individuals with
diabetes, recruited from primary care and community settings in and around
Morgantown, WV, in hour-long one-on-one interviews. These health states were anchor
states, single-attribute level states including corner states, and marker states. The
interviews provided data to calculate a Multi-Attribute Utility Function (MAUF) that
calculates utilities for any of the 768 health states that can be defined by the DUI, on a
scale where 1.00=Perfect Health and 0.00=the all worse ‘Pits’ state, from respondents’
answers to its five questions. In addition to an overall index score, attribute-level
preference scores were also calculable by the function. Finally, a validation survey was
conducted in collaboration with the West Virginia University (WVU) Diabetes Institute.
For concurrent and construct validation purposes, the DUI was mailed to individuals with
diabetes along with generic PBMH like the EuroQol EQ-5D, the SF-6D and other
patient-reported outcomes measures like the Diabetes Symptoms Checklist-Revised, the
Short Form 12 (SF-12) and the Well-Being Questionnaire (W-BQ12), and their surveys
responses (n=396) were merged with a clinical database consisting of ICD-9 diagnosis
codes. The DUI utilities were found to be largely free of socio-demographic effects and
its scores were well distributed between 0.00 and 1.00. The DUI moderately correlated
with generic PBMH and distinguished between severity groups based on diabetes
symptoms and complications. The scoring function of the DUI calculated utilities
favorably compared against cardinal Standard Gamble utilities obtained directly from
patients for three DUI health states. These results show evidence of the feasibility and
validity of the DUI. Further research is suggested to demonstrate the generalizability of
these findings, to study the responsiveness of the DUI, and to examine the clinical
meaningfulness of the DUI change scores.
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Chapter One

CHAPTER ONE

1.1

The Economic, Clinical and Humanistic Burden of Diabetes
The National Institute of Diabetes and Digestive and Kidney Diseases (2005) has

estimated that about 21 million people in the U.S., seven percent of the population, had
diabetes in 2005. Diabetes is a chronic disease associated with complications and other
co-morbid conditions that add to the burden of diabetes. Some of the more significant
complications resulting from the inefficient management of diabetes are eye disease
(blindness, retinopathy), kidney disease (nephropathy, end stage renal disease), and
nervous system damage (neuropathy, foot ulcers), among others. The Centers for
Disease Control and Prevention (CDC) estimates that the risks of heart disease and stroke
are both two to four times higher in persons with diabetes, and an estimated 73% of
persons with diabetes have hypertension (CDC, 2003).
Diabetes is also the leading cause of adult blindness and end stage renal disease
accounting for 44% of new cases of kidney failure (CDC, 2003). Approximately 60-70%
of persons with diabetes have neuropathies; severe forms of diabetic nerve disease are a
major contributing cause of lower-extremity amputations (CDC, 2003). Other conditions
associated with diabetes include acute life-threatening events such as diabetic
ketoacidosis and hyperosmolar coma, both short-term complications of the disease.
People with diabetes are also more susceptible to many other illnesses and once they
acquire these illnesses, their prognoses worsen (CDC, 2003). It is not surprising that
diabetes is the sixth leading cause of death by disease in the U.S. (Kochanek & Smith,
2004).
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Traditional measures of clinical outcomes like morbidity and mortality continue
to be measured and reported, but there is increasing appreciation for the patient’s
perspective on health, disease, and medical treatments – referred to as ‘patient-reported
outcomes’ (PROs) or ‘humanistic’ outcomes. While healthcare professionals examine
the impact of diseases using clinical parameters, patients can provide their own
assessments of their health-related quality of life (HRQoL), treatment satisfaction and
adherence, and symptom burden, and others. Among these, HRQoL (often considered
synonymous with quality of life or QoL) is one of the widely assessed patient-reported
outcomes in the evaluation of healthcare interventions. There is an ongoing debate on the
need to differentiate between the constructs representing QoL and HRQoL that considers
the former to be a broader term encompassing the latter (Bradley, 2001). For the sake of
simplicity, this document will use the term HRQoL in reference to both. Patient-reported
outcomes, including HRQoL, are assessed using instruments that measure their respective
constructs in a descriptive manner. These instruments can be commonly referred to as
profile-based measures; some of these measures provide a single score, while others
provide a profile of scores.
Diseases like diabetes can affect people in different ways depending on the
aspects of life that are compromised. The management of diabetes imposes considerable
demands on patients and their families as well. Apart from the emotional and social
burdens this may cause, they face the acute distresses of hypoglycemia or hyperglycemia
and chronic distress of diabetes-related complications (Rubin, 2000). Hence, diabetes is
said to impact the physical, psychological and social functioning of individuals. In order
to measure this impact, it is necessary to take into account several factors: patient's
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perceived physical distress due to diabetes-specific symptoms, loss of physical function
and independence, as well as the perceived emotional distress due to symptoms, self-care,
and the interference with common activities and social situations (Polonsky, 2000).
While this list is neither complete nor standard, it is clear that such measurements are not
straight-forward. Hence profile-based instruments are used that provide a descriptive
assessment of the impact of disease on health in general or in specific aspects of life.
The economic expense of diabetes was estimated at $132 billion in 2002, with
direct medical expenditures totaling $92 billion and $40 billion due to the indirect costs
of lost productivity resulting from lost workdays, restricted activity days, permanent
disability, and mortality (Hogan, Dall, & Nikolov, 2003). Recognizing that the
population with diabetes tends to be older, on average, than the population without
diabetes, the total health care costs for people with diabetes in the U.S. have been found
to be between four to five times the costs for people without the condition ( American
Diabetes Association, 1998; Rubin, Altman, & Mendelson, 1994; Hogan et al., 2003).
This forms a tremendous national economic burden.
The dynamics of the U.S. health care system have influenced how diabetes
treatments and interventions are evaluated. The scarcity of healthcare resources and the
emergence of managed care as a dominant influence on health care delivery has lead to
an increasing emphasis on assessment of the costs associated with new and existing
treatments relative to their effectiveness. Such economic assessments, in the form of
cost-effectiveness analysis (CEA) and cost-utility analysis (CUA), may be sought as an
input to aid in decision-making or simply may be required to make submissions due to
legislative mandate.
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1.2

Statement of the Problem
One of the key inputs for the CEA and CUA models are utility values for health

states of interest in the treatment or intervention being evaluated. A utility-gathering
exercise is typically a separate study in which, people (a sample of similarly diseased
subjects or the general population) are given comprehensive descriptions of specific
health states under consideration. Respondents then answer questions, which involve the
use techniques such as the Rating Scale, the Standard Gamble, or the Time Trade-Off,
that will enable the estimation of a numeric value that represents their utility for that
health state. The direct evaluation of health state utilities in this manner is a challenging
task. While these techniques themselves help researchers in enabling participants to state
their health-state preferences, they can be time-consuming and expensive. People may
find it cognitively difficult to understand health state scenarios, to state their preferences
for health states, and to undertake the gambles and trade-offs with health.
An alternative to this approach is to obtain utilities indirectly, by using
preference-based measures of health (PBMH). All these measures contain health-state
classification systems, composed of attributes of health that may be influenced, and
severity levels for those attributes, which can together describe diverse health states.
Respondents’ answers to the classification are fed into a pre-coded valuation function that
identifies the pattern of responses and provides a numerical value of utility. Examples of
PBMH are the EuroQoL EQ-5D, the Health Utilities Index (HUI), the Quality of Well
Being (QWB), and the Short Form 6D (SF-6D). These measures differ in the types and
number of attributes included and the severity levels allowed to be assessed.
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Most of the existing PBMH employ generic classification systems and, like
generic measures of HRQoL, may be inappropriate or insensitive for specific disease
conditions. There are several disease-specific profile-based measures available that
provide descriptive assessments of the impact of disease and its treatments. Some of
them provide more than one score, which when used in economic evaluations would
require multiple cost-effectiveness ratios. However, these are largely profile-based
measures that do not explicitly incorporate preferences for different possible health states
into their scoring algorithms. Hence, such instruments are not suitable to be used in
economic evaluations of healthcare interventions in their current formats.
One solution to this problem would be to link the disease-specificity of existing
profile-based measures with the convenience and appropriateness of existing generic
PBMH. This process would involve concurrently administering the two measures and
using statistical techniques to predict utility weights from profile-based scores. The
resultant conversion algorithms can be used to obtain utility values for health states in
other studies that failed to incorporate PBMH but used the same profile-based measure.
This is regarded as only the second-best approach as the utilities obtained in this manner
are limited to the range of the utilities calculated from the original generic PBMH.
An alternative solution would be to develop disease-specific PBMH. Such
measures would have the dual advantages of disease-specificity and ease in obtaining
utilities, as opposed to directly evaluating health state utilities. Developing such a
measure involves formulating a disease-specific health classification system along with a
valuation function that will enable the calculation of utilities for the all health states that
can be described by the classification system. While such systems can be based on input

5

Chapter One

from comprehensive primary research for content, they can also benefit from established
disease-specific profile based measures. In their current format, many existing profile
based measures will give rise to classification systems that are too complex from which
to meaningfully elicit utilities. However, it is feasible to suitably modify them for the
purpose of developing a concise disease-specific classification system and then develop a
valuation function to calculate utilities for the health states it describes. Based on
existing knowledge of published research, there currently is no diabetes-specific PBMH
providing utilities that can be directly used in economic evaluations.

1.3

The Proposed Study

1.3.1

Objectives of the Study
The Audit of Diabetes Dependent Quality of Life (ADDQoL) is a diabetes-

specific measure of that provides a descriptive assessment of quality of life in patients
with diabetes. Independent reviews have recommended the instrument for QoL
assessments of both Type 1 and Type 2 patients with diabetes, and have described it as a
brief and recent instrument generated with patient input, with good reliability, internal
and external construct validity (Garratt, Schmidt, & Fitzpatrick, 2002; Wildes,
Greisinger, & O'Malley, 2003). The instrument was not designed to allow respondents to
indicate their individual preferences for different health states. Consequentially, the
score on the ADDQoL is not preference-based and cannot be used in economic
evaluations of healthcare interventions in diabetes.
There are two key components in constructing PBMH: 1) Designing a healthstate classification system (or health state descriptive system) that is composed of
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attributes or domains that influence health; and 2) Estimating a valuation function that
provides numerical values of utility for all health states that can be described by the
classification system (Feeny, 2002a). Given the satisfactory reports of validity and
reliability of the instrument and encouraging reviews, the content of the ADDQoL can be
used in place of extensive primary research on diabetes-specific issues that is normally
necessary as a part of the development of a new PBMH, and supplemented with input
from a clinical expert panel. Like any other new instrument, a new PBMH will need to
be tested for the validity of its measurements. It is also important to know what causes
the variation in utilities – whether it is due to real differences between people or if it is
due to construct-irrelevant variation (Lenert & Kaplan, 2000).
The purpose of the proposed study is to develop and validate a brief diabetesspecific PBMH. The specific objectives are:
1. To develop a diabetes health state classification system;
2. To derive a valuation function for the diabetes health state classification
system; and
3. To assess the validity and predictors of the utilities derived from the diabetes
health state classification system.
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1.3.2

Research Plan & Conceptual Framework of the Study
The conceptual framework of the proposed study is presented in Figure 1.

Objective One:
A combination of theory, subjective and statistical approaches was employed to
identify attributes and severity levels for a diabetes-specific health state classification
system. The statistical approaches used were guided by the principles of both classical
and modern theories of measurement. The results from the statistical analyses were
discussed with a clinical expert panel to ascertain adequate coverage of issues important
to patients with diabetes, and to make suitable modifications using an established
consensus-gathering technique. Finally, the attributes and levels of severity chosen were
adequately worded to create a diabetes-specific classification system, christened the
Diabetes Utility Index (DUI), and were pilot tested on a patient samples.

Objective Two:
Phase One: The Multi-Attribute Utility Theory (MAUT) was used as the
framework to develop a valuation function for the DUI. The MAUT guided the selection
of health states from the classification system developed in Objective One. Health state
descriptions were constructed from the attributes and severity levels of the DUI and the
utility elicitation tasks were designed in accordance with existing measurement
guidelines. The scenarios and tasks were pilot tested on a general population sample.
Phase Two: Patients with diabetes were administered the utility elicitation tasks
designed in Phase One using one-on-one interviews.
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Phase Three: The data collected in Phase Two were used to calculate the
necessary metrics required as per the MAUT framework. This led to the formulation of a
valuation function, also called as a multi-attribute utility function (MAUF), which would
yield utility values for all health states described by the DUI.

Objective Three:
Objective Three was accomplished alongside Phases Two and Three of Objective
Two, and involved administering the DUI to a separate outpatient sample of patients with
diabetes in the form of a mail survey. The utilities of patients for their current health
states were obtained using the MAUF, and were merged with a clinical and demographic
data to conduct construct validation analyses and to understand the predictors of patients’
utilities. In addition, the concurrent validity of the DUI was analyzed by comparing its
scores with those obtained from other generic PBMH.
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Figure 1: Conceptual Framework of the Study
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1.3.2

Significance of the Study
There is increasing interest in the development of disease-specific PBMH for use

in economic evaluations. This study will be the first to report the development of a
diabetes health state classification system using inputs from an existing diabetes-specific
measure of quality of life in combination with expert panel inquiry and statistical
analyses. In addition to the classical approach to reviewing item content, the study
incorporated techniques based on the Modern Test Theory as well as subjective
approaches based on expert review. The valuation function for the classification system
was based on the MAUT, an established theory to model utilities for health states defined
by multi-attribute health status classification systems. Finally, this study reported on the
feasibility of the development of a PBMH specifically for use in economic evaluations of
diabetes interventions.
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CHAPTER TWO: Literature Review

2.1

Health-Related Quality of Life as a Humanistic Outcome
Humanistic outcomes are increasingly being used along with traditional outcome

measures as end-points in clinical trials of healthcare interventions. While one of the
traditional outcomes in the number of years or ‘quantity of life’, humanistic outcomes
help understand the ‘quality’ aspect of life of patients in terms of how it is influenced by
disease and its treatments. Patient-reported humanistic outcomes are of several types,
differing in terms of the range of issues to which they pertain; one such important
outcome is health-related quality of life (HRQoL).
Hareendran (2005) summarizes the value that patient reported outcomes like
HRQoL can add to the evaluation of new treatments: They are key measures of treatment
outcomes when there are no objective markers of symptoms and no objective markers of
the impact of symptoms. They also complement traditional endpoints to evaluate the
significance of a treatment effect from a patient’s perspective. Information on HRQoL
outcomes can facilitate patients’ involvement in treatment decision-making. Finally,
HRQoL outcomes can provide guidance for health care decision-making by enabling a
better understanding of the burden of illnesses and in making healthcare allocation
decisions.
Descriptive measures of health, called by a variety of names including profilebased measures, health status measures, and HRQoL measures, are used to assess the
impact of diseases and treatments on health. Profile-based measures of HRQoL are
descriptive in that they help identify impairments in health in general or in specific
domains of life that affect health. However, the scores on these instruments do not
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incorporate preferences of users of healthcare (Brazier, Roberts, & Deverill, 2002).
Hence it is difficult to incorporate profile-based scores, of these instruments into costeffectiveness analyses (Revicki, 1996). Additionally, when such measures generate a
profile of scores rather than a single score, it can becomes difficult to interpret the
multiple and potentially conflicting cost-effectiveness ratios (Revicki, 1996; Revicki,
Leidy, Brennan-Diemer, Sorensen, & Togias, 1998a; Revicki, Leidy, Brennan-Diemer,
Thompson, & Togias, 1998b). Another issue hindering the use of profile- based scores
has to do with the lack of interpretability of changes on these scores in economic
evaluations, within the context of relative cost of therapy (Revicki, 1996).

2.2

Utility as a Humanistic Outcome
In comparison to HRQoL, a Quality-Adjusted Life Year (QALY) is an outcome

measure that takes into account both the quantity as well as the quality of the added life
provided by a healthcare intervention; it is the arithmetic product of the added life
expectancy and the quality of the remaining years (Drummond, O'Brien, Stoddart, &
Torrance, 1997a). In other words, the added number of years of life afforded by an
intervention is adjusted or weighted for the quality of those years as perceived by the
patient. Quality-Adjusted Life Years constitute the denominator to calculate cost per
QALY gained in cost-utility analysis (CUA) (Drummond et al., 1997a). In fact, one of
the key features of a CUA is its use of the QALY concept. The use of QALYs allows the
direct economic analysis of interventions that have more than one important outcome
measure, and also facilitates the comparison of interventions that have diverse outcome
measures (Drummond et al., 1997a). Cost-effectiveness analysis (CEA) is inappropriate
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in both these cases since the technique requires that the outcomes be measured in
program-specific units. Hence CUA and CEA are similar on the cost side, but differ on
the outcomes side. Additionally, CUA can be used only with final outcomes data (e.g.
lives saved, disability-years averted) and not intermediate outcomes data because the
latter cannot be converted into QALYs (Drummond et al., 1997a).
The adjustment factors or quality weights needed to calculate QALYs in
economic evaluations are measured preferences for health states in an intervention,
interchangeably called ‘values’, or ‘preferences’, or in economic terms, ‘utilities’ (Gold
et al., 1996a), all of which are used under the umbrella term ‘preferences’ (Drummond et
al., 1997a). In general terms, it is acceptable that the terms be used in place of each
other, since there is more utility attached to preferable outcomes (Drummond et al.,
1997a). However, in technical terms, there are differences arising due to the way
preferences are measured – when measured under risk they are referred to as utilities;
when measured under certainty they are referred to as values. Preferences are also
classified as ‘ordinal’ or ‘cardinal’ – in the former, health states are simply rank ordered
whereas the latter requires a number to be attached to it that represents the strength of the
preference for that health state in comparison with others (Drummond et al., 1997a).
Utility values are gathered by asking people about their preference for health
states, specifically those health states of interest occurring among patients in the course of
the healthcare intervention being assessed. Utilities are required to meet some
conditions: 1) they should meet individuals’ preferences for health states and not merely
provide a descriptive assessment of health as provided by profile-based measures
(Brazier et al., 2002); 2) they must be measured on an interval scale in which equal
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intervals have equivalent interpretation (Gold, Siegel, Russell, & Weinstein, 1996b); 3)
they must be anchored on measures of perfect health and death. Traditionally, a scale
ranging from 1 (indicating perfect health) to 0 (indicating death) is used (Gold et al.,
1996b) with allowance for negative values for health states perceived worse than death.

2.3

Methods to Obtain Preferences/ Utilities
There are two approaches to obtaining utility values for use in economic

evaluations: referred to as direct and indirect utility elicitation techniques. In a direct
utility-elicitation exercise, respondents are given comprehensive descriptions of specific
health states under consideration, and techniques such as the rating scale, the standard
gamble (SG), or the time trade-off (TTO) are used to obtain their preferences for being
in those health states. Although guidelines are available to undertake each of these
techniques, the actual exercises differ in terms of the health states presented and other
information describes to the respondents. The indirect approach makes use of
preference-based measures of health (PBMH). Health states do not have to be presented
to respondents, because these PBMH contain unique standardized multi-attribute healthstate descriptive systems. Utility values are obtained from respondents’ answers to the
health-state descriptive system by using a pre-determined scoring algorithm. Both of
these approaches are discussed in detail in the following sections.

2.3.1

Direct Approaches
In the rating scale approach, respondents are asked to assign a single number to a

health state on an anchored scale where the lowest number corresponds to the worst
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imaginable state (like death), and the highest number corresponds to the best imaginable
state (usually perfect health). The rating scales have been given different names like
‘visual analog scale’ (VAS) and ‘feeling thermometer’, among others.
A standard gamble (SG) begins with presenting a written description of the health
state under evaluation. The respondent is then asked to imagine a hypothetical situation
in which a choice has to be made between two alternatives: to continue living in a health
state of interest which is not perfect health (the certain outcome) or to take a gamble with
two possible outcomes – perfect health or death (or another negative state, which could
be worse than death), with probabilities ‘p’ and ‘1-p’ respectively. The probabilities in
the gamble are systematically altered until the respondent cannot choose between the
described health state and the gamble, (i.e. the respondent is indifferent about the two
alternatives). The probability at this point of indifference is considered the utility of the
health state (Krabbe, Essink-Bot, & Bonsel, 1997). Or, the expected value of the gamble
at this point is an estimate of the utility of the standard relative to perfect health or death
(Gold et al., 1996a). Thus, it can be seen that the SG method differs from the rating scale
in two important ways: the SG method incorporates the trade-off concept by introducing
a choice between alternatives; also one alternative contains uncertainty and hence
incorporates risk and probabilities.
The time trade-off (TTO) technique measures how much time a subject is willing
to trade off to avoid a specific health outcome. A TTO begins with presenting a written
description of the health state under evaluation. The respondent is then asked to imagine
a hypothetical situation in which a choice has to be made between two alternatives: to
continue living in the health state described (the poorer state) for a defined time, or to
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choose perfect health for a lesser amount of time. The time in the healthier (and more
desirable) health state is varied (shortened) until the respondent is indifferent between the
two alternatives, which becomes the indifference point. The TTO utility for the health
state under consideration is equal the remaining number of years in perfect health (life
expectancy) at the point of indifference divided by the length of remaining life with that
health state (Gold et al., 1996a). It incorporates two easily understood aspects of health:
morbidity and longevity. As compared to the rating scale, and like the SG, the TTO
method incorporates the trade-off concept. However, since the outcomes presented to the
respondent are understood to occur with certainty, the concepts of risk or probabilities are
not associated with a TTO task.

2.3.2

Comparison of Direct Approaches
Rating scales can be used to obtain preference values, but which are not

unanimously thought of as having interval scale properties. Rating scales only ask
subjects to indicate the relative value of a health state under consideration compared to a
worst and perfect health state, and thus has no utility-theoretic basis (Louviere, 1988).
For use in economic evaluations, utility weights that represent individual’s relative
preferences for different health states are needed (like those obtained from other
techniques like TTO or SG). This had lead researchers to doubt the validity of the
preference values generated using rating scales as a measure of strength of preference
(Bleichrodt & Johannesson, 1997; Schwartz, 1998; Robinson, Loomes, & Jones-Lee,
2001). Hence, rating scale values need to be converted to utility weights that incorporate
some concept of tradeoffs—how much of one thing an individual is willing to give up in
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return for something else. The relationship between rating scale values and utility
estimates from the TTO and SG have been found to be highly non-linear (O'Leary,
Fairclough, Jankowski, & Weeks, 1995; Stiggelbout et al., 1996; Furlong et al., 1998;
Lenert, 2000), while there are reports the relationship is linear (Mrus et al., 2003).
Measurement biases may also occur depending on the respondents’ capabilities to
perform the rating task. Respondents may space out health states presented on the rating
scale irrespective of the severity of those states, suggesting that the preference values
obtained are relative rather than absolute. In other words, the valuation of a health state
is influenced by the presence of another state in the same rating task. Also, respondents
may not use the ends of the rating scale, leading to end-of-scale bias that needs to be
corrected for (Furlong, Feeny, Torrance, Barr, & Horsman, 1990; Torrance, Feeny, &
Furlong, 2001). In order to overcome this, an end-of scale correction bias has been
suggested (Furlong et al., 1998).
Rating scales are quick to complete, less expensive and are said to be the least
burdensome among preference elicitation techniques. Thus, the technique lends itself to
self-administration better than other techniques, and is easier to implement in a mail
survey format (Torrance et al., 2001). They can also be used as a warm-up technique, to
familiarize respondents with the descriptions of health states before moving on to another
preference-elicitation technique, and to obtain ordinal preferences for health states
(Torrance et al., 2001).
Because of their ease of use, rating scales are used as a proxy for other preference
elicitation methods (O'Leary et al., 1995), and are best used in conjunction with other
methods. Adopting such an approach, rating scales can be used to obtain ordinal
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preferences for those health states in a study that are not valued by the SG or TTO
techniques. The values obtained in a rating scale have been converted to SG or TTO
utility values using an appropriate conversion formula (Schackman et al., 2002; Mrus et
al., 2003; Raat, Bonsel, Hoogeveen, & Essink-Bot, 2004). Noting that a standard
conversion equation that could be applied universally has evaded researchers thus far,
Torrance (2001) recommends that such equations be developed specific to each study so
that the conversion is appropriate to the study context. However, there are reports that
relationships between SG and rating scale scores are not stable (Robinson et al., 2001).
The main advantage of the SG method is that it provides utility estimates using a
method that is consistent with von Neumann and Morgenstern’s (vN-M) expected utility
theory (von Neumann, Morgenstern, & Rubinstein, 2004). Standard Gamble is the one
utility elicitation method that has a well-developed basis in utility theory, and is hence
considered as a gold-standard against which other methods are compared (Torrance,
1976b). Feeny (2002b) has summarized the reasons for the widespread use of the vN-M
theory as the foundation of health utility assessments: one, it makes only simple
assumptions to provide a scale with interval-scale properties; and two, vN-M utilities deal
with risk which naturally exists in the context of healthcare decision-making.
The virtues of the SG method do come at a cost. It is better administered in an
interview format with well-trained interviewers and effective props, which makes it more
expensive than the rating technique. The technique, with an iterative process of changing
probabilities, is more cognitively demanding than the rating scale and other techniques
(Drummond, O'Brien, Stoddart, & Torrance, 1997b; Furlong et al., 1990). Further, the
relative risk associated between sets of probabilities presented in the SG may not be
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understood by respondents as expected by researchers. Standard Gamble is affected by
risk-aversion – a respondent who is risk averse does accept the trade-offs no matter what
the probabilities be. Risk aversion leads to an upward bias in SG utilities (Bleichrodt,
2002; van Osch, Wakker, van den Hout, & Stiggelbout, 2004). Also, respondents may
find the risk of death to be unacceptable whatever its probability, especially in cases of
acute conditions where a full recovery is expected. Naturally, for such conditions,
respondents generally are not expected to take any risk of death.
Another bias affecting SG scores is due to loss-aversion. This bias is introduced
when respondents are more sensitive to losses than to gains (Tversky & Kahneman,
1992), leading to losses weighing more heavily in decisions and causing an upward bias
to SG utilities (van Osch et al., 2004). van Osch and colleagues (2004) also point out that
people tend to over-weight small probabilities and under-weight large probabilities. This
leads to an upward bias in SG utilities (Bleichrodt, 2002).
As compared to the SG, a TTO may be less cognitively demanding and more
comprehensible to a respondent. The utilities may be easier to obtain using the TTO than
SG because the TTO does not require an iterative process with changing probabilities.
However, like with the SG, the method may have problems for acute conditions where a
person might not be willing to give up any life expectancy in exchange for an immediate
return to perfect health. The TTO approach is based on the assumptions that the utility
time is linear (Torrance, Thomas, & Sackett, 1972; Stiggelbout et al., 1995), which has
been stated as untrue (Pliskin, Shepard, & Weinstein, 1980), and that the perception of
the severity of illness is independent of the time spent in this state (Rosser & Kind, 1978).
In addition, the trade-off concept is difficult for many people to understand.
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Overweighting of traded future years in TTO leads to a downward bias in TTO utlities
(van Osch et al., 2004). These issues do not affect SG measurements. In the TTO, lossaversion causes people to be more reluctant to give up life-years, and hence causes an
upward bias into measurements (van Osch et al., 2004). Probability weighting is not an
issue with the TTO since they do not play a role in TTO measurements. Bleichrodt
(2002) contends that since SG is mainly susceptible to upward bias and TTO to both
upward and lower biases, TTO is hence preferable overall.

2.3.3

Indirect Approaches
Direct measurement of preferences for health states can be a very resource and

time consuming, complex task. An alternate approach bypasses the direct measurement
task by indirectly obtain preferences using PBMH. All these PBMH contain a healthstate classification system, covering attributes or domains that describe aspects of health
that are influenced by disease and treatments, or both. The attributes and levels of
severity together form the instrument’s health state classification system. The developers
of the PBMH have already established a valuation algorithm that provides utilities for
each multi-attribute health state that is conceivable in the health-state classification
system. These utilities have been typically obtained by using one of the direct techniques
discussed earlier: the rating scale, the SG or the TTO.
The PBMH indirectly provide utilities in two steps. In the first step, the
respondent self-rates the extent of impairment, if any, in each attribute using the scales
provided in the PBMH. This is the only measurement to be undertaken, on the basis of
which the respondents is assigned to a multi-attribute health state. In the second stage,
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the pre-scored valuation algorithm is applied to provide utilities for the respondent’s selfreported current health state.
The most popular PBMH are the Quality of Well-Being (QWB) scale, the
EuroQoL-5D (EQ-5D), the Health Utilities Index (HUI), and the SF-6D. Following is a
description of these instruments in terms of their classification systems and the utility
elicitation technique employed in the formulation of their valuation algorithms:
The QWB (Kaplan & Anderson, 1988; Kaplan & Anderson, 1996) consists of
four attributes: mobility, physical activity, social activity, and symptom-problem
complex, represented by 38 items. This system describes 1,170 health states. The
scoring function of the QWB uses category scaling measurements, and hence provides
values and not utilities. The EQ-5D (Brooks, 1996; Kind, 1996) includes five attributes
represented by one item each : mobility, self-care, usual activities, pain/discomfort,
anxiety/depression. Each attribute has three levels; thus the descriptive system of the
EQ-5D can define 243 health states. Both the VAS and TTO have been separately used
to obtain scoring functions for the EQ-5D. The TTO was employed in a U.K. community
sample (Dolan, Gudex, Kind, & Williams, 1995; Dolan, Gudex, Kind, & Williams,
1996). Recently, a scoring function was formulated for the U.S. population as well
(Shaw, Johnson, & Coons, 2005).
The HUI (Feeny, Furlong, Boyle, & Torrance, 1995) is a family of three
measures: the HUI Mark 1 (HUI-1), the HUI Mark 2 (HUI-2), and the HUI Mark 3 (HUI3). The original HUI (Torrance, Boyle, & Horwood, 1982; Boyle, Torrance, Sinclair, &
Horwood, 1983) was based in part on the QWB, and has been modified since then. The
six attributes covered in the HUI 2 include sensory, mobility, emotion, cognitive, self-
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care, pain, and fertility, with levels of severity ranging between three and five (Torrance
et al., 1996). With 30 items in all, the HUI 2 system describes 24,000 heath states. The
HUI 3 system is closely based on the HUI 2, dropping out the application specific
attribute – fertility, and adding sensory attributes. The eight attributes now covered in the
HUI 3 are vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain,
with levels of severity ranging between five and six (Feeny et al., 2002). With 45 items
in all, the HUI 3 system describes 972,000 heath states. The HUI 2 and HUI 3 scoring
functions were obtained using the VAS transformed into SG using a power conversion
algorithm (Furlong et al., 1998).
The SF-6D (Brazier et al., 2002; Brazier & Roberts, 2004b) consists of six
attributes which include physical functioning, role limitation, social functioning, pain,
energy, and mental health, with levels of severity ranging between four and six. With 36
items in all, the SF-6D system describes 18,000 heath states. The SG was used in the
development of the scoring function of the SF-6D.
All the PBMH described above are generic in content that differ mainly in the
types of attributes and the degrees of impairment included in their respective health state
classification systems. One important difference is in the scope of attributes that they
include. In the development of the HUI, a ‘beneath of the skin’ approach was chosen,
that confines the descriptions of items in the measure to individuals. The HUI 2 and HUI
3 do not include a social dimension or any health condition incorporating social
interaction or role definition (Feeny et al., 1995; Torrance, Furlong, Feeny, & Boyle,
1995). This approach eliminates problems arising due to complex environmental factors
(Gold et al., 1996a) that may often be difficult to measure. In the development of the
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QWB, the EQ-5D, and the SF-6D on the other hand, the ‘out of the skin’ approach was
employed. This approach recognizes that aspects of an individual’s role functioning and
social activities do influence individuals performing a valuation task (Gold et al., 1996a;
Brazier, 2005), as this enables them to better understand scenarios presented to them.

2.4

Source of Utilities
The methods used to obtain utilities have been discussed in a preceding section.

Sometimes, researchers may not be able to perform such assessments, and hence obtain
utilities simply by taking the opinion of clinicians or other experts instead. The primary
justification for using clinicians or other healthcare professionals is that they are
sufficiently knowledgeable about the health states and may be more accessible, and thus
serve as reasonable proxies for patients.
The two main sources of respondents to the direct utility elicitation techniques or
the PBMH, however, are patients and the general community. A choice between the two
is important because significant differences in the utility estimate provided by these two
sources could lead to changes in the results of economic evaluations that use them. There
is no consensus on whether community members value a given health state the same as
patients who are experiencing that health state. Some studies have shown that patientbased and community-based utilities do not differ (Llewellyn-Thomas et al., 1984;
Jenkinson et al., 1997), while some others have shown otherwise (Furlong et al., 1990;
Gabriel et al., 1999; Postulart & Adang, 2000).
Since patients have directly experienced a health state, one view is that they can
better assess its effect on their life and express a true preference. Thus studies of new
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therapies are most often conducted from this perspective (Torrance et al., 1982). On the
other hand, members of the community may provide more objective evaluations without
any bias. Another point of view is that utilities should be obtained from the community
as decisions pertinent to public policy should be based on the general population that
ultimately incurs the cost of resource allocation decisions (Drummond et al., 1997b;
Dolan, 1999).

2.5

Disease-Specific Utilities Using PBMH
In the assessment of HRQoL, two broad categories of instruments have emerged –

generic or global, and disease-specific measures. Generic HRQoL scales are designed to
be used with any population regardless of the specific disease, and hence allow
comparison across diseases. However, the domains or attributes contained in generic
measures may have little or no relevance to a specific patient group or disease entity in
which they are intended to be used. Generic measures may also lack the items that are
necessary to gain a complete understanding of patients’ health conditions. Generic
measures offer the benefit of being applicable across disease categories, but this can be a
disadvantage when research questions pertaining to specific diseases are being studied.
Disease-specific instruments, on the other hand, focus on specific problems posed
by a particular illness and reflect the restrictions associated with specific disease
conditions. They can include aspects of health considered by patients and clinicians to be
of greatest importance. The targeted focus of disease-specific instruments has the
potential to make them more responsive to changes in health as a result of improvement
in disease prognosis.
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These arguments comparing the content of instruments apply to the measurement
of health state preferences using generic PBMH as well. Applicable across many
different disease areas, they are much easier to administer than obtaining preferences
using preference elicitation interviews, and also can be mailed to respondents. However,
like generic measures of HRQoL, a general limitation of generic PBMH is that they may
lack sensitivity to important differences in particular diseases (Gold et al., 1996a). The
validity of the preference weights derived from such measures thus depends upon the
coverage of issues important in a particular disease in them, as well as the underlying
utility elicitation technique employed.
Most existing disease-specific measures are profile-based and are descriptive in
nature, without any assessment of preferences or utilities for health states they describe.
There is increasing interest in estimating preference weights for disease-specific
measures with the twin objectives of utilizing their disease-specificity, and to enhance
their use in economic evaluations. Two distinct approaches have been used in this
regard: mapping of disease-specific measures on to PBMH, and developing diseasespecific PBMH. These two approaches are described in the following sections.

2.5.1

Mapping Disease-specific Measures on to PBMH
Disease-specific measures can be mapped on to existing generic PBMH to

overcome the lack of preference-weights in the former. The ‘mapping’ process is
generally a statistical approach, using regression models, to predict utility scores from
scores on a disease-specific measure. In most of the early attempts in this direction,
general populations have been considered rather than disease-specific groups.
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One variant of this approach involves identifying individual items on health status
questionnaires or surveys, such as those from publicly available national databases,
which may be considered similar to items on existing generic PBMH. Hence, the
simultaneous availability of PBMH is not warranted. For example, identical data
elements from the National Health and Nutrition Examination Survey (NHANES) were
matched on the HUI-1 index (Gold, Franks, & Erickson, 1996). In other studies, data
from the National Medical Expenditure Survey (NMES) were matched on to two multiattribute preference-based measures, the HUI-1 (Rizzo, Pashko, Friedkin, Mullahy, &
Sindelar, 1998), and the EQ-5D (Rizzo & Sindelar, 1999).
The rationale for these studies was to obtain interval level utility values without
having to develop scales that provide such assessments. These studies demonstrated that
items from the NHANES and the NMES could be grouped and linked in such a way as to
obtain health state utility values. The usefulness of this approach, however, depends
upon the extent to which items on the surveys can be suitably matched on to items on
existing PBMH.
Another variant of this approach requires the simultaneous availability of scores
on both the PBMH as well as the disease-specific HRQoL measure in one dataset. A
regression equation or algorithm that can predict utility scores based on the scores on the
HRQoL measure is then estimated. It is however desirable that the algorithm be obtained
from a dataset with a population comparable to the one in which the predicted utilities
will be employed. The usefulness of this approach lies in that such an algorithm can be
used to perform economic evaluations in the context of other studies where only scores
on a descriptive measure is available (Brazier, Deverill, Green, Harper, & Booth, 1999;
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Tsuchiya, Brazier, McColl, & Parkin, 2002). Possible reasons for the non-inclusion of
PBMH in clinical studies range from the desire to limit patient burden to resource
constraints.
In one of the earliest studies using this approach, an empirical equation allowing
prediction of the utility scores on the QWB from HRQoL scores using the SF-36 was
formulated (Fryback, Lawrence, Martin, Klein, & Klein, 1997) from data in a
community-based study. More recent studies have developed mapping algorithms to
estimate EQ-5D index scores from the SF-12 in nationally representative US populations
(Sullivan & Ghushchyan, 2006; Franks, Lubetkin, Gold, Tancredi, & Jia, 2004) using
preferences originally obtained from a community sample in the UK population (Dolan,
1997). A similar mapping study involving the SF-12 (Sullivan et al., 2006) was
performed using EQ-5D scores derived from preference weights for the U.S. population
(Shaw et al., 2005). As can seen from these studies, utility weights were obtained for
generic HRQoL measures.
Similar conversion algorithms have been estimated involving disease-specific
descriptive measures. In a community-based study involving patients participating in a
weight-loss program, the Impact of Weight on QoL-lite (IWQOL-lite), an obesityspecific HRQoL measure was mapped on to the SF-6D (Brazier, Kolotkin, Crosby, &
Williams, 2004a). In another study, the Asthma Quality of Life Questionnaire (AQLQ)
was mapped on to the EQ-5D (Tsuchiya et al., 2002). Both studies reported that it was
possible to produce robust algorithms that predicted preference scores based on the
generic preference measures used in those studies.
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However, this may not be the best available solution to the problem of conducting
economic evaluations in the absence of preference weights for health states. This is
because the preference weights obtained in this manner are limited to the range of the
preference weights of the original generic PBMH. There may be aspects of the condition
captured by the disease-specific measure that may not be covered by the generic multiattribute measure and vice versa (Tsuchiya et al., 2002). The formulation of the two
types of measures, in terms of the extent to which they address disease-specific issues,
can explain these differences. If the spectrum of coverage of these two types of
instruments can be considered to be different, it is likely that important dimensions of
health may not be valued appropriately (Brazier, 2005).
Brazier (2005) explains two additional assumptions made under this approach that items representing attributes included in the instruments all have the same
importance, and that equal importance is accorded to the intervals included in rating
scales of the instruments. Since the extent of convergence between the two measures in a
mapping exercise will depend on the type of instruments used and the condition being
considered, Brazier and colleagues (2004a) argue that the ultimate utility of this approach
is influenced by the degree of this overlap.

2.5.2

Developing Disease-specific PBMH
Mapping exercises, such as those discussed in the previous section, have been

described as a second best option compared to directly obtaining utilities using
preference-weighted instruments (Tsuchiya et al., 2002; Brazier, Roberts, Platts, &
Zoellner, 2005). This suggestion excludes the option of direct elicitation of utilities using
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techniques like rating scales, standard gamble, and time-trade off because these
techniques are time-intensive and expensive. While mapping exercises seem easier to
perform in comparison, Brazier and Fitzpatrick (2002) caution that the validity of the
approach in estimating utility values for disease conditions will depend on the extent to
which the preference-weighted measure used provides coverage of issues regarding the
disease and its treatment. On the basis of these inputs, one can infer that in order to
obtain utility values that reflect disease-specificity, and that too in a timely manner,
disease-specific preference-weighted instruments should be used.
The process of developing new disease-specific measures, like any other measure
in any field of research, is iterative. It involves a combination of theory, primary data
collection, and statistical analyses. Theory helps in the formulation of a framework to
describe the construct being measured. In the development of disease-specific measures,
it is necessary to build a pool of items that reflect the areas of impairment caused by the
disease (Juniper, Guyatt, & Jaeschke, 1996). In addition to interviewing patients,
conducting focus groups, and consulting experts, the process can include a review of
literatures and existing instruments (Juniper et al., 1996; Juniper, Guyatt, Streiner, &
King, 1997). Primary data collection at the pilot stage helps instrument developers to
identify aspects of the instrument that may need modifications. This sets the stage for
another round of primary data collection from a larger sample that lends itself to robust
statistical analyses, which may include the testing of reliability, validity, and
responsiveness of the instrument. Needless to say, the process of developing a new
disease-specific PBMH is time-consuming.
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2.5.3

Disease-specific PBMH Based on Profile Measures
Feeny (2002a) has summarized the two key components in constructing

preference-based measures: 1) designing a health-state classification system that
describes health states composed of attributes or domains that influence health; and 2)
estimating a valuation function that provides numerical values of utility for all health
states that can be described by the health-state classification system.
Profile-based HRQoL measures are descriptive in nature, as discussed previously.
Many of them contain multiple domains, with several items measuring the construct
represented by each domain. Such descriptive systems may be very complex and it may
be very challenging to design valuation functions for them (Brazier et al., 2002).
However, it may be appropriate and feasible to develop preference-based measures that
are based on the descriptive system offered by existing valid and reliable profile-based
measures. This avoids the need to perform extensive research on content identification
and item pool composition, thereby aiding the faster completion of component one
described above. In a review of methods used to shorten existing HRQoL instruments,
Coste and colleagues (1997) discuss these as key reasons considered by researchers who
developed shortened versions of existing instruments. This approach was used to
generate the classification system for a generic, preference-based measure, later called
the SF-6D, from a widely used measure of HRQoL, the SF-36 (Brazier, Usherwood,
Harper, & Thomas, 1998; Brazier et al., 2002), and later from the SF-12 (Brazier et al.,
2004b) as well. Similarly, a menopause-specific instrument, the QualiPause Inventory
(QPI) was used to develop a preference-based measure for the condition (Brazier et al.,
2005).
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Traditional approaches of identifying item content more applicable to diseasespecific areas continue to be used for the purpose of designing disease-specific PBMH.
Contemporaneous to the SF-6D was the development of the Asthma Symptom Utility
Index (ASUI) (Revicki et al., 1998a) and the Rhinitis Symptom Utility Index (RSUI)
(Revicki et al., 1998b). More recently, preference-based instruments have been
developed for use in conditions such as stroke (Poissant, Mayo, Wood-Dauphinee, &
Clarke, 2003) and erectile dysfunction (Torrance et al., 2004; Casey, Tarride, Keresteci,
& Torrance, 2006).
Based on the existing literature, the process involved in directly eliciting
preference weights for any condition-specific profile-based measure can be summarized
as consisting of the following basic steps:
1. The first step in the process involves making suitable modifications to an existing
measure to obtain a more compact disease-specific health state classification
system, on the lines of those found in generic PBMH;
2. In the next, a sample of health states derived from such systems are then valued
using one of the direct preference elicitation techniques like rating scale, standard
gamble or time-trade off; and
3. Finally, these preference weights are modeled using statistical techniques to
produce a valuation function that can generate preference weights or utilities for
all states described the disease-specific health state classification system.
Steps 2 and 3 together constitute the process of modeling a valuation function for the
PBMH. Once a valuation function is made available, the disease-specific preference
measure can even be administered, in the form of interviews or even as a survey, to
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obtain preference weights for the health state of respondents. The following sections
discuss these steps in detail.

2.6

Step One: Designing a Health State Classification System

2.6.1

Theories in Measurement
O’Connor (2004) summarizes two different views measurement-related views that

influence the development of patient-reported outcomes instruments. One view contends
that most psychological and behavioral constructs, although ordinal, can be considered to
be interval in nature for the purpose of statistical assessments. An alternate view
emphasizes the need for psychological constructs to possess interval properties in order
for assessments to be deemed scientific. It has been suggested that the main reason that
impedes the acceptance of the analysis of human behavior as a science is the perceived
lack of need among researchers in ensuring that these instruments possess interval
properties (Wright, 1999; O'Connor, 2004). These diverse viewpoints have spawned
comparisons between theories that they inspire – Classical test theory (CTT) and Modern
test theory (MTT).

2.6.1.1 Classical Test Theory
Classical Test Theory has been used as the foundation for the development of
instruments for several decades now. The theory does not have a single founder, and
neither was it explicitly laid out with a set of principles. Rather, CTT refers to a broad
range of measurement principles that have been used in the past, and that guided
instrument development. Over the years, several instruments have been developed and
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improvised using the principles of CTT, and have performed well under existing
standards of assessments.
However, as in any other field, advancements in the field of measurement of
behavior point to some drawbacks to CTTs. One issue pertains to the assumption that it
is possible to infer a person’s standing on the attribute being measured by summing
responses to individual items in an instrument, and calculating a total score. This is a
type of additive scaling model that does not take item hierarchy into account (Nunnally &
Bernstein, 1994). Inherent in model is the erroneous assumption that each item on that
instrument contributes equally to the total score (Prieto, Thorsen, & Juul, 2005). This
approach to additivity is said to be a direct derivation from CTT (Crocker & Algina,
1986; Nunnally et al., 1994).
It has been suggested that some of the item performance feature used in CTT like
item difficulty, item discrimination as well as reliability are sample-dependent. Item
difficulty in CTT can be explained as the proportion of individuals who endorse or pass
an item, or give a correct response (which refers to more of the attribute) to a particular
item (Kline, 2005). Thus, items with high item difficulty are easy items and vice-versa.
Item discrimination in CTT indicates the capacity of an item to discriminate between
high and low scorers in the attribute that the instrument measures. Hence, CTT
estimators are not generalizable across populations. One of the biggest limitations of
CTT is that it does not provide measures with interval properties, but assumes that they
can be treated that way for statistical purposes.
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2.6.1.2 Modern Test Theory
An alternative scaling approach to the prevailing ideas of the CTT was proposed
by the Danish mathematician Georg Rasch (Rasch, 1960), leading to the birth of a new
measurement and ideas that are now termed as MTT, which is anchored around Item
Response Theory (IRT) models. The Rasch model, also known as the one-parameter
logistic model (1PL), is one of the simplest of IRT models. The model works under the
condition of unidimensionality, i.e. it is applied to the measurement of a single construct
or dimension (O'Connor, 2004). Rasch analysis is a probabilistic model of analysis
based on IRT (Rasch, 1960) in which a response to each item in is defined as the result
of a linear probabilistic interaction of a person's ‘ability’ and a question's ‘difficulty’.
Hence, according to the model, individual items are considered more likely to be
endorsed (or rated higher) by subjects at a given level of the construct that is being
measured (like HRQoL), while other items are considered more likely to be rated lower.
The terms ‘ability’ and ‘difficulty’ come from the educational field, where IRT was first
applied.
Summarizing these features, Fisk and Doble (2002) point out that in the Rasch
model, the ordering of items is not determined a priori by such means as ‘expert’ opinion
but is dictated by empirical data obtained from respondents’ answers. Using such
criteria, the Rasch model places items hierarchically and provides the following fit
statistics (O'Connor, 2004): item fit, that indicates the extent to which the responses,
across persons, fit a particular item; person fit, that indicates the of fit of the responses
by a person, across items; and the overall fit of the data to the model. When using the
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Rasch model, the emphasis is on the fit of the data to the unidimensional model, not of
the model to the data (O'Connor, 2004).
O’Connor (2004) summarizes the advantages that the Rasch model offers over
CTT in the measurement of patient-reported outcomes:
1.

Both the classical estimates of difficulty and discrimination are sample-

dependent. In contrast, one of the unique features of Rasch model is that it provides
sample-free measurement and test-free measurement;
2.

The main advantage of adopting this approach is that it recognizes that ignoring

interval properties leads to poor items. When data fit the Rasch model, it transforms item
data from ordinal scores into interval level measurement with the logit (log odds unit) as
the unit of measurement based on empirical evidence; and
3.

Rasch models are more robust to missing data, in comparison to CTT where data

have to either be discarded or imputation employed (Bond & Fox, 2001).

2.6.1.3 Using Theories of Measurement in Instrument Design and Modification
The basic structure of generic PBMH has been discussed in an earlier section.
Existing PBMH vary in their coverage of attributes, and hence the number of health
states they represent. Structurally, profile-based measures are similar, in that they
contain items representing various domains that are important in the measurement of the
overall construct they measure, like HRQoL. However, they are typically longer than
PBMH. The items in a profile-based measure and the levels of those items together can
generate descriptive systems, like those in PBMH, but the number of health states would
be too large. Consequentially, there would be problems in valuing such a large number
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of health states. This was an issue that Brazier and colleagues (2002) reported in the
process of developing a generic PBMH, the SF-6D, from a generic measure of HRQoL,
the SF-36. The approach chosen was to reduce the number of items of the parent HRQoL
instrument without loss of descriptive information.
Efforts to produce shorter HRQoL instruments, in order to reduce respondent
burden, have typically involved reducing existing instruments. This has mostly been
done using various statistical methods available for this purpose, including correlations
between item and total scores, Cronbach’s alpha per scale, stepwise regression, and factor
analysis (FA) (Coste, Guillemin, Pouchot, & Fermanian, 1997); most of these are based
on CTT. However, there is lack of standardization in the methodology of shortening
existing HRQoL instruments (Coste et al., 1997; Prieto, Alonso, & Lamarca, 2003).
Among these techniques, FA has been widely used in the development and
validation of HRQoL instruments. One of the objectives of applying the technique to
HRQoL instruments is for construct validation (Fayers & Machin, 2000). When little is
known about the structure of an instrument, FA helps identify the existence of latent
constructs, called factors, as well as the associations of individual items to those factors.
When there is enough available information on the structure of HRQoL instruments, FA
helps confirm the number of latent factors and to confirm the items in the instrument that
are better associated, or that contribute to, the measurement of that factor (Fayers et al.,
2000). Since FA is a parametric method requiring interval level data, doubts have been
raised about the use of this technique with measures that do not have interval-level
properties (Doward, Meads, & Thorsen, 2004).
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Rasch analysis, introduced in the previous section as an alternative scaling
approach, can also be used as a reduction procedure (Rasch, 1960). When used with
HRQoL instruments, categorical items are mapped on to a continuous latent scale which
can be said to be a continuous measure of HRQoL. The use of the technique for the
purpose of item reduction of existing HRQoL measures is growing. Rasch analysis has
been recommended as a preferred technique in reducing redundant items in an HRQoL
instrument (Conrad & Smith, Jr., 2004; Tennant, McKenna, & Hagell, 2004). Some
examples of instruments that have been shortened using the technique are the Nottingham
Health Profile (Prieto, Alonso, Lamarca, & Wright, 1998), the Fatigue Impact Scale
(Fisk & Doble, 2002), the Asthma Quality of Life Questionnaire (Young, Yang, Brazier,
& Tsuchiya, 2005), and a dermatology-specific index called Skindex-29 (Nijsten,
Sampogna, Chren, & Abeni, 2006).
A couple of studies have provided some useful insight by comparing the Rasch
model and the CTT approach in reducing HRQoL instruments. In one study using data
on the Nottingham Health Profile, the two shortened versions using the two different
approaches were found to be comparable in measurement properties to the original
instrument but they well differed in the items chosen from the original instrument (Prieto
et al., 2003). Another study using Impact of Psoriasis Questionnaire data reported similar
results with regards to item selection, but suggested the use of the Rasch-shortened
version largely due to its unidimensionality and resultant ability to produce an outcome
measure in a single numeric (Nijsten, Unaeze, & Stern, 2006).
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2.6.2

Patient-Reported Outcomes of Diabetes and its Management
Type 1 and Type 2 diabetes are chronic illnesses that can influence patient-

reported outcomes because the treatments are burdensome and the complications can be
debilitating and/or life-threatening. For those with diabetes, the disease and the demands
of its day-to-day management can be very challenging. Patients have to deal with their
diabetes almost every instant of their life and have to make continuous decisions that
interfere with living a normal life. The management of diabetes itself imposes
considerable demands on patients and their families, and affects patients both physically
and psychologically. Patients with diabetes may feel overwhelmed by the management of
the disease. Apart from the emotional and social burdens this may cause, they face the
acute physical distresses of hypoglycemia or hyperglycemia and chronic physical distress
of diabetes-related complications. Thus, diabetes has major psychosocial implications
and it influences self-management behavior in terms of diminished self-care, leading to
worsened glycemic control in the long run.
Satisfactory diabetes control can be achieved when this interdependence between
physical and psychological well being is addressed (Eiser & Tooke, 1993). In this
context, humanistic assessments, using validated and reliable instruments of health status
(or HRQoL), QoL, and other patient-reported outcomes, can play a role in predicting
individuals’ capacities to manage their diabetes and stay healthy in the long run.
Preference-based measures of health additionally provide the necessary metric to conduct
the economic evaluations of diabetes interventions. Polonsky’s (2000) suggestions can
be a useful source of guidance in determining the classification for a diabetes-specific
PBMH. The following three discussions deliberate on the impact of diabetes on physical,
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psychological and social functioning, and list Polonsky’s suggestions on how best to
measure these outcomes from the perspective of an individual with diabetes.

Impact of Diabetes on Physical Functioning
Diabetes can negatively affect physical well-being in three major ways. The most
important factor is the development of long-term complications like vision loss, kidney
damage, peripheral neuropathy resulting in chronic pain, amputation, and/or difficulty
walking. Other complications include sexual dysfunction, autonomic neuropathy
problems, and acute conditions like ketoacidosis. The Pittsburgh Epidemiology of
Diabetes Complications Study showed that patients with macrovascular disease or
nephropathy reported significantly poorer QoL compared with those who were free from
all complications, and that QoL significantly deteriorated according to the presence of
multiple complications (Lloyd, Matthews, Wing, & Orchard, 1992; Lloyd, Wing,
Orchard, & Becker, 1993).
The second factor is short-term complications and physical symptoms. Elevated
blood glucose levels may lead to increased fatigue, sleep problems, and other associated
problems. Tight glycemic control may lead to unwanted weight gain, hypoglycemia,
and/or loss of hypoglycemic warning signs. The third major factor is the lifestyle
changes resulting from the demands of the diabetes regimen.
Polonsky (2000) suggests that to assess the impact of diabetes on physical
functioning most effectively, evaluation should focus on a patient's perceived distress due
to diabetes-specific symptoms as well as the perceived loss of physical function,
interference with common activities and loss of independence due to diabetes.
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Impact of Diabetes on Psychological Functioning
Diabetes care can have a short-term and long-term impact on mood of patients.
Frustration can emerge out of the fact that the disease may not seem to respond in spite of
sincere efforts by patients. Cycles of elevated blood glucose levels and hypoglycemic
episodes can be exhausting, and can worsen already dampened spirits. Depression is not
generally listed as a complication of diabetes, but is widely prevalent in patients with
diabetes. Lloyd and colleagues (Lloyd et al., 1992) reported greater depressive
symptoms in patients with macrovascular disease; greater number of complications were
found related to higher depression symptom scores. There is some suggestion that the
stress of depression may lead to neglect of diabetes care. Polonsky (2000) suggests that
to assess this dimension, evaluation should focus on a patient’s perceived emotional
distress due to diabetes-related symptoms, self-care, and broader diabetes issues.

Impact of Diabetes on Social Functioning
The management of diabetes itself poses many challenges to a patient, as this may
necessitate changes in daily habits in order to manage the illness most effectively. For
instance, some patients are embarrassed to check their blood glucose or inject insulin in
front of others. For some, the requirement of meal planning may affect food choices at
social events that may be different from family/friend preferences. Thus, a patient with
diabetes may not receive all the cooperation from family and friends in social settings, be
it home or outside of home. Polonsky (2000) suggests that to assess this dimension,
evaluation should focus on a patient's perceived emotional distress due to diabetes-related
social situations.
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2.6.3

The Audit of Diabetes Dependent Quality of Life
Among diabetes-specific QoL measures, the Audit of Diabetes Dependent Quality

of Life (ADDQoL) is an individualized instrument designed to measure individuals’
perceptions of the impact of diabetes on their QoL (Bradley et al., 1999; Bradley &
Speight, 2002). The design of the ADDQoL is influenced by the development of the
Schedule for the Evaluation of Individual Quality of Life (SEIQoL), an interview-based
approach to QoL measurement (O'Boyle, McGee, Hickey, O'Malley, & Joyce, 1992).
The SEIQoL method involved asking the respondents to generate domains of life that are
important to them, evaluate how good or bad each aspect was currently felt to be, and
indicate the importance of each for their own QoL. This approach was adapted to address
diabetes-specific issues and presented in a questionnaire format, resulting in the creation
of the ADDQoL. The last published version of ADDQoL is a 18-item instrument that
presents a comprehensive list of 18 life domains that diabetes might affect (Table 1).
Two additional items report estimates of overall quality of life, comparing life with and
without diabetes.
The ADDQoL evaluates diabetes-specific QoL from an attributional perspective,
i.e. how diabetes may be perceived as interfering with well-being. In contrast, the
majority of the other diabetes-specific instruments assess QoL from an intrinsic
perspective, i.e. how the different aspects of diabetes may be perceived as burdensome.
Rather than asking about the degree to which problems associated with diabetes are
occurring, the ADDQoL asks patients to imagine how life might be different without
diabetes and compares it to their current QoL with diabetes. This is a more complex task,
one step removed from direct questions about diabetes-specific quality of life (Polonsky,
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2000). One advantage of this approach is that it is unbiased in that it allows respondents
to indicate how diabetes may be having a positive effect in certain domains.
In answering the ADDQoL, respondents rate how diabetes impacts individual items on a
seven-point scale (the impact rating), as well as how important the individual items are to
their QoL on a four-point scale (the importance rating). A ‘not applicable’ (N/A) option
is provided for three items that may not be applicable to a given individual. Impact
ratings when multiplied by the respective importance ratings yield scores ranging from –9
to 9 for each item (Table 2). An average weighted impact score is derived by summing
the weighted impact scores for each item and dividing the number of applicable items.
Thus, the patient's 18 scores can then be arithmetically weighted, such that the total score
is more strongly influenced by those items that a patient has selected as being most
important. Bradley and colleagues (1999) assert that none of the other existing diabetesspecific QoL measures contain this property.
Patients and diabetes experts were involved in the generation and confirmation of
items (Bradley et al., 1999), contributing to face and content validity. Reliability for the
ADDQoL, using Cronbach’s alpha coefficient has been found to be in the range of 0.85
to 0.92 (Bradley et al., 1999; Sundaram et al., 2006). This property, along with the
results of the forced one-factor factor analysis, indicated the feasibility of combining the
weighted items into a single ADDQoL score (Bradley et al., 1999; Bradley et al., 2002).
As a measure of the construct validity of the measure, insulin-users generally reported
greater negative impact on the ADDQoL than non-users, and patients with diabetes
complications reported significantly greater negative impact of diabetes on QoL than did
those without complications (Bradley et al., 1999; Bradley et al., 2002). Recently,
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Sundaram and colleagues (2006) demonstrated the utility of the instrument in measuring
QoL in patients with Type 2 diabetes in the presence of conditions commonly co-morbid
to the disease. The instrument has been reported to be able to detect negative influence
of diabetes on QoL even as satisfaction with the treatment was high (Bradley et al.,
2002), and to detect significant changes in QoL over time due to the effects of a diabetes
educational intervention (The DAFNE Study Group, DAFNE Study Group, 2002).
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Table 1: Content of the ADDQoL

Item Number

Item Description

1

Working life

2

Family life

3

Social life

4

Sex life

5

Physical appearance

6

Physical activities

7

Holidays/ leisure

8

Ability to travel

9

Confidence in ability

10

Motivation

11

Society reaction

12

Worries about Future

13

Finances

14

Dependence

15

Living conditions

16

Freedom to eat

17

Enjoyment of food

18

Freedom to drink
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Table 2: Summary of the Scoring of the ADDQoL

Weighted ratings

=

[unweighted rating (-3 to +3)] x importance rating (0 to 3)
for each domain]
Unimportant domains score 0, regardless of magnitude of effect
of diabetes. Domains unaffected by diabetes score 0, regardless
of their importance for QoL. Any non-applicable domains are
not scored.

ADDQoL score

=

Sum of weighted ratings of applicable domains
N of applicable domains

Scores vary from:

-9 (maximum negative impact of diabetes)

to:

+9 (maximum positive impact of diabetes)

New Scoring of the ADDQoL (unpublished)

Weighted ratings

=

[unweighted rating (-3 to +1)] x importance rating (0 to 3)
for each domain]
Unimportant domains score 0, regardless of magnitude of effect
of diabetes. Domains unaffected by diabetes score 0, regardless
of their importance for QoL. Any non-applicable domains are
not scored.

ADDQoL score

=

Sum of weighted ratings of applicable domains
N of applicable domains

Scores vary from:

-9 (maximum negative impact of diabetes)

to:

+3 (maximum positive impact of diabetes)
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In separate reviews, the ADDQoL has been recommended for use in QoL
assessments in both Type 1 diabetes and Type 2 diabetes populations, and has been
described as a brief and recent instrument generated with patient input, with good
reliability, internal and external construct validity (Garratt et al., 2002; Wildes et al.,
2003). As an established diabetes-specific instrument with reported use in different
populations, the ADDQoL can be a suitable candidate to determine item content for a
proposed diabetes-specific PBMH.

2.7

Steps Two & Three: Modeling Health State Valuations
Once a health-state classification system has been described, the next task

involves incorporating stated preferences into it. One logical way to proceed would be to
list all the health states that can be described by the classification system and then obtain
preferences weights or utilities for those health states. However, the classification,
depending on the number of attributes or domains contained in them, may be large to the
extent that the valuations of all the health states it defines may be considered infeasible.
The total number of such health states will depend upon the number of attributes and the
level of severity assigned to each attribute. For example, the classification systems in the
EQ-5D, SF-6D, and the HUI-3 describe 243, 18,000, and 972,000 health states,
respectively. Valuing such a high number of health states, especially for the SF-6D and
the HUI-3 is a complex task. The approach used so far has been to elicit preferences only
for a sample of health states and then extrapolate them to all health states (Feeny et al.,
1995; Dolan, 1997; Brazier et al., 1998).
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There are two basic approaches to model health state valuations, although the
literature does not use standardized terminology for these approaches. Froberg & Kane
(1989) and Dolan (2000; 2002) refer to them as the decomposed versus the composite
approach, Feeny (2002b) uses the terms decomposed versus statistical methods of
interference, while Brazier and colleagues (2002) describe them as methods based on
multi-attribute theory versus econometric methods, respectively. For the purpose of
standardization, the terms decomposed and composite will be used henceforth. Both
approaches have been used in modeling health state valuations for existing preferencebased instruments, and according to Feeny(2002b), the two approaches are not mutually
exclusive.

2.7.1

Modeling Considerations
The following discussions will help better appreciate the difference between the

two modeling approaches.
First, it will be useful to revisit the content of preference instruments. These
instruments are made up of attributes or domains that describe aspects of health that are
influenced by disease and treatments, or both. Respondents are allowed to rate each
attribute on a rating scale that denotes the extent to which disease and treatments, or both,
influence that attribute. The attributes and levels of severity together form the
instrument’s health state descriptive system. Since the combinations of attributes and
severity levels give rise to several hundreds or thousands of health states, called
composite health states since they include all aspects of health described by the
instrument, it will be difficult to value them entirely.
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Second, the kind of interactions between attributes needs to be discussed. Three
such interactions are possible: no interactions, synergistic interactions, and antagonistic
interactions (Torrance et al., 1995; Furlong et al., 1998). When attributes are
complements of one another, the combined preference weights will always be more than
the sum of weights for each attribute alone. This is a synergistic preference interaction in
that the total is greater than the sum of effects of it parts. In other words, to enjoy one
attribute, you may also need to have the other attributes (Keeny & Raiffa, 1976; Keeny &
Raiffa, 1993). When attributes are substitutes for one another, the combined preference
weights will always be less than the sum of the weights for each level. This is an
antagonistic preference interaction in that the total is less than the sum of effects of it
parts. In other words, either attribute is good enough, since one substitutes the other
(Keeny et al., 1976; Keeny et al., 1993).
Third, it will also be helpful to define some functional forms governing the
relationship between attributes. Torrance and colleagues (1995) explain that one of the
following types of utility independence is necessary, as an additional assumption, to be
able to extend the traditional vN-M theory to multi-attribute outcomes that we come
across in healthcare applications:
1.

The additive functional form (also referred to as additive utility independence)

assumes attributes to be independent, permitting no interaction. This is the most
restrictive form (i.e. it makes the strongest assumption) in which preference weights for
each level of attributes are simply added to one another. In measurement terms, only the
preferences for the levels of individual attributes need to be considered, ignoring the
manner in which levels of different attributes are combined (Torrance et al., 1995).
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Hence, additive models are considered appropriate only if the interactions in preferences
among attributes are not important. Data from health status applications have generally
rejected this model due to this constraint (Furlong et al., 1998);
2.

In the multiplicative functional form (also referred to as mutual utility

independence), interactions between attributes are allowed but the interactions are forced
to be of the same kind (Furlong et al., 1998; Dolan, 2002). This functional form specifies
no interaction between preferences for levels on some attributes and fixed levels for other
attributes (Torrance et al., 1995). In other words, the interaction is limited in that it is the
same between all attributes and for all levels of each attribute (Furlong et al., 1998). The
multiplicative functional form is said to be the least complex among non-additive models
(Furlong et al., 1998); and
3.

The multilinear form (also referred to as first-order utility independence) specifies

no interaction between preferences for levels on any one attribute and fixed levels for the
other attributes (Torrance et al., 1995). This functional form is the least restrictive
functional form, allowing some pairs of attributes to be complements and other pairs to
be substitutes; in other words, it is the weakest form of utility independence (Torrance et
al., 1995). However, these are very complex models requiring too large number of
valuations (Furlong et al., 1998).
Details of the decomposed and composite approaches are discussed in the
forthcoming sections.
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2.7.2

The Composite Approach
In the composite approach, a subset of such composite health states is valued.

Related to this approach is the method of directly valuing a profile-based measure
(Brazier, 2005) in which the measure is administered along with a self-administered
valuation technique, like Lundberg and colleagues who used the TTO along with the SF12. When the profile-based score is regressed against the utility score derived from the
valuation technique, preference weights for the profile-based score can be obtained.
However, the drawback of this technique is that the utility scores can only be obtained for
health states that naturally exist in the population, which may exclude rare health states,
thereby impact the prediction capability of the regression model (Brazier, 2005).
Hence, the composite approach advocates the selection of composite health states
from the descriptive system by statistical design. One way to do this is by using an
orthogonal design for estimating an additive model (Brazier, 2005). The composite
approach was used in the estimation the EQ-5D (Dolan, 1997), the SF-6D (Brazier et al.,
2002) and in developing a menopause-specific preference-based index (Brazier et al.,
2005), among others. In the development of the menopause-specific index, for example,
a statistical program was used to generate an orthogonal array of health states that had to
be valued to fit an additive model. While the program selected 49 health states as
essential for the modeling valuation exercise, 47 more were randomly indicated to
enhance the number of degrees of freedom (Brazier et al., 2005). These many health
states had to be valued for the menopause-specific descriptive system that had seven
attributes and between three and five levels per attribute. In the SF-6D, with six
attributes that had between two and six levels per attribute, the number of health states
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selected was 249, of which 200 were randomly selected (Brazier et al., 2002). The
requirement will be greater for more complex descriptive systems.

2.7.3

The Decomposed approach
The ‘decomposed’ approach advocates valuing a health state at the level of its

constituent attributes, and modeling the values of individual attributes, by making
theoretically sound assumptions, to obtain preferences for the overall health state. In the
decomposed approach, each level within a particular attribute or domain from the health
state classification system is valued, keeping the levels of all other attributes constant.
This approach makes simple assumptions about the relationship between the attributes
(Dolan, 2002) that are consistent with the multi-attribute utility theory (MAUT) (Keeny
et al., 1976; Keeny et al., 1993). The MAUT is an extension of conventional utility
theory that can be applied to model preference scores for health states defined by multiattribute health status classification systems (Torrance et al., 1982; Torrance et al., 1995;
Torrance et al., 1996). The theory specifies that the preferences should be measured
within the axioms of the expected utility theory, and can be used to fit additive,
multiplicative and multilinear models depending on the type of preference interaction (or
independence) among attributes (Torrance et al., 1995). In the decomposed approach,
MAUT is used to determine the sample of states to be valued, with the most commonly
used specifications being the additive and multiplicative forms (Brazier, 2005).
The valuation process under MAUT comprises the following steps (Furlong et al.,
1998):
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1.

Single-attribute level states are valued. In a single-attribute level state for

attribute A, attribute A is at less than full function and all other attributes are set at their
best levels. If attribute A has five levels, then it has four single-attribute level states, each
containing varying levels of attribute A (except the best level) and all other attributes at
their best level;
2.

Corner states are valued. Corner states are those states where one attribute is at

the lowest level and all other attributes are their best level. There will be as many corner
states as there are attributes. The use of corner states makes the necessary MAUTstipulated calculations easier (explained in detail in section 3.3.2.2). A corner state is a
special case of a single-attribute level state where, using the previous example, A is at
level five (lowest level for A) and all other attributes are at their best level ;
3.

A group of methodological marker states are valued. These are a set of multi-

attribute determined by the model specification, and spanning a wide range of severity
across attributes; and
4.

Other anchor states valued are dead, perfect health (highest level of function on

all attributes) and pits (lowest level of function on all attributes).
The MAUT has been used in the development of two generic PBMH, the HUI-2
and the HUI-3 (Torrance et al., 1995). For the HUI-3 (having eight attributes and
between five and six function levels for each attribute), a total of 43 health states were
valued to fit a multiplicative functional form (Furlong et al., 1998; Feeny et al., 2002).
Two of the earliest disease-specific preference measures to be valued using MAUT were
the Asthma Symptom Utility Index (ASUI) (Revicki et al., 1998a) and the Rhinitis
Symptom Utility Index (RSUI) (Revicki et al., 1998b); both were based on a
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multiplicative model. In the valuation of the ASUI, consisting of four
symptoms/attributes, two dimensions (frequency and severity), and with a four point
rating scale for both these dimensions, a total of 23 health states were valued (Revicki et
al., 1998a). A same number of health states were valued for a similarly structured RSUI
(Revicki et al., 1998b).
The single-attribute level states, corner states, methodological marker states and
anchor states can be valued using any of the established preference elicitation techniques.
For the HUI 2 and the HUI 3, VAS rating scales were used to perform most of the
valuations which were then converted to SG utilities, which were also collected for a
sample of the health states in the study, using a power transformation curve (Furlong et
al., 1998; Torrance et al., 2001). This approach was also employed by Revicki and
colleagues in the estimation of valuation functions for the ASUI (1998a) and the RSUI
(1998b).

2.7.4

Choosing the Modeling Approach
An advantage of the composite approach is that it accounts for heterogeneity in

the data (Dolan, 2002) by using statistical modeling using random effects techniques or
by modeling mean health state values, as noted by Brazier (2005) citing methods used for
valuation in the EQ-5D (Dolan, 1997) and the SF-6D (Brazier et al., 2002). Few a priori
restrictions need to be placed on models using this approach (Dolan, 2002). Also, there is
no need to specify corner states, which may be difficult for respondents to comprehend
(Brazier, 2005). In general, the composite approach requires a large sample of health
states, as can be seen from the example cited above, because of which each respondent
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has to value more states. Brazier (2005) contends that with the composite approach, there
are difficulties in modeling interaction terms that require a random addition of health
states to be valued, as was discussed with the example of the menopause-specific
measure. Also, it is important that the health states selected be widely spread over the
valuation space so that many combinations of attributes and levels be included (Dolan,
2002).
One of the main advantages of the decomposed approach is that the complexity of
the valuation task is reduced (Dolan, 2002; Brazier, 2005). One of the reasons
contributing to the simplicity is that for the most part in the valuation exercise,
respondents have to consider only one attribute with impairment at a time rather than
several different attributes at the same time (Dolan, 2002). However, respondents may
also find it difficult to value combinations that they find infeasible – for example,
impairment in one attribute and the best levels in other attribute, especially if the
attributes are related (Dolan, 2002; Brazier, 2005). By making simplifying assumptions
about the relationships between attributes, this approach requires less number of
valuations, and can be used to model almost an infinite number of health states (Dolan,
2002). Additionally, these assumptions are consistent with a well-specified, theoretical
model like the MAUT (Dolan, 2002).
In both the decomposed and composite approaches, the required sample size for
the utility elicitation process will depend upon the extent of restrictions placed on the
models that are to be estimated. The less restrictive the models, the more states that will
have to be valued (Dolan, 2002). Considering that there needs to be a limit on the
number of health states that can be valued per subject to minimize respondent burden, a
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greater number of health states will require planning to recruit more respondents. Feeny
(2002b) recommends that while it is important to ascertain the suitability of the
functional form chosen, another desirable feature would be the requirement of fewer
number of health states to be valued to estimate the valuation function. Hence a
discussion on functional form is needed when designing valuations for a health state
descriptive system since this has a bearing on planning of available resources to perform
this task.
In choosing the right modeling approach, it is useful to discuss the relative merits
and demerits of the composite and the decomposed approaches, as discussed above.
Those who attach importance to an approach with a theoretical basis should choose the
decomposed approach, whereas the composite approach would be the choice when the
ability to estimate interactions between attributes is needed (Dolan, 2002). Another
important practical consideration is regarding the time and resources available to do the
modeling task. If there are limitations on the availability of subjects to perform the
valuations, then the method of choice is the decomposed approach. The composite
approach is suited to situations where the ratio of direct values (utilities for measured
health states) to estimated values (utilities estimated by modeling) is relatively high
(Dolan, 2002). Finally, available expertise to conduct the research may be a factor in
choosing one approach over the other – the composite approach requires use of
econometric-type modeling, while the decomposed approach requires an understanding
of the MAUT to health-services research.
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CHAPTER THREE: METHODOLOGY

3.1

Study Design and Population
For Objective One of the study, a combination of exploratory and secondary

research was used to develop a brief diabetes-specific health state classification system.
For Objectives Two and Three, cross-sectional designs using representative samples of
patients from their respective study populations were employed.
The study population of interest for the pilot surveys of the newly developed
diabetes-specific health state classification system that were part of Objective One, and
for the one-on-one utility elicitation interviews in Objective Two included patients with
diabetes, either Type 1 or Type 2, in a combination of outpatient and community settings
in North Central West Virginia (WV). Following are descriptions of the venues where
the study populations were recruited:
1.

The Diabetes Education Center at Ruby Memorial Hospital, Morgantown, WV, is

a department of West Virginia University Hospitals (WVUH) and is located in the
hospital building. The Center offers inpatient and outpatient diabetes education by
Certified Diabetes Educators (CDE), dietitians, and nurse educators. Outpatient
education is offered in both a one-on-one setting for those requesting it and group
classes. Group classes are offered for those patients with Type 2 diabetes and those
patients on insulin, whether they have Type 1 or Type 2 diabetes. The group classes
contain three to four sessions over a three to six-month time frame, with up to six
patients in each group. On an average, two new classes are held each month;
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2.

Milan Puskar Health Right Clinic is a free clinic located in downtown

Morgantown, WV. One of the services provided at the clinic is a diabetes education
program. Two 1-hour classes are held each Tuesday afternoon. There are 1 to 8
participants in each class with some participants being newly diagnosed with diabetes
and others having had the disease for several years. Patients new to the classes complete
a series of six sessions covering the basics of diabetes self-management. Following these
six classes, participants return once a month for continued education and support;
3.

Monongalia General Hospital is a general, acute care hospital located in

Morgantown, WV. Diabetes education programs at this site are conducted by CDEs,
dietitians and nurses. Two different kinds of education programs are offered. Classes for
those patients with Type 2 diabetes who do not use insulin are group classes, with four
sessions conducted over a three-month period. The classes for those patients who are on
insulin (whether they have Type 1 or Type 2 diabetes), are one-on-one classes with four
sessions conducted over a four-month period. On average, two new classes begin each
month, with eight to ten patients participating in each session;
4.

The Rite Aid Pharmacy #1982 is a community pharmacy located in Grafton, WV.

The Pharmacy Care Center located in the pharmacy currently utilizes the Rite Solutions
Diabetes Self-Management Education programs for diabetes education. The Grafton
Rite Aid employs five registered pharmacists, one dietician/CDE, and one registered
nurse/CDE to provide patient education. Diabetes education classes are offered both on
an individual basis and in groups of three to five, and target patients with Type 2
diabetes;
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5.

Other outpatient venues included the diabetes education programs conducted by

the Departments of Family Medicine and Endocrinology at WVU; and
6.

Diabetes Support Group meetings conducted in a community setting in

Morgantown, WV, and Fairmont, WV. These meetings are typically conducted once a
month by diabetes education centers operating in the local area at community settings
such as churches.
The study population of interest for Objective Three included patients with
diabetes receiving care at the outpatient clinics of the West Virginia University Diabetes
Institute (WVUDI). The WVUDI is a collaborative effort to standardize outpatient
diabetes education and care imparted by the department of Family Medicine and the
Physician Office Center’s Medical General Practice (MGP) and Endocrinology clinics.
While the department of Family Medicine sees patients of all ages including children, the
MGP and Endocrinology clinics provide care for patients older than 18 years of age. In a
mailed survey, patients receiving care at the WVUDI provided responses to the health
state classification system developed in Phase One.

3.2

Sampling Design and Patient Recruitment
Objective One commenced with the analysis of a dataset containing responses of

385 patients with Type 2 diabetes to the ADDQoL from previous research (Sundaram et
al., 2006) and consultations with experts. Different versions of the health state
classification system were then piloted on convenience samples of people with diabetes,
either Type 1 or Type 2, at the sites described above, in the form of self-administered
surveys.
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Objective Two of the study similarly utilized a convenience sample of patients
who responded to flyers posted in the outpatient settings and to handouts distributed in
the community settings described in the previous sections. In order to participate in the
study interviews, patients had to a) have diabetes, either Type 1 or Type 2, b) be at least
18 years of age, c) be without significant visual or hearing impairment, and d) be
conversant in written and spoken English. The flyers indicated a participant reward of
$15 for individuals meeting these criteria and completing the interviews.
Objective Three of the study included a survey mail-out to a convenience sample
of patients receiving care for their diabetes, either Type 1 or Type 2, at the outpatient
clinics of the WVUDI. An individual from the WVU Hospital’s Office of Medical Staff
Affairs (OMSA) served as a coordinator for identifying patients with diabetes from the
WVU hospital’s medical records, while maintaining compliance to the Health Insurance
Portability and Accountability Act (HIPAA). The physicians currently providing care to
these patients were contacted and informed about the purpose of this study. Letters of
endorsement were obtained, in which the respective physician’s signature was affixed to
a personalized letter addressed to individual patients on OMSA letterheads. The letters
indicated a participant reward of $5 for individuals completing the survey.
Separate approvals were obtained from the WVU Institutional Review Board to
conduct the pilot surveys (Objective One), the utility elicitation interviews (Objective
Two) and the survey mail-out (Objective Three).
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3.3

Data and Measures

3.3.1

Objective One
The methodology involved in the process of finalizing the diabetes health state

classification system is summarized in Figure 2. Objective One commenced with the use
of a dataset with ADDQoL responses from 385 patients with Type 2 Diabetes collected in
previous research (Sundaram et al., 2006). In answering the ADDQoL, respondents rated
the impact of their diabetes on (those applicable among) 18 items representing domains
of life, and also indicated how important they considered those domains. Three variables
were available for each ADDQoL item in the dataset – a seven-point un-weighted impact
rating (-3 through zero to +3) and a four-point importance rating or weight (0 to 3), both
indicated by the respondent, and a calculated weighted impact rating (-9 through zero to
+9). This dataset was used to perform the necessary statistical analyses that informed the
process of gathering input for the classification system from the items contained in the
ADDQoL.
In addition to performing statistical analyses, subjective input was obtained from
an expert panel in order to ensure adequacy of content. The expert panel consisted of
diabetes clinicians, diabetes educators, registered nurses and a psychometrician. The
seven members were: Betsy Elswick, PharmD, and Tara Whetsel, PharmD from the
Clinical Pharmacy department at the WVU School of Pharmacy; Charlotte Nath, RN,
EdD, CDE, from the Family Medicine department at the WVU School of Medicine;
Elizabeth Quintana, RD, CDE, from the Endocrinology section of the department of
Medicine at the WVU School of Medicine; Andrea Hasley, RD, CDE, from the WVU
Diabetes Center; April Lombardo, RN, CDE, from the Monongalia General Hospital
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Diabetes Education Center; and Clarice Hayes, EdD from the Global Health Outcomes
group at Eli Lilly & Company. A modified method based on the Delphi technique was
used in order to gather consensus on the item content of the proposed diabetes health
state classification system. The Delphi technique, which was originally developed by the
Rand Corporation for technological forecasting, is commonly used in medical, nursing
and health services research (Jones & Hunter, 1995; Hasson, Keeney, & McKenna,
2000).
One of the reasons for the choice of this technique over other consensus methods,
such as the Nominal Group Technique, was that it does not require that the panelists be
brought together physically for group discussions (Jones et al., 1995; Hasson et al.,
2000). Hasson and colleagues (2000) report in their review on the Delphi technique that
while the classical Delphi had four rounds, two to three rounds are preferred, and that the
number of panelists involved in studies employing the technique were as low as 15 to as
high as 60. Although the technique can be administered using any combination of faceto-face interviews, and communication by postal mail, email, and facsimile, it has been
recommended that personal interviews be employed in the first round (McKenna, 1994).
The objective of constituting the expert panel was to obtain subjective input on:
1) arriving at a four to five-attribute classification system based in part on the results of
the statistical analysis of the ADDQoL data; and 2) describing the attributes and severity
levels of the classification system in a concise manner using situations relatable to people
with diabetes. Each member was individually contacted in order to explain health
outcomes concepts including ‘utility’ and ‘value’ and the above-mentioned objectives in
one-on-one discussions. As a handy reference, they were emailed a written document
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(Appendix 1) containing an explanation of the concepts and links to useful websites that
describe them as well. In addition, the document listed the specific expectations from the
panel members in the form of distinct action items, as well as examples of health state
classifications systems from both generic and disease-specific PBMH. This was followed
by qualitative-input gathering exercises conducted using structured formats explained in
the paragraphs below.
In Round One, Panel members were emailed a document (Appendix 2) containing
a list of plausible attributes based on statistical analysis of the previously collected
ADDQoL dataset and our own interpretation and intuition. Each panel member was
requested to perform the following tasks electronically within the document:
1. Rate the importance of each aspect of life (represented by the respective
ADDQoL item, on a scale where ‘0’ is ‘not at all important’, and ‘3’ is ‘very
important’) in terms of its influence on the utility that a person with diabetes may
place on his or her health condition;
2. Describe briefly in words how, using their own experience in dealing with
persons with diabetes, this aspect of life may be influenced by diabetes;
3. Suggest an attribute (from the plausible list provided in the document or any
another attribute that the panel member may consider appropriate) that the
ADDQoL item under consideration best fits under;
4. Indicate other items not included in the ADDQoL, but which may be needed to be
considered, and perform the above three tasks for those additional items as well.
5. Update names of the attributes and additionally provide a brief description for
each of the selected attributes; and
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6. Describe up to four attribute levels, in sentences, for each of the selected
attributes.
The answers to the structured qualitative input-gathering exercise in Round One
were pooled together to create a suggested version (Suggested Version One, Appendix 3)
of the heath state classification system. As a general format, it was decided to
incorporate the following components in all versions of the heath state classification
system under development:
a. A title followed by an introduction to the questionnaire;
b. A table summarizing the three aspects related to diabetes care that the respondent
is requested to keep in mind (wherever applicable) while answering all questions:
Symptoms, Complications, and Daily Care needs; and
c. One question each pertaining to the attributes selected for inclusion in the
classification system and including:
i. A one-sentence question;
ii. A bulleted paragraph containing a description of the attribute under
consideration, put together by listing the items that were thought of as
comprising the attribute from the qualitative analysis conducted at the end of
Round One; and
iii. Sentences describing severity levels for the attribute.
In Round Two, Suggested Version One was emailed to the panel members. Each
panel member was requested to perform the following tasks electronically within the
document:
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1. Substitute words or phrases that could potentially bias patients’ perceptions of the
impact of diabetes with alternative words or phrases, keeping in mind the need to
remind patients, via the classification system, of the potential challenges (or
responsibilities) that diabetes may introduce into their lives;
2. Substitute complex words or phrases with simpler words or phrases (seventh
grade readability level was desired) and make the classification system less
verbose without compromising its diabetes-specificity; and
3. Comment on the appropriateness of the grouping of items into attributes and the
manner in which attributes were described on the basis of their constituent items.
The answers to the structured qualitative input-gathering exercise in Round Two
were pooled together to create Version One of the health state classification system
(Appendix 4) which was then sent to an English expert to make any suitable changes in
wording and grammar in line with the expectations from the expert panel in Round Two
of inquiry. It was then pilot tested (Pilot 1, n=52) in the outpatient and community
settings described in sections 3.1 and 3.2. Flyers were placed at prominent locations in
these settings requesting patients with diabetes to pick up and answer the classification
system along with which a cover letter signed by the Principal Investigator (PI) and CoInvestigator (Co-I) was attached. Responses were anonymous and no demographic
information or any other kind of information (other than the venue) was collected.
Respondents were requested to drop the answers in specially designated boxes.
Statistical analysis of the Pilot 1 responses to Version One informed the necessary
modifications to be made leading to the development of another suggested version
(Suggested Version Two, Appendix 5) of the classification system. In order to discuss
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the changes from the previous version and to explain the reasons thereof, the expert panel
was contacted over the phone or in person. Given the extent of the prior involvement of
the panel, this step in the process of receiving qualitative input was relatively faster, and
led to the development of Version Two (Appendix 6 ) of the classification system that
was pilot tested (Pilot 2, n=65) in a manner similar to the methodology adopted in Pilot
1.
Statistical analysis of the Pilot 2 responses informed the necessary modifications
to be made to Version Two. Instead of making suggested changes and then submitting it
the expert panel, the panel was consulted beforehand due to the nature of the
modification suggested in this version (dropping of a redundant attribute and replacement
with another, discussed in detail in the Results Chapter). The resultant classification
system was reviewed by an English expert for content and by a graphics designer for
layout and related formatting, leading to the development of Version Three that was pilot
tested (Pilot 3, n=111). Due to the satisfactory results obtained from the analysis of Pilot
3 results, Version Three was declared the Final Version (Appendix 7) of the diabetesspecific health state classification system. In this final version, four attributes (Physical
Ability & Energy Level, Relationships, Mood & Feelings, and Enjoyment of Diet) were
designated with four severity levels each and the fifth attribute (Satisfaction with
management of changes) was designated with three severity levels. The classification
system was accommodated in two standard-sized pages, and titled the ‘Diabetes Utility
Index’ (DUI).
Health states can be described from the DUI simply by choosing levels of severity
on each DUI attribute. For example, ‘1,1,1,1,1’ represents a Perfect Health state where
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each DUI attribute is at its best level, and ‘4,4,4,4,3’ represents and all-worse health state
where each DUI attribute is at its worst level. Health states such as these can then be
incorporated into preference elicitation interviews, as discussed in the next section. The
diabetes-specific classification system of the DUI can describe 768 unique health states in
all (calculated by multiplying the number of levels of severity in each attribute, or
4x4x4x4x3).
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Figure 2: Summary of the Steps Involved in the Development of the Final Version
of the Diabetes-Specific Health State Classification System.
Secondary Dataset with ADDQoL items
Statistical Analysis

Suggested
Æ Attributes

Pooling of qualitative comments

Æ

Round One of Expert Panel Inquiry

Suggested Version One
Round Two of Expert Panel Inquiry
Pooling of qualitative comments
Language assessment

Æ
Æ

Version One
Pilot Testing of Version One (Pilot 1, n=55)
Statistical Analysis of Pilot 1 data Æ

Suggested Version Two
Round Three of Expert Panel Inquiry
Pooling of qualitative comments

Æ

Version Two
Pilot Testing of Version Two (Pilot 2, n=62)
Statistical Analysis of Pilot 2 data
Round Four of Expert Panel Inquiry
Pooling of qualitative comments
Language and format assessment

Æ
Æ

Version Three
Pilot Testing of Version Three (Pilot 3, n=111)
Statistical Analysis of Pilot 3 data

Æ

The Diabetes Utility Index (DUI)
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3.3.2

Objective Two: Phase One

3.3.2.1 Overview of the Multi-Attribute Utility Function
Phase One of Objective Two involved selecting and describing health states from
the classification system designed in Objective One, based on the framework of the
Multi-attribute Utility Theory (MAUT). The relative merits and demerits of the
decomposed approach, using the MAUT, have been discussed in the previous Chapter.
The decomposed approach was chosen as the health state modeling technique in this
study due to a combination of factors. The technique requires relatively fewer valuations
as compared to the composite approach (Dolan, 2002; Brazier, 2005). Another important
consideration that went into the choice of method was that the necessary expertise to
guide this research study using the MAUT approach was available. Finally, the
decomposed approach enabled the study to be feasibly conducted, given the prevailing
time and resource constraints for completing the study.
A general multiplicative Multi-Attribute Utility Function (MAUF) for the five
DUI attributes can be given by:

5

u = [1 / k] [ ∏ ( 1 + k * kj* uj) – 1] …. Equation (1)
j=1

where:
1. the subscript ‘j’ refers to a DUI attribute, where j=1 through 5, and ∏ is a
multiplication sign indicating the product of all (1+ k * kj * uj) from j1 to j5;
2. ‘u’ is the cardinal utility score of a multi-attribute health state on the worst-healthy
scale, a scale on which the utility score of the all-worst state (Pits state, where all the
five DUI attributes at their worst level: 4,4,4,4,3) is 0.00 and the utility score of Perfect
Health (all the five DUI attributes at their best level:1,1,1,1,1) is 1.00;
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3. ‘uj’ refers to the single-attribute utility function for attribute ‘j’, on a scale where the
worst level of attribute ‘j’ has a utility score of 0.00 and the best level has a utility
score of 1.00. Each level of an attribute has a value for ‘uj’, representing the utility
attached to being in a particular level on that attribute, and is obtained from the
preference-elicitation interviews;
4. ‘kj’ are constants, with one value for each attribute (k1 through k5), and are obtained
from the preference-elicitation interviews. They represent the weight attached to that
attribute and its importance in calculating the utility of the overall health state;
5. ‘k’ is a constant, a scaling parameter estimated from the data, which captures the
preference interaction between attributes, and is calculated by solving Equation (2)
5

below using the values of k1 through k5

1 + k = ∏ (1 + k * kj) …. Equation (2)
j=1

The multiplicative functional form, as discussed earlier, specifies one type of
preference interaction between all attributes: they are all either preference complements
or preference substitutes.
5

If ∑ kj > 1, then -1 < k < 0 (Equation 3a) (i.e. ‘k’ is negative), and the attributes are all
j=1

preference substitutes, i.e. the interaction between attributes is synergistic, and
5

if ∑ kj < 1, then k > 0 (Equation 3b) (i.e. ‘k’ is positive), and the attributes are all
j=1

preference complements, i.e. the interaction between attributes is antagonistic.
5

However, if ∑ kj = 1 (Equation 3c), then k = 0. This can be considered as a special case
j=1

of the multiplicative function, known as the linear additive function where there are no
interactions in preferences between attributes. It follows that the additive model fails
when ‘k’ is not equal to zero, and that other non-additive models should be considered.
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In order to simplify the measurement task and to make calculations easier
(Torrance et al., 1996; Furlong et al., 1998; Feeny et al., 2002), a ‘disutility’ (disutility =
1 minus utility) approach was considered. The resultant Multi-Attribute Disutility
Function (MADUF) for the five DUI attributes can be specified as:
5

u` = [1 / c] [ ∏ ( 1 + c * cj`* u`j) – 1] …. Equation (4)
j=1

where:

1. the subscript ‘j’ refers to a DUI attribute, where j=1 through 5, and ∏ is a
multiplication sign indicating the product of all (1+ c * cj * u`j) from j1 to j5;
2. ‘u`’ is the disutility score of a multi-attribute health state on the worst-healthy scale, a
scale on which the disutility score of the all-worst state (Pits state, where all the five
DUI attributes at their worst level: 4,4,4,4,3) is 1.00 and the disutility score of Perfect
Health (all the five DUI attributes at their best level:1,1,1,1,1) is 0.00;
3. ‘u`j’ refers to the single-attribute disutility function for attribute ‘j’, on a scale where
the worst level of attribute ‘j’ has a disutility score of 1.00 and the best level has a
disutility score of 0.00. Each level of an attribute has a value for ‘u`j’, representing the
disutility attached to being in a particular level on that particular attribute which is
obtained from the preference-elicitation interviews;
4. ‘c’ and ‘cj’ are scale parameters, the counterparts of ‘k’ and ‘kj’ explained earlier such
5

that:

1 + c = ∏ (1 + c * cj) …. Equation (5)
j=1

The interpretation will differ in that an interaction that is synergistic on the utility
scale will be antagonistic on the disutility scale and vice versa (Furlong et al., 1998).
Thus a negative value of ‘c’ is indicative of attributes that complement each other.
The simplicity of the disutility approach results from the ease in the calculation of
the cj’s, as is explained in the next paragraph.
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3.3.2.2 Selection of Health States for the Preference Elicitation Interview
Phase Two was based on the approaches described by Feeny and colleagues
(2002) in the development of the generic HUI-3, and Revicki and colleagues in the
development of the asthma-specific ASUI (1998a) and the rhinitis-specific RSUI
(1998b). The number of health states required to be specified to estimate a MAUF
depends on the structure of the health state classification system of the instrument. Thus,
for a hypothetical five-attribute classification system with three severity levels in each
attribute, about 13 to 16 states in total will need to be described as illustrated in Figure 3.
In accordance with these approaches, the following types of health states were selected:
1.

Single-attribute level states
In a single-attribute level state, a given attribute is at less than full function and all

other attributes are set at their best levels. For example, a given attribute with three levels
would have two single-attribute level states other than the best level and Perfect Health
(which is common for all attributes), such that each health state contains a varying level
of the given attribute, and all other attributes within the classification system at their best
level. Each such single-attribute level state was described holistically explaining the
extent of loss of function in the attribute being measured (i.e. severity level of the
attribute in question) as well as the best levels for the other attributes. Valuations of
these single-attribute level states provided the data to calculate ‘u`j’ in the MADUF
explained in Equation 4.
2.

Corner states
Corner states can be considered to be a special kind of single-attribute state.

These are health states where one attribute is at its lowest level and all other attributes are
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at their best level. Hence, there will be as many corner states for a health state
classification system as there are attributes. For example, the DUI classification system
with five attributes had five corner states. Their primary role is to provide values for ‘c’
and ‘cj’. The specification of the five corner states makes calculations easy because
Equation 4 reduces to the form cj = u` when it is solved for each of the corner states. In
other words, cj’s are the disutility scores of the corner states on a scale where the allworst state, Pits, has a disutility of 1.00 and Perfect Health has a disutility of 0.00. The
five values of cj (c1, c2, c3, c4, and c5, i.e. one for each DUI attribute) then enable the
calculation of the scaling parameter ‘c’.
The nature of the description (where the one attribute is at the lowest level) of
these states affords the use of the term ‘disutility corner states’. These type of corner
states are said to be easier for respondents to imagine and are easier to discriminate
among as compared to corner states that are described with one attribute at the best level
and all other attributes at their worst levels (Torrance et al., 1996; Furlong et al., 1998).
3.

Methodological marker states
These are a set of multi-attribute states with attributes at different levels of

severity. There is not a fixed number of marker states required to be used, but the states
chosen should span a wide range of severity across attributes. Three such states were
reportedly chosen in the development of the valuation function for the eight-attribute
HUI-3 (Furlong et al., 1998; Feeny et al., 2002), and five were chosen for the fiveattribute ASUI (Revicki et al., 1998a) and the RSUI (Revicki et al., 1998b). Marker
states were not used in the calculation of MAUF parameters directly; their purpose was to
provide the data to facilitate the conversion of values into utilities for the single-attribute
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level states and corner states for which only values, not utilities were obtained (a more
detailed explanation is available in Section 3.3.3). A variety of marker states were
tested, allowing the severity levels for the five DUI attributes to vary. Expert panel
members rated the marker states on a VAS where 100 equals Perfect Health and Pits
equals zero. Among the marker states tested, three easy-to-understand states were chosen
such that on average:
•

the first marker state was rated to be in the top one-third of the VAS (between
100 and 67 on the VAS - the mild marker state);

•

the second marker state was rated to be in the middle one-third of the VAS
(between 66 and 34 on the VAS – the moderate marker state); and

•

the third marker state was rated to be in the bottom one-third of the VAS
(between 33 and 0 on the VAS - the severe marker state).

4.

Scaling anchor states - These were Dead, Perfect Health (all attributes at their

best level), and Pits (all attributes at their worst level). Perfect Health was fixed as the
best possible state with a value of 100 (i.e. a utility of 1.00).
Applying the above principles, the estimation of a MAUF for the DUI involved
describing twenty health states in all, as illustrated in Figure 4, out of the 768 health
states that could be described by the instrument. Fourteen single-attribute level states,
which included five corner states, were required to be described in addition to the three
scaling anchors of Dead, Perfect Health and Pits, and three Marker States. They were
described in a manner that would enable respondents to conceptualize the health
situations they represent. To do so, the relevant sentences representing the severity levels
for the five attributes contained in the DUI were used. Since Dead is undefined in the
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DUI (it is not one of the 768 health states that the DUI can describe), it was simply
pictorially represented. More detail on the presentation format of these cards is provided
in the next section (Section 3.3.3).
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Figure 3: Representation of Health States to be Valued as per MAUT for a
1
Hypothetical Classification System.
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The Hypothetical Health State Classification System consists of five attributes: A, B, C, D &
E. Each attribute consists of three levels, where 1 is the best and 3 is the worst for that
Attribute.
2
Perfect Health is a health state where all attributes are at their best levels.
3
Corner states are health states where one attribute is at the lowest level and all other
attributes are at their best level.
4
In a single-attribute level health state for a given attribute, that attribute is at less than full
function and all other attributes are set at their best levels.
5
Pits is the health state where all attributes are set at their lowest or most severe levels.
6
Marker states are a set of multi-attribute states with attributes at different levels of severity,
spanning a wide range of severity across attributes.
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Figure 4: Representation of Health States Derived from the Diabetes Utility Index
1
That Were Valued as per MAUT.
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The DUI system consists of five attributes: Physical Ability & Energy Level (P), Relationships (R),
Mood & Feelings (M), and Enjoyment of Diet (D) with four severity levels each and Satisfaction
with management of changes (S) with three levels.
2
Perfect Health is a health state where all attributes are at their best levels.
3
Corner states are health states where one attribute is at the lowest level and all other attributes are at
their best level.
4
In a single-attribute level health state for a given attribute, that attribute is at less than full function
and all other attributes are set at their best levels.
5
Pits is the health state where all attributes are set at their lowest or most severe levels.
6
Marker states (MA, MB, and MC) are a set of multi-attribute states with attributes at different levels
of severity, spanning a wide range of severity across attributes.
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3.3.3

Objective Two: Phase Two
Phase Two involved conducting one-on-one interviews to obtain patients’

preferences for the health states selected and described in Phase One. The interviews
used a combination of the VAS and SG techniques used by Feeny and colleagues (2002)
and Revicki and colleagues (1998a; 1998b) in the development of valuation functions for
the PBMH that were designed in their respective studies. The choice of the SG is
necessitated since the MAUT specifies that preferences be obtained in a manner
consistent with the expected utility theory. Interview participants were contacted based
on their expressed interest (via their response to study-related flyers and handouts) to take
part in these interviews, and appointments were scheduled to conduct the interviews
either at their private residence or any available convenient, quiet and private meeting
rooms in the Health Sciences Center of WVU.
The interviews commenced with the names and descriptions of the five DUI being
verbally narrated to the respondent in the manner of a free-wheeling conversation. This
provided an opportunity for the respondent to gain an understanding of the attributes to
the satisfaction of the interviewer. Respondents were also shown five pictures, one each
representing a DUI attribute and a color scheme in which one color each corresponded to
a severity level. The color scheme was standardized across attributes (level three for the
Satisfaction attribute, the last level for that attribute, was designated the color
corresponding to the color used to represent level four on the other attributes). The
description of the attributes and their representative pictures as well as the color scheme
was color-printed and laminated on a handout that was available to the respondents at all
times during the interview. The respondent then provided their answers to the DUI.
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Respondents were then asked how many additional years they expected to live.
Respondents were asked to keep this expected life-expectancy in mind in all the health
state scenarios presented to them from that point onward. They were allowed to expect
everything else in their lives to be just the same, barring the extent to which each attribute
was affected, which would be in the manner contained within a health state description.
In the course of the interview, the following major measurement tasks, based on
the those outlined in a detailed technical report on the valuations conducted for the HUI-3
(Furlong et al., 1998), were performed:
1. A VAS was established such that Perfect Health, the most desirable state, was
assigned a value of 100 and the respondent choose either Pits or Dead as the least
desirable state and placed it at 0;
2. On the appropriate 0-100 VAS established above, the respondent valued the
methodological marker states and also valued either Pits or Dead (whichever was not
chosen as the least desirable state);
3. On the same 0-100 VAS, the single-attribute level states and corner states were valued
in sets. Each set represented single-attribute level states and corner states for one
attribute in the classification;
4. The methodological marker states were valued using SG, on a Pits=0/ Perfect
Health=1.00 scale; and
5. Depending on the choice of Pits or Dead as the least desirable state, SG measurements
of Dead on the Pits=0.00/ Perfect Health=1.00 scale, and Pits on the Dead=0.00/ Perfect
Health=1.00 scale were undertaken.
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When administering these tasks, respondents were requested to focus only on the
descriptions provided, and assume that other factors were all constant. Before wrapping
up, demographic information and respondents’ perceptions regarding the interview were
also collected. The answers were recorded anonymously in a booklet (see Appendix 8).
In summary, the single-attribute level states and the corner states were valued in
sets, in VAS tasks. Data for the Multi-Attribute Utility Function (MAUF) required to
provide the valuation function of the health state classification comes mainly from the
single-attribute level states and the corner states (Furlong et al., 1998; Feeny et al., 2002).
The marker states (and the applicable anchors, Pits or Dead) were presented in both VAS
as well as SG tasks. While Perfect Health was fixed as the best possible state with a
utility of 1.00, Dead and Pits were valued using both VAS and SG tasks. The primary
role of the marker states (and the applicable anchors, Pits or Dead) was to provide data
for a value-to-utility conversion model, since both VAS value scores and SG utility
scores were available only for these health states (Furlong et al., 1998; Feeny et al.,
2002). Figure 5 provides an illustration of the type of valuation tasks that were
performed for the health states that were described from the DUI.
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Figure 5: Representation of the Valuation Tasks Performed as per MAUT for the
1
Diabetes Utility Index.
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The DUI system consists of five attributes: Physical Ability & Energy Level (P), Relationships (R),
Mood & Feelings (M), and Enjoyment of Diet (D) with four severity levels each and Satisfaction
with management of changes (S) with three levels.
2
Perfect Health is a health state where all attributes are at their best levels.
3
Corner states are health states where one attribute is at the lowest level and all other attributes are at
their best level.
4
In a single-attribute level health state for a given attribute, that attribute is at less than full function
and all other attributes are set at their best levels.
5
Pits is the health state where all attributes are set at their lowest or most severe levels.
6
Marker states (MA, MC, and MC) are a set of multi-attribute states with attributes at different levels
of severity, spanning a wide range of severity across attributes.
7
VAS=Visual Analog Scale task, administered using the Feeling Thermometer prop.
8
SG=Standard Gamble task, administered using the Chance Board prop.
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In the estimation of MAUFs, either an individual-level approach or a personmean level approach can be chosen. The former involves calculation of a multiattribute function for each respondent. This study employed a Person-Mean approach,
i.e. the mean of all respondents’ values and utilities for each health state were
calculated (details regarding the calculations involved are discussed in detail in the Data
Analysis section) before estimating an MAUF. This approach permits two strategies in
allotting health states to respondents: 1) all the health states (corner states, singleattribute level states, marker states and anchor states) be required to be completed by
each respondent; or 2) health states be randomly assigned – one way to accomplish this
is by assigning corner states and single-attribute level states for two or more attributes
to one respondent, and so on. While the former approach was selected, the suggestion
by Torrance and colleagues (2001) to limit the number of health states on a single VAS
task to about six, and to value health states in sets, one set at a time, was also
considered.
The instrumentation and props for conducting these valuation tasks were based on
those developed and used by the HUI group and illustrated in detail in the technical
reports published by this group (Furlong et al., 1990; Furlong et al., 1998). For the VAS
tasks in this study, the Feeling Thermometer prop was used, while for the SG tasks, the
Chance Board prop was used. Both were designed employing suggestions from the HUI
manuals (Furlong et al., 1990) with appropriate revisions to the color scheme and
materials as necessary. The health states were printed in color on cards, including the
severity level-statements (borrowed from the DUI) along with a representative picture for
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each attribute, and then laminated. Production of the props was contracted to the
Department of Graphic Design at WVU.

3.3.4

Objective Two: Phase Three
The methodological Marker States and Dead (or Pits, depending on which state

was considered the worst) were valued using both VAS and SG. This provided the
necessary data to estimate a model for converting VAS scores for health states that were
not valued using SG (single-attribute level states and corner states), into SG utility scores.
The VAS valuations of the single-attribute level states and corner states, when converted
into utilities using the conversion model, provided the measurements necessary to
estimate a multiplicative Multi-attribute Utility Function (MAUF) (Furlong et al., 1998;
Feeny et al., 2002) for the DUI. The purpose of the MAUF is to convert individuals’
responses to the DUI questions into a score that estimates the utility that the individual
places on his or her life. In other words, the MAUF was intended to provide utility
estimates for each of the 768 health states that can be described by the diabetes-specific
health state classification system of the DUI without having to individually perform
preference-elicitation tasks for each of these health states. These calculations are
explained in greater detail in the Data Analysis section.

3.3.5

Objective Three
As mentioned in section 1.3.1, it is important to know what causes the variation in

utilities – whether it is due to real differences between people or if it is due to constructirrelevant variation. However, like with other humanistic constructs, a majority of the
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variation in utilities may go unexplained in research. Lenert and colleagues (2000)
suggest that researchers may be more confident in the ability of utilities to reflect actual
patient preferences if the variation in utilities can be explained by demographic, clinical
and QoL-related factors. Demographic and clinical variables were therefore obtained for
the survey respondents in order to validate the utilities estimated by the MAUF of the
DUI, as well as to account for the variation in utilities. In addition, other PRO
questionnaires were also included that will aid in the validation of the classification
system and MAUF of the DUI.
The Diabetes Symptoms Checklist Revised (DSC-R) (Grootenhuis, Snoek, Heine,
& Bouter, 1994) was designed to assess the frequency and severity of diabetes-associated
symptoms that can impact both physical and psychological aspects of health. Symptoms
are grouped into the following subscales comprising 34 items in all: cardiovascular,
hyperglycemic, hypoglycemic, neurologic, psychological, and visual. A higher score on
the instrument is indicative of greater burden of diabetes-related symptoms, and could be
expected to be associated with the more severe levels on the ‘Physical Ability and Energy
Level’ and ‘Moods & Feelings’ attributes of the DUI. The instrument was hence
included in order to compare its scores against the severity classification and the utilities
associated with the ‘Physical Ability and Energy Level’ and ‘Moods & Feelings’
attributes of the DUI, as well as the overall utility reported by the DUI.
The Well-Being Questionnaire (WB-Q) was originally developed to provide a
measure of depressed mood, anxiety, and various aspects of positive well-being to
evaluate new diabetes treatments. The instrument was further developed into the 12-item
version of the WB-Q (WB-Q12), offering a balanced selection of positive and negative
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items and providing negative well-being, positive well-being, and energy sub-scales that
can be totaled for a total general well-being score (Bradley, 2000; Riazi, Bradley,
Barendse, & Ishii, 2006). Although originally developed and validated in diabetes
populations (Bradley, 1994), the item content of the WB-Q12 is not diabetes-specific and
is hence not intended to be used in diabetes populations alone. A higher score on the
instrument is indicative of greater general well-being, and can be expected to be
associated with the less severe levels on the ‘Moods & Feelings’ attribute of the DUI.
The instrument was hence included in order to compare its scores against the severity
classification and the utilities associated with the ‘Moods & Feelings’ attribute of the
DUI.
The Diabetes Empowerment Scale (DES) was developed to measure the
psychosocial self-efficacy of people with diabetes via its three measured subscales:
managing the psychosocial aspects of diabetes, assessing dissatisfaction and readiness to
change, and setting and achieving goals (Anderson, Funnell, Fitzgerald, & Marrero,
2000). A brief assessment of overall self-efficacy encompassing these concepts can also
be made using the validated eight item short form of the DES (DES-SF) (Anderson,
Fitzgerald, Gruppen, Funnell, & Oh, 2003). A higher score on the instrument is
indicative of greater self-efficacy, which can be expected to result in a greater sense of
satisfaction that people with diabetes experience in relation to what needs to be done to
manage the condition on a daily basis. The instrument was hence included in order to
compare its scores against the severity classification and the utilities associated with the
‘Satisfaction with management of changes’ attribute of the DUI.
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The EuroQol EQ-5D (EQ-5D) is a generic PBMH consisting of five dimensions:
mobility, self-care, usual activity, pain/discomfort, and anxiety/depression (Brooks, 1996;
Kind, 1996). An overall preference-weighted summary score or utility, represented as
the EQ-5Dindex, is obtained from the pattern of responses to the EQ-5D questions by using
previously derived valuation functions, that essentially ‘weight’ the answers to the EQ5D questions using social preferences obtained empirically in tested populations (Dolan,
1997; Shaw et al., 2005). A greater EQ-5Dindex score indicates greater utility or better
HRQoL. Since the EQ-5D is a widely used generic PBMH, the EQ-5Dindex scores can be
directly compared to the utilities obtained using the MAUF of the DUI.
The Medical Outcomes Study Short-Form 12 (SF-12) is a widely used 12-item
measure covering eight domains of health status or HRQoL (Ware, Jr., Kosinski, &
Keller, 1996). The SF-12 yields two scores: the Physical Component Score -12 (PCS-12,
or physical health status), and the Mental Component Score (MCS-12, or mental health
status) (Ware, Jr., Kosinski, Turner-Bowker, & Gandek, 2002). The SF-12 was used to
generate the classification system for a generic PBMH called the SF-6D (Brazier et al.,
2004b) that consists of six attributes including physical functioning, role limitation, social
functioning, pain, energy, and mental health. Because of this relationship between the
two instruments, SF-6D scores, which are preference-based or utility scores, can be
directly obtained from responses to the SF-12 itself (Brazier et al., 2004b), and can then
be compared to the utilities obtained using the MAUF of the DUI.
Additionally, responses to the SF-12 have also been used to predict utility scores
obtained from the HUI-3, another widely used generic PBMH (Sengupta, Nichol, Wu, &
Globe, 2004). Since the SF-12 is not directly related to the HUI-3 like it is to the SF-6D,
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the predicted HUI-3 scores can be considered as ‘derived’ HUI-3 scores, in order to
distinguish them from the utility scores that are obtained by the direct use of the
instrument. Nevertheless, using the SF-12 thus allows the calculation of health status
scores, the PCS-12 and MCS-12 in addition to the SF-6D utility scores and derived HUI3 utility scores, while at the same time minimizing the survey booklet-induced
respondent burden since the SF-6D and the HUI-3 do not have to be separately included.
At the time interviews were being conducted in Phase Two of Objective Two,
there was a concurrent survey mail-out containing:
1.

a personalized, signed cover letter from the patient’s specific physician on an

OMSA letterhead, explaining the purpose of the study and providing the contact
information of the research investigators of the current study, and the co-investigators at
OMSA;
2.

a battery of PRO instruments arranged in a booklet including the DUI, SF-12,

DSC-R, EQ-5D, WB-Q12, and the DES-SF ; and
3.

a postage-paid return envelope.

Follow-up reminder post cards were sent two weeks after the commencement of the
mailing. The above materials were sent a second time to patients who responded to the
reminder cards and requested an additional copy.
The MAUF developed in Phase Three of Objective Two was used to obtain the
survey respondents’ utilities for their current health conditions without having to conduct
lengthy preference elicitation interviews. These utilities were merged with a collection of
retrospective clinical, medical history and demographic data in order to examine the
nature of associations between these variables, as stated earlier. A set of three different
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databases, linked by patients’ medical record numbers (MRN) were used to obtain the
necessary clinical and medical history information: 1) The Diabetes Clinic Database can
be described as a lab-value database consisting of clinical lab values of patients who
consult physicians at the WVUDI clinics for the management of their diabetes; 2) The
University Health Associates (UHA) database derives its information from the IDX
billing system, which is a software package that tracks patient office visit appointments
and billings. After receiving care from a provider, patients receive a fee slip that is
tracked by the IDX system within two days of the visit. In addition to the charges, the fee
slip also consists of diagnosis information that is later coded into ICD-9 CM format by
the coding department; 3) The WVU Hospital database provides information on hospital
and ER encounters. It tracks the bills that patients receive upon discharge from the
hospital, and among others, it contains ICD-9 CM diagnosis codes associated with each
hospital and ER visit.
The co-investigators at OMSA coordinated the collection process of patient
responses with the clinical and medical history data to be used in the study using
respondents’ MRN. In order to de-identify patient information, a unique identification
number was assigned to each survey respondent.
The following is a summary of the data that was collected in Objective Three:
1.

Self-reported data:
a.

Demographic information - including age in years, gender, education, race,

marital status, and annual income;
b.

Duration of diabetes in years ;

c.

Diabetes type;
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d.

Insulin use; and

e.

Height (in feet) and weight (in pounds) – this was used to calculate BMIs using

the formula (CDC, 2006) : BMI = [Weight in pounds / (height in inches)2 ] * 703.
f.

Number of physician office visits, ER visits and hospitalizations related to

diabetes in the past one year
2.

Data obtained from electronic records:
a.

A1C - An A1C test result reflects the average blood glucose level for the previous

2-3 months, in comparison to blood glucose testing which identifies control on a dayto-day basis. Not only can A1C allow healthcare professionals to judge how well a
patient’s diabetes treatment plan is working, it can also assist in evaluating the longterm effects of diabetes management. In order to assess the long-term impact of
glycemic control on utility, the average of A1Cs in a 12-month period prior to the
survey was recorded for each patient. The A1C results were made available from the
Diabetes Clinic Database;
b.

ICD-9 CM Diagnosis codes - Diagnosis codes for office visits, emergency room

visits and hospital admissions, made available from the UHA database and the WVU
Hospital database, were used to calculate the following:
i.

Index of Co-morbidity - A Charlson Co-morbidity Index based on ICD-9 CM

codes for medical claims in a 12-month period prior to the survey was used to measure
co-morbidity for each respondent. The required ICD-9 CM codes were made available
by the OMSA. The Charlson Index consists of a list of 19 medical conditions, with
each condition being assigned a weight from one to six. This weight was derived from
relative risk estimates of proportional hazard regression models using clinical data
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(Charlson, Pompei, Ales, & MacKenzie, 1987). The Charlson index for an individual
is the sum of weights for all prevalent conditions (among the list of 19 conditions)
during a specified time period. A version of the index by D’Hoore and colleagues
(d'Hoore, Bouckaert, & Tilquin, 1996), one of the few Charlson indices for use with
administrative claims data, was used in this study. This version is based on only the
first three digits of ICD-9 CM codes. Diagnosis codes related to diabetes will be
excluded in the computation of this index; and
ii.

Index of diabetes complications - A diabetes complication score based on ICD-9

CM codes for medical claims in a 12-month period prior to the survey was calculated
for each respondent. The required ICD-9 CM codes were made available by the
OMSA. Specific ICD-9 CM diagnosis codes under the series 250.xx have been
designated for conditions related to diabetes and its associated complications. Since
the 250.xx series of codes are not always the only ones used to code for conditions that
result from complications arising due to diabetes, the risk of underestimating the
burden due to diabetes-related complications by using only the 250.xx series cannot be
ruled out. In order to address this issue, a list of ICD-9 diagnosis codes for diabetesrelated complications was consolidated using a set of ICD-9 CM codes compiled by the
Endocrine Society (Dickey, 2005) as well as by identifying other ICD-9 CM codes, not
included in this list, that indicate a condition potentially arising due to a complication
directly related to diabetes, through consultations with an Endocrinologist practicing at
the WVU Hospitals. The diabetes complications score was finally calculated as a sum
of the number of diabetes-related long-term complications (renal, ophthalmic,
neurological, cardiac, cerebrovascular, and peripheral circulatory disorders, and
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depression) as well as short-term complications (hypoglycemia, diabetic coma,
hyperosmolar coma, and ketoacidosis). Thus, the diabetes complications score can
take values from zero to 11.

3.4

Data Analysis

3.4.1 Objective One
3.4.1.1 Classical Methods
The impact ratings were first subject to item analysis using standard statistical
procedures based on Classical Test Theory (CTT). The classical index of discrimination,
the item-total correlation coefficients (r) for an item’s impact score with the total average
impact score (Nunnally et al., 1994), was obtained for each item. Those items with an r
<0.4 were marked for exclusion (Streiner & Norman, 1989). The remaining items were
subjected to factor analysis using the SPSS Version 15 software package (SPSS, 2007).
Exploratory factor analysis (EFA) attempts to explain the number of factors that are
required to explain the relations among a set of items (Fayers et al., 2000), and is used
when the factor structure of an instrument is unknown. Confirmatory factor analysis
(CFA), on the other hand, is used to test the number of factors purported to be underlying
the relations among a set of items in an instrument (Fayers et al., 2000).
In previous research using the ADDQoL, it was observed that very few
respondents endorsed impact ratings of +2 and +3 (indicating increasing amounts of
positive impact of diabetes on QoL), across the 18 ADDQoL items. Hence, the impact
ratings of +2 and +3 were replaced with a rating of +1. This is similar to the approach
adopted in the newer version of the ADDQoL (not published), in that it uses a 5-point
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impact rating scale i.e. -3 (through zero) to +1. While the importance weights remained
unchanged, the weighted impact scores were now expected in the range of -9 (through
zero) to +3. The un-weighted impact ratings were used to perform the factor analysis that
further informed the process of gathering input for the classification system from the
items contained in the ADDQoL, for the following reasons:
One, a single-factor structure for the ADDQoL has been established on the basis
of a combination of the results of factor analysis and reliability testing using internal
consistency reliability (Bradley et al., 1999; Bradley et al., 2002) on the weighted impact
ADDQoL scores. This was confirmed by Sundaram (2005); who, however, reported
using CFA that the single factor (obtained from a forced one-factor solution) explained
only 45.63% of the variance from the 18 ADDQoL items. Factor loadings for each item
on that single unrotated factor showed that 15 items loaded greater than 0.5 on that factor,
with factor loadings for the other three items being 0.492, 0.481, and 0.375, respectively.
Since the purpose of this study was to explore the creation of a brief diabetes-specific
health state classification system based on the content of the ADDQoL, it was necessary
to further explore the dimensionality among the items of the instrument. An alternate
approach to assessing dimensionality to the ones already described above would involve
using un-weighted impact ratings, using the modified rating scale, in place of weighted
impact scores; and
Two, the proposed diabetes-specific health state classification system was being
designed as a PBMH, with intentions to also calculate a different set of weights for the
items included in it – aggregated preferences of a diabetes population to be on different
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levels of the items of the classification system. Hence, it was decided to explore the
ADDQoL items without applying any other kind of weighting system.
Two tests were initially conducted in order to assess the adequacy of the data for
conducting factor analysis. In the Kaiser-Mayer-Olkin (KMO) measure of sampling
adequacy, high values (close to 1.0) generally indicate that a factor analysis may be
useful with the data. The second test is the Bartlett test of sphericity - very small values
(less than 0.05) indicate that significant relationships among variables probably exist.
Exploratory Factor Analysis (EFA), employing Principal Axis Factor (PAF) extraction
and Promax rotation, were performed on the items other than those marked for deletion.
Promax rotation is a type of Oblique or non-Orthogonal rotation which is employed when
the underlying latent factors are expected to correlate somewhat with one another
(DeVellis, 2003).
A broad overview on the prevailing dimensionality of the ADDQoL items was
obtained by examining the following: the scree plot, the total percentage variance
explained by the factors, and the loading of items or subscales on the factors emerging
from the rotated solution. This enabled the estimation of the number of factors that
adequately and parsimoniously capture the original information contained within the
ADDQoL items as well as making an initial observation on the constitution of those
factors in terms of individual ADDQoL items. A secondary reduction was then
performed by deleting those items with communalities < 0.3, those items showing its
highest factor loading on the main factor to be lower than 0.4, and those items with
similar loadings on different factors (such that the differences in loadings across factors is
≤ 0.1) (Prieto et al., 2003). This second step helped identify the major underlying factor
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that each item contributed in explaining, so that any one factor could be described in
terms of its constituent items. The interpretation of the results of these analyses were
presented to the clinical expert panel, who provided subjective input on items and
reviewed pilot version of the diabetes-specific classification system, as outlined earlier.
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3.4.1.2 Rasch Analysis
Rasch analysis was employed in order to provide guidance in the creation of
broad attributes and in the construction of severity levels for each attribute of the diabetes
health state classification system. Fit of the data from the resultant classification system
to the Rasch model would impart desirable measurement characteristics to the
instrument: uni-dimensionality, interval-level measurement, additivity and sample-free
measurement. After the initial determination of attributes using CTT (factor analysis)
and qualitative input from experts, Rasch Analysis was employed on data obtained from
the pilot testing of three versions of the classification system (n1=52, n2=65, n3=111)
using a software package called Winsteps (Linacre, 2007). As a confirmatory measure,
the technique was also employed on data obtained from the larger validation survey
(n=396) that included the classification system that was finalized after three rounds of
pilot inquiry.
Rasch Analysis also has applications in determining dimensionality in data, which
means that it could be used in place of, or along with, Factor Analysis based on CTT.
While Rasch and factor analysis produce similar results, the two have been reported to
suggest different factors in case the factor structure is vague. Since there is relatively
greater uniformity in the interpretation of the CTT Factor Analysis, it was the preferred
technique in the assessment of dimensionality. Rasch Analysis, on the other hand has
been widely acclaimed as a valuable tool in developing items and response scales for
instruments, and was the preferred technique to provide guidance in the development of
the diabetes health state classification system.
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Statistics generated by Rasch analysis was used to determine the extent to which
individual respondents and each of the items on the classification system fit the
expectations of the Rasch measurement model (Wright & Masters, 1982). The following
tests were conducted:
i.

Chi-square fit statistics were used to determine how well each item contributed to

the measurement of the same underlying construct. The most commonly used Chi-square
tests are known as Outlier-sensitive Fit (Oufit) and Information-weighted Fit (Infit), and
are reported as Mean-Squares (MNSQ), that is, the chi-square statistics divided by their
degrees of freedom (Wright et al., 1982). Item Outfit or Infit MNSQ values of about 1
are ideal by Rasch model specifications, while items with Outfit or Infit MNSQ values
greater than 1.3 are usually diagnosed as potential misfits to Rasch model conditions and
considered for deletion (Smith, Schumacker, & Bush, 1998). Wright and Linacre (1994)
have recommended that standardized Infit and Outfit mean square values greater than 1.4
be used as the criterion to define those items and respondents that fail to demonstrate
acceptable goodness-of-fit with the measurement model. Fit statistics exceeding these
values for individual subjects indicate that the subjects failed to respond to the scale items
in a manner consistent with the measurement model. On the basis of the summarized
recommendations in the Winsteps manual (Linacre, 2007):
a. Items were considered adequately fitting the Rasch model if the Infit MNSQ was
in the range 0.8-1.2 and the Outfit MNSQ was in the range 0.6-1.4;
b. Items were considered to be overfitting if the Infit and Outfit MNSQs were less
than 0.6 and 0.8 respectively; and
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c. Items were considered to be misfitting if the Infit and Outfit MNSQs were greater
than 1.2 and 1.4 respectively.
2.

Several Rasch Analysis criteria were used to assess the adequacy of the

performance of the severity levels employed for the attributes of the diabetes health state
classification system (Linacre, 1999):
a. Average measures for each rating category were required to advance evenly up
the severity level, so that higher categories indicate greater amount of the latent
variable, .i.e. severity on an attribute;
b. Average measures are reasonably close to their expected values, which are the
average measures predicted in case of fit of the data to the Rasch model;
c. Step calibrations were required to advance in an orderly manner such that the
distance between adjacent categories was between 1.5 logits and 5.0 logits,
indicating categories that are neither too narrow a segment nor too broad a
segment of the latent variable, i.e. severity on an attribute; and
d. Outfit MNSQs for category levels were required to be < 2.0, indicating less
randomness and unexpected use of category levels that could lead to a nonperforming measurement system where responses appear more similar.
Rasch item difficulty statistics (in logits) were obtained to examine the efficiency
of measurement of the impact of diabetes by the DUI attributes, with a greater spread in
difficult estimates of attributes indicating a wider measurement range. The ItemSeparation Index was examined as a range of item difficulty, with larger values indicating
a greater item spread. Item-Reliability, a Rasch estimate that is independent of the length
of the instrument was also obtained. Rasch Person-Reliability of the DUI, analogous to
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Cronbach’s alpha, was calculated along with the Person-Separation Index, an indicator of
the extent to which the DUI attributes could distinguish between different levels of
impact of diabetes.

3.4.3

Objective Two: Phase Two
After the diabetes health state classification system was finalized at the end of

three rounds of piloting and Rasch analysis in Objective One, select health states were
described for use in preference elicitation interviews in Phase One of Objective Two, as
discussed earlier. The analysis plan for the data obtained in Phase Two was based on the
strategy outlined in the technical report of the valuation function of the HUI-3 (Furlong et
al., 1998):
1)

The respondents were classified into groups depending on their choice of state as

least desirable in the first VAS task (see section 3.3.3): those reporting Pits as least
desirable belong to Group A, while those reporting Dead as least desirable belong to
Group B;
2)

The preference measurements (value and utility scores) were summarized using

the ‘trimmed mean’ measure of central tendency. A trimmed mean is calculated by
discarding a certain percentage of the lowest and the highest scores and then computing
the mean of the remaining scores. It is used in order to minimize the effects of outlier
scores and is less susceptible to the effects of extreme scores than is the arithmetic mean.
In this study, a 10% trimmed means (5% trimmed off of each end of the distribution)
were used for all states valued on the VAS. Wherever stated, a Person-Mean score will
denote the trimmed mean for a health state aggregated across respondents, and Person-
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Mean(A) and Person-Mean(B) scores will denote the aggregated trimmed means for
Groups A and B, respectively. Person-Mean(A) and Person-Mean(B) value and utility
scores were calculated for the methodological marker states, the corner states, the singleattribute level states and the scaling anchors Pits and Dead;
3)

An End-of-scale bias adjustment (EOSBA) was applied to Person-Mean(A) and

Person-Mean(B) trimmed mean value scores to correct for end-of-scale bias (EOSB).
This type of bias, also referred to as end-aversion bias or central tendency bias, refers to
the tendency of respondents to avoid using extreme ends of the rating scales like the
VAS, as reported in an earlier section. It was corrected for in this study by using an
EOSBA factor of 1.78. The adjustment was applied in sets, only if the value score of a
state was greater than 75 (on a scale of 100), and for the second-ranked state (just below
Perfect Health, a conceptual anchor placed at 100). In the present study, health states
were valued on the VAS in sets – first involving the anchor and marker states, followed
by separate sets for each attribute’s single-attribute level states and corner states, with the
previous set of health states removed from the VAS FT board before a new set was
introduced.
The EOSBA was applied in the following manner for each set: a) If the
difference between the score for the highest ranked state (Perfect Health, anchored at
100) and the Person-Mean score for the second-ranked state was 10, then this difference
was divided by 1.78 to obtain an EOSBA difference of 5.6 units; b) The EOSBA
difference was subtracted from the highest score, i.e. 100, to obtain the EOSBA for the
Person-Mean score of the second-ranked state at 100 - 5.6 = 94.4; c) The Person-Mean
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values of all other health states valued on the same set were rescaled using positive linear
transformations, so that the relative distances between health states were maintained;
4)

The VAS value ratings and SG utility scores obtained for the methodological

marker states were utilized to estimate value-to-utility conversion models using a
regression technique. Two such models were estimated, one each using EOSB-corrected
Person-Mean(A) and Person-Mean(B) scores, respectively. Furlong and colleagues
(1998) report from their prior work that a simple power function fared as good as or
better than regressions involving transformations, non-linear techniques, and spline
functions. A review of conversion models reported in the literature noted that while
Torrance’s (1976a) power transformation was replicable (Stiggelbout et al., 1996),
researchers have also reported simple linear relationships between VAS ratings and SG
utilities (Torrance et al., 2001). The present study utilized the best statistical approach
possible for the data collected to obtain a study-specific conversion;
5)

The value-to-utility conversions models were used to calculate Person-Mean(A)

and Person-Mean(B) utility scores for the single-attribute level states and corner states
(for which only VAS value scores are previously available);
6)

Using positive linear transformations, the Person-Mean(B) utility scores were

rescaled from a Dead=0.00/Perfect Health=1.00 scale to a Pits=0.00/Perfect Health=1.00
scale for the single attribute-level states and corner states; and
7)

The above transformation facilitated the calculation of overall Person-Mean

utility scores using Person-Mean(A) and Person-Mean(B) utility scores for the singleattribute level states and corner states using a weighted approach. The weights for
Groups A and B were the respective prevalence proportion of each group. The Person-
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Mean(A) and Person-Mean(B) utility scores were multiplied by their respective weights
to yield overall Person-Mean utility scores.

3.4.3

Objective Two: Phase Three
The overall Person-Mean values (henceforth referred to as Person-Mean values)

were used to fit a MAUF based on a strategy outlined in the technical report for the
valuation function of the HUI-3 (Furlong et al., 1998), with the chosen approach of
describing ‘disutility’ corner states.
1)

The overall Person-Mean utility scores were converted to disutility scores, and

the disutility scores for the corner states were designated as cj’s (where j=1 through 5);
2)

The scaling parameter ‘c’ was calculated by iteratively solving the equation:
n

1 + c = ∏ (1 + c * cj)
j=1

where,
n(=5) is the number of attributes;
n

∏ is the product of all (1 + c * cj) from c1 to cn ; and

j=1

cj is the Person-Mean disutility for the corner state.
3)

Using positive linear transformation, the Person-Mean single-attribute level utility

scores for each attribute were converted from a Pits=0.00/ Perfect Health=1.00 scale into
a scale where the lowest level of attribute=0.00 and the highest level of the
attribute=1.00. On the transformed scale, the highest level was Perfect Health with a
utility=1.00 and was fixed;
4)

The Person-Mean single-attribute level utility scores for each attribute were

converted to disutility scores (on a scale where the disutility of Perfect Health=0.00 and
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the disutility of the lowest level of attribute=1.00) that were designated as u`j’s (where
j=1 through 5);
5)

Fit to the additive model was then tested using the following condition:
5

If ∑ cj = 1, then c = 0 and the additive model holds.
j=1

The strategy employed was that if the additive model did not hold, the multiplicative
model would be fitted;
6)

The general multiplicative MADUF on a Pits=1.00/ Perfect Health=0.00 scale is

given as:

n

u` = [1 / c] [ ∏ ( 1 + c * cj* u`j) – 1]
j=1

where (as indicated previously in Equation 4),
n (=5) is the number of DUI attributes,
u` is the disutility of the health state on the Perfect Health =0.00 / Pits =1.00 scale,
cj is the Person-Mean disutility for the corner state obtained in (1),
c is a scaling parameter obtained in (2),
u`j is the single-attribute level disutility score on the lowest level=1.00 /Perfect
Health=0.00 scale obtained in (3).

3.4.3

Objective Three
An instrument is said to be valid to the extent that it measures what it purports to

measure. The DUI was tested for its Concurrent Validity as well as Construct Validity.
Concurrent validity is demonstrated when a test correlates well with a measure
that has previously been validated. In the context of the DUI, the two measures may be
for the same construct (diabetes-specific utility), or for different, but presumably related
(diabetes-specific utility and generic utility) constructs. In order to test the concurrent
validity of the DUI utilities, the correlation between utility scores on the DUI, EQ-5D,
SF-6D and HUI-3 (derived) was assessed.
Construct validation of an instrument or measure is concerned with validity of
inferences made by that instrument about unobserved variables (the constructs) on the
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basis of observed variables (their presumed indicators) (Pedhazur & Schmelkin, 1991).
One way to assess construct validity is to identify probable high and low scoring groups
on an instrument on logical grounds a priori, and then demonstrate that certain groups
obtain higher scores on that instrument than other groups (Pedhazur et al., 1991). In the
present study, construct validity of the DUI utilities were examined by investigating
differences in utilities within groups based on external indicators such as the extent of
diabetes-related complications, and insulin use, using ANOVAs and t-tests.
The severity levels of the DUI classification system were assessed by studying the
differences in scores on other relevant measures across these levels, using one-way
ANOVAs: physical health status (using the SF-12) was compared between the levels on
the ‘Physical Health and Energy’ attribute, mental health status and well-being (using the
SF-12 and the W-BQ12 respectively) were compared between the levels on the ‘Mood
and Feelings’ attribute well-being, while DES-SF (hence forth referred to as DES) scores
were compared against the levels on the Satisfaction attribute of the DUI. Similarly, the
total and subscales scores of the DSC-R were compared: the total symptom score, the
neurological subscale score and the cardiovascular subscale score were compared
between the levels on the ‘Physical Health and Energy’ attribute; and the psychological
subscale score was compared between the levels on the ‘Mood and Feelings’ attribute.
Finally, the correlations between single-attribute scores of the five DUI attributes and
relevant measures listed above were also examined.
Univariate and multivariate statistics were used in order to identify the
demographic, clinical, and medical history variables significantly influencing utility.
Hierarchical regression models were built in order to explain the relationship between
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utility and the various demographic, clinical, and medical history predictors. It is used in
explanatory situations when there is some basic knowledge on the relationships between
at least some of the variables being used. In hierarchical regression, the order of entry of
variables is assigned by the researcher according to logical or theoretical considerations
(Tabachnick & Fidell, 2001). One point of view is to accord early entry to variables of
greater theoretical importance. The opposite view is to introduce the relatively
unimportant variables first, and then test the added prediction obtained by the introducing
the remaining variables in the model. In this study, covariates were entered sequentially
into the model in the following order:
Block 1: A1C, Insulin use, Index of diabetes-related complications, Duration of diabetes,
Diabetes symptom burden (DSC-R total score);
Block 2: BMI, Index of co-morbidity; and
Block 3: Demographic variables: Age, Gender, Race, Education, Marital status, Income.
The regression model was checked for violations of assumptions: multi-collinearity,
heteroscedasticity, autocorrelation, and non-normality of residuals. The list of variables
that were used in the univariate and multivariate analyses, including information on the
source, type, and categorization for analysis, is presented in Table 3.
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Table 3: Description of Variables Used in Univariate and Multivariate Analyses

Category

Variable

Source of

Variable

Name

Information

Type

Self-report

Continuous

N/A

Gender

Self-report

Categorical

Male, Female

Race

Self-report

Categorical

White, Not White

Education

Self-report

Categorical

Less than college,

Demographic Age (years)

Categorization

College degree or more

Clinical

A1C
BMI

EMR
EMR

Continuous/

A1C < 7.0 (in control),

Categorical

A1C ≥ 7.0 (not in control)

Categorical

BMI < 30 (not obese),
BMI ≥ 30 (obese)

Medical

Insulin Use

Self-report

Categorical

Insulin user,
Insulin non-user

History
Duration of

Self-report

Continuous

N/A

EMR

Continuous

N/A

EMR

Continuous/

No complications, one

Categorical

complication, two or more

diabetes (years)
Index of Comorbidity
(Charlson score)
Index of
diabetes-related
complications

complications

Diabetes

Calculated

Symptom

based on

burden (DSC-R

responses

total score)

from Self-

Continuous

report
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3.5

Sample Size Calculations and Power
Power is the likelihood that a study will detect a true effect of a given magnitude

if it actually exists (a true positive). Power can also be broadly termed as the probability
that a statistical significance test will reject the null hypothesis for a specified value of an
alternative hypothesis. Hence, power of a study is also the probability of avoiding a beta
error, in which we fail to reject a null hypothesis that is false. It is important to consider
power in research designs because studies with low power may be inconclusive.
A priori power analyses are conducted in order to ascertain the sample size
required to perform the analyses necessary for a study at a level of power desired prior to
the start of the study. For this purpose, it is necessary to decide upon the alpha level (the
probability of making an alpha or Type 1 error) for the analysis, the desired power
(1 minus the probability of making a beta or Type 2 error), and the effect size. Effect size
can be conceived of as a measure of the distance between the null hypothesis and the
alternate hypothesis. Hence, effect size refers to the underlying population rather than a
specific sample. Although desirable to specify an effect size in research that has clinical
implication, it is typical to decide the degree of deviation from the null hypothesis that is
large enough to be clinically relevant.
In order to perform power calculations for the analyses in the study, a software
package called G-Power (Faul & Erdfelder, 1992; Erdfelder, Faul, & Buchner, 1996) was
used in conjunction with any available statistical guidelines. For a priori power
calculations that could not be performed using G-Power, statistical guidelines were used.
In addition, more practical time and resource considerations were taken into account.
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Objective One:
There is no consensus on the sample size required to perform factor analysis, and
methodologists differ in this regard. One rule of thumb suggests at least 10 cases for
each item in the instrument being used. Bryant and Yarnold (1995) recommend that the
subjects-to-variables ratio be no lower than 5. With a dataset containing 385 cases for an
18-item instrument, the study had adequate sample size to conduct factor analyses in
Phase One.

Objective Two:
A very practical consideration in undertaking studies of this type pertains to the
time and resources available to do the modeling task. One of the reasons for choosing the
decomposed approach over the composite approach was its ability to model a large
number of health states by necessitating fewer valuations (Dolan, 2002). If the health
states that are required to be valued are randomly assigned to respondents, then it is
necessary to ensure sufficient numbers of valuations for those health states. The MAUF
is fitted mainly by using valuations for the corner states, single-attribute level states and
anchor states. In order build in precision into models that provide the VAS to SG
conversion curve, it was necessary that the marker states be valued using both VAS and
SG tasks by a sufficient number of respondents as well.
In this regard, it is useful to look at studies that have designed PBMH using the
MAUT framework. In the valuation study for the HUI-3 classification system, a sample
size of 256 respondents was arrived at using a 28 fractional factorial design (Furlong et
al., 1998). This was arrived at considering a couple of factors, including the need to
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maintain precision of the multiplicative MAUF of the HUI-3 in comparison to other
instruments in the HUI family. All of the 256 respondents valued the marker states,
while only 64 valued the single-attribute level states and corner states (Furlong et al.,
1998). In the development of the ASUI (Revicki et al., 1998a), 161 patients participated
in the study, while 100 provided valuations for the RSUI (Revicki et al., 1998b).
Respondents completed valuations for all the necessary health states in these two studies.
In the present study, the necessary health states required to develop the valuation
function for the health state classification system of the DUI, were each valued by a total
of 100 subjects.

Objective Three:
The a priori calculation of required sample size necessitated making a decision on
the anticipated effect size index for regression, f2 (Cohen, 1988). f2 reflects the
proportion of variance accounted for by some source in the population (PVs) relative to
the residual variance proportion (PVe), such that f2 = PVs / PVe. For multiple regression
with a set of predictors, the hypothesis tested was that the correlation of a set of
predictors with a dependent variable is zero in the population. While f2 is equal to R2 / 1R2 (where R2 is the coefficient of determination obtained from the regression using the
set of predictors), the required power was decided as 0.8 with an alpha level of 0.05. For
a set of predictors explaining 20% of the variance in the dependent variable, f2 would be
0.25, and with 12 predictors, a sample size of 81 was needed to achieve a power of 0.8.
Another conservative estimate necessitated at least 15 subjects per variable; for 12
predictors the required sample size was 300.
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CHAPTER FOUR: RESULTS
4.1

Objective One

4.1.1

Classical Test Theory

4.1.1.2 Overview
The process of designing a diabetes health state classification system began with
the exploratory analysis of a dataset containing responses of 385 people with Type 2
Diabetes to the 18-item ADDQoL collected in previous research (Sundaram, 2005). The
profile of these respondents can be summarized as: about 57% respondents were female,
64 % in 40-69 age range, 94% were Caucasian. The mean diabetes duration was 10.2
(+9.1) years, mean A1C of respondents was 7.2 (+1.4), with about 50% experiencing at
least one diabetes-related complication, and 62.1% were obese (BMI>30). About 49 %
of respondents were on oral medications only, 32% on oral medications and insulin, and
13% on insulin only.
A negative score on the ADDQoL would indicate that diabetes was negatively
affecting the QoL of the individual, while a positive score would indicate a positive effect
of diabetes. Intuitively, a person with diabetes is expected to report a negative influence
of the disease on his or her QoL. At the same time, the bipolar scale allows for some
respondents to have positive scores, although these were expected to be uncommon. As
shown in Table 4, the maximum negative impact of diabetes was felt on ‘freedom to eat’,
‘enjoyment of food’, and on ‘finances’, while diabetes least impacted ‘society reaction’,
‘dependence’, and ‘living conditions’. The original and recoded means of the impact
ratings for the 18 items are respectively represented in Columns 4 and 5 of Table 4.
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Table 4: Mean Scores for ADDQoL Items

Item
no.

ADDQoL Item
Weighted
Impact
Mean Score 1

Original
Un-weighted
Impact
Mean Rating 2

Recoded
Un-weighted
Impact
Mean Rating 3

1

Working life

-1.73 (±2.52)

-1.04 (±1.05)

-1.04 (±1.05)

2

Family life

-2.17 (±2.72)

-1.00 (±1.00)

-1.00 (±1.00)

3

Social life

-1.56 (±2.34)

-0.74 (±0.91)

-0.74 (±0.91)

4

Sex life

-1.60 (±2.64)

-0.94 (±1.14)

-0.95 (±1.13)

5

Physical Appearance

-1.33 (±2.30)

-0.65 (±0.95)

-0.66 (±0.93)

6

Physical activities

-2.16 (±2.67)

-1.04 (±1.05)

-1.04 (±1.04)

7

Holidays/ leisure

-1.75 (±2.47)

-0.87 (±1.01)

-0.87 (±1.01)

8

Travel

-1.84 (±2.51)

-0.98 (±1.04)

-0.98 (±1.04)

9

Confidence in ability

-1.67 (±2.48)

-0.79 (±0.97)

-0.79 (±0.97)

10

Motivation

-1.59 (±2.38)

-0.77 (±0.94)

-0.77 (±0.94)

11

Society reaction

-0.88 (±1.84)

-0.47 (±0.80)

-0.47 (±0.80)

12

Future

-2.13 (±3.34)

-0.92 (±1.28)

-0.96 (±1.20)

13

Finances

-2.20 (±2.90)

-0.98 (±1.06)

-0.98 (±1.06)

14

Dependence

-1.23 (±2.89)

-0.55 (±1.17)

-0.59 (±1.09)

15

Living Conditions

-1.32 (±2.31)

-0.61 (±0.92)

-0.61 (±0.92)

16

Freedom to eat

-3.10 (±3.04)

-1.54 (±1.13)

-1.54 (±1.12)

17

Enjoyment of food

-2.89 (±3.10)

-1.36 (±1.13)

-1.36 (±1.12)

18

Freedom to drink

-1.89 (±2.75)

-0.99 (±1.15)

-1.01 (±1.11)

1. Original Weighted Impact Score ranges between -9 to +9
2. Original Un-weighted Impact Rating ranges between -3 to +3
3. Recoded Un-weighted Impact Rating ranges between -3 to +1
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4.1.1.2 Examination of Factor Structure
The classical index of discrimination, the item-total correlation coefficients (r) for
an item’s weighted impact score with the total average weighted impact score was greater
than 0.4 for each item, and hence, none of the items were marked for exclusion on this
basis. Exploratory Factor Analysis (EFA), employing Principal Axis Factor (PAF)
extraction and Promax rotation, was performed on all the 18 items. The Kaiser-MayerOlkin (KMO) measure of sampling adequacy as well as the Bartlett test of sphericity
indicated that FA would yield useful information from the data. The Scree plot indicated
one major factor accounting for 49% of the total variance. The loading pattern of items
to the dominant factor was unclear due to which the factor could not be described without
ambiguity. From the loading of the items on the rotated factor solution, two smaller
factors could be identified as diet-related (‘food’, ‘eat’, and ‘drink’) accounting for 11%
of the total variance, and relationships-related (‘work’, ‘family’, ‘friends’, and ‘sex’)
accounting for 6% of the total variance. Overall, these results were similar to those
obtained from the EFA of the weighted impact scores.
The next steps involved iterative EFAs excluding items with:
• communalities less than 0.4 – ‘worries’, ‘sex’, ‘drink’, ‘dependence’, and ‘finance’;
• similar loadings on different factors (such that the differences in loadings across
factors is ≤ 0.1) – ‘leisure’.
Excluding the above six items again resulted in a factor structure with one dominant
factor accounting for 53% of the total variance. Again, this factor could not be described
without ambiguity on the basis of the loading of items, but a smaller factor (accounting
for 6% of the total variance ) could be identified as diet-related (‘food’, and ‘eat’). Since
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the exploratory nature of the exercise was geared more towards understanding the
composition of plausible factors, a forced-three factor solution was requested with the
same set of (12) remaining items. In addition to the diet-related factor, the relationshipsrelated factor could be identified again (‘work’, ‘family’, and ‘friends’), while the
remaining seven items could at best be described as a functioning-related attribute. The
factor loadings of the 12 items from the forced 3-factor rotated solution is represented in
Table 5.
This factor structure formed the basis of the plausible attributes suggested to the
Clinical Expert Panel members as part of the process of designing the diabetes-specific
health state classification system. The plausible attributes submitted to the expert panel
was expanded in its scope, in that they also included relevant ADDQoL items that were
excluded in successive EFAs in adherence to statistical criteria (see Appendix 2).
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Table 5: Factor Loading from the Forced 3-Factor Rotated Solution of ADDQoL
Items
Factor Loadings 1
Factor 1 2

Factor 2 3

Factor 3 4

Motivation

0.879

0.024

-0.037

Confidence in Ability

0.848

0.023

-0.042

Travel

0.842

-0.083

0.114

Physical

0.715

0.068

0.052

Living

0.690

0.041

0.030

Society Reaction

0.462

0.257

-0.061

Appearance

0.452

0.320

-0.149

Family

0.023

0.822

0.037

Friends

0.066

0.724

0.035

Work

0.297

0.510

0.042

Eat

0.019

-0.028

0.932

-0.021

0.066

0.806

ADDQoL Item

Food

1. Factor loadings for each variable on the factors; using Principal Axis Factoring and Promax Rotation.
2. Plausible variable: Functioning-related.
3. Plausible variable: Relationships-related.
4. Plausible variable: Diet-related.
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4.1.2 Input from the Clinical Expert Panel
The importance ratings provided by patients with Type 2 Diabetes to the 18
ADDQoL items (contained in a dataset from previous research, n=385) were compared
with the ratings provided by the expert panel members (n=7). On the basis of these
importance ratings, two lists of the ten most important items, one each generated from
patient and expert panel input, were generated. Added to this pool were items not
contained in the ADDQoL but which the experts considered to be important. The intent
behind the exercise was to build an item pool with which to construct and describe up to
five attributes for the diabetes-specific classification system, in concert with the results
obtained from the statistical analyses described in the previous section.
A comparison of ratings showed that the patients and the expert panel both
included five ADDQoL items in their respective lists of ten important items. These items
are listed as ‘top consensus items’ in Table 6, and were added to the item pool discussed
above. Other items that figured in either but not both lists are listed as ‘top nonconsensus items’ in Table 6, and were also added to this pool along with those items that
are not contained in the ADDQoL but which the experts considered to be important,
listed as ‘others’ in the table. Finally, these items were organized into attributes (see
Table 6) to be included in the first version of the diabetes health state classification
system based on the factor loadings observed in the final iteration of EFA and expert
panel input on the composition of attributes from ADDQoL and other items.
Successive pilot versions of the diabetes health state classification, titled the
Diabetes Utility Index (DUI), were analyzed using Rasch Analysis.
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Table 6: Pooling Items for the Classification System based on Patient and Expert
Panel Input
Top Consensus
Items 1,2

Top Non-Consensus
Items 2,3

Other
Items 4

Plausible
Attribute 5

Food
2.0 (±0.79) [10] /
2.6 (±1.13) [4]

Eat
2.0 (±0.78) [12] /
2.9 (±0.38) [1]
Drink
1.6 (±0.88) [18] /
2.1 (±0.69) [9]

Enjoyment of Diet

Family
2.4 (±0.72) [1] /
2.7 (±0.49) [2]

Work
2.1 (±0.76) [2] /
2.4 (±0.53)[5]
Friends
2.1 (±0.81) [6] /
1.9 (±1.21)[11]
Sex
1.9 (±0.92) [14] /
1.9 (±0.90) [12]

Relationships

Physical
2.1 (±0.71) [3]/
2.0 (±1.00) [10]

Dependence
2.0 (±0.84) [13] /
2.3 (±0.76) [7]

Pain
Energy

Physical ability &
Energy level

Confidence
2.0 (±0.78) [8]/
2.1 (±0.90) [8]

Worries
2.0 (±0.79) [9] /
1.9 (±0.90) [14]
Motivation
2.0 (±0.76) [7] /
1.4 (±0.98) [15]

Depression

Mood and feelings

Confidence
/2.0 (±0.78) [8]/
2.1 (±0.90) [8]

Motivation
2.0 (±0.76) [7] /
1.4 (±0.98) [15]

Finances
2.1 (±0.76) [4] /
2.7 (±0.49) [3]

Living Conditions
2.0 (±0.74) [5] /
1.0 (±0.82) [17]
Dependence
2.0 (±0.84) [13] /
2.3 (±0.76) [7]
Travel
1.8 (±0.81) [16] /
2.3 (±0.76) [6]

Satisfaction

Self-Care

Lifestyle freedom/
Life Situations/
Freedom Living Life

1. Items that were ranked by both patients and experts in their Top 10 among most important attributes
2. The statistics are present as follows:
patient importance rating: Mean (SD) [importance rank] / expert importance rating: Mean (SD)
[importance rank]. Importance ratings are on a scale were ‘0’represents ‘not at all important’ and
‘3’represents ‘very important’. A Rank of ‘1’ denotes the highest possible rank.
3. Items that were ranked by either patients or experts, but not both, in their Top 10 among most important
attributes.
4. Other items considered as important by the experts
5. Plausible attribute that can be explained by a combination of consensus, non-consensus, and other
important items.
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4.1.3

Modern Test theory

4.1.3.1 Fit of Items to the Rasch Model
Rasch Analysis was employed on data obtained from the pilot testing of three
versions of the diabetes health state classification system (n1=52, n2=65, n3=111) using a
software package called Winsteps (Linacre, 2007). This section also includes results
from the Rasch Analysis of the dataset obtained from the Validation Survey (n=396) that
was sent out after the diabetes health state classification system, the DUI, was finalized at
the end of the last pilot round. Table 7 summarizes the endorsement by the survey
respondents of the severity levels contained in the various versions of the classification
system. The fit of the selected attributes (or items, since each attribute is also one item of
the classification system) to the Rasch model was assessed on the basis of the Chi-Square
based statistics of Infit and Outfit Mean Squares (MNSQs). These statistics are
represented in Table 8.
The versions tested in pilots 1 and 2 differed, among others, largely in the nature
of the rating scales employed. The rating scale was standardized to some extent in Pilot 2
for all the attributes. From the Infit and Outfit MNSQs in the Pilot 2 results (Table 8), the
relative benefits of this standardization are not entirely evident, presumably because of
issues related to the overfit of the attribute (item) ‘freedom living life’. This was the only
major deviation from the Rasch model identified across the different pilot versions tested.
The problem persisted even upon modification of the attribute (‘freedom living life’ in
Pilot 1) to present a related construct of ‘life style freedom’ (in Pilot 2). Overfit of an
item to the Rasch model indicates item redundancy, or dependence on other items
included in the model which in this case would be the attribute ‘physical ability and
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energy level’. This dependence can be explained on the basis of the theoretical
expectation that the respondents with impaired physical ability may also naturally report
constraints with their lifestyle freedoms.
The issue of dependent items needed to be addressed because of two reasons.
First, the classification system was being designed to be as comprehensive as logically
feasible and parsimonious - this necessitated the exclusion of an attribute that may be
found to be redundant with another that provided more useful information. Second,
attribute independence was a characteristic desired in the classification system in order to
avoid complications in the determination of its utility scoring function as noted in the
development of the HUI-2 (Torrance et al., 1996). The preference elicitation of some
health states required to be specified when the decomposed approach is being employed
(for example, those with the worst level in one attribute, yet the best in others) could be
problematic if such states are implausible because of the lack of independence among
attributes (Feeny, 2002a).
Exclusion of the ‘lifestyle freedoms’ attribute corrected the problem of misfit that
came to be identified in the related ‘physical ability & energy level’ attribute (compare
Pilot 2 and Pilot 3 results for the attribute in Table 8), perhaps on account of the
dependent nature of the association between the two. The replacement was made in
concert with the opinions of the clinical expert panel and tested in Pilot 3. The attribute
‘Satisfaction with management of diabetes’ was found to fit the Rasch model desirably
without impairing the fit of the other attributes (especially the ‘Mood & Feelings’
attribute, with which it can be marginally expected to be related). It was also expected
that, with the inclusion of the satisfaction attribute, no major problems would arise during

117

Chapter Four

the preference elicitation of health states that are required to be specified in order to
calculate a MAUF for the classification system using the decomposed approach.
The final DUI attributes were: ‘Physical Ability & Energy’, ‘Relationships’,
‘Mood & Feelings’, ‘Enjoyment of Diet’, and ‘Satisfaction with Management of
diabetes’. Results of the validation survey, included in Table 8, indicated Infit MNSQs
ranging between 0.83 and 1.1, and Outfit MNSQs ranging between 0.77 and 1.07 for the
five attributes indicating that the five DUI attributes in general adequately fit the Rasch
uni-dimensional model. Person and item reliabilities were 0.71 and 0.96, while the
respective separation ratios were 1.55 and 5.01. The ‘Physical Ability & Energy Level’
attribute was the most difficult and the ‘Satisfaction’ attribute was the easiest. The ItemSeparation and Item-Reliability at 5.01 and 0.96, respectively, indicated a fair spread of
items. The Person-Separation was moderate at 1.55, while the Person-Reliability was
acceptable at 0.71.
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Table 7: Endorsement of Severity Ratings of Versions of the Diabetes Utility Index
Pilot 1 1
n
Attribute 1
Level 1
Level 2
Level 3
Level 4

%

Physical Ability
13
29
8
2

25.0
55.8
15.4
3.8

Pilot 2 2
n

%

Physical Ability &
Energy Level
23
35.4
31
47.7
8
12.3
3
4.6

Pilot3 2
n

%

Physical Ability &
Energy Level
57
51.4
44
39.6
7
6.3
3
2.7

Physical Ability &
Energy Level
183
46.2
148
37.4
49
12.4
16
4.0

Attribute 2 Relationships
Level 1 21
40.4
Level 2 20
38.5
Level 3
9
17.3
Level 4
2
3.8

Relationships
18
27.7
35
53.8
9
13.8
3
4.6

Attribute 3

Mood &
Feelings
21.2
48.1
25
5.8

Mood &
Feelings
2
3.1
38
58.5
21
32.3
4
6.2

6
83
20
2

Mood &
Feelings
5.4
74.8
18.0
1.8

Mood &
Feelings
38
9.6
244
61.6
101
25.5
13
3.3

Enjoyment
of Diet
12
23.1
26
50.0
12
23.1
2
3.8

Enjoyment
of Diet
8
12.3
39
60.0
14
21.5
4
6.2

Enjoyment
of Diet
31
27.9
60
54.1
15
13.5
5
4.5

Enjoyment
of Diet
111
28
194
49.0
67
16.9
24
6.1
Satisfaction with
Managing
Diabetes
126
31.8
210
53.0
60
15.2
396

Level 1
Level 2
Level 3
Level 4
Attribute 4
Level 1
Level 2
Level 3
Level 4
Attribute 5
Level 1
Level 2
Level 3
Level 4
Total N

11
25
13
3

Freedom Living
Life

Lifestyle
Freedoms

Relationships
33
29.7
60
54.1
17
18.3
1
0.9

Validation
Survey 4
n
%

20
22
6
4

38.5
42.3
11.5
7.7

7
43
12
3

10.8
66.2
18.5
4.6

Satisfaction with
Managing
Diabetes
44
39.6
48
43.2
19
17.1
-

52

100

65

100

111

100

1. Pilot data from the testing of Version One. See Appendix 4 to view this version.
2. Pilot data from the testing of Version Two. See Appendix 6 to view this version.
3. Pilot data from the testing of Final Version. See Appendix 7 to view this version.
4. Data from the Validation Survey using the Final Version.

119

Relationships
127
32.1
168
42.4
76
19.2
25
6.3
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Table 8: Item and Person Fit Statistics for Versions of the Diabetes Utility Index
Pilot 1 1

Pilot 2 2

Pilot3 3

Validation Survey 4

0.53

0.87

0.92

0.96

1.07

2.63

3.34

5.01

0.68

0.77

0.65

0.71

1.46

1.81

1.36

1.55

Item
Reliability
Item
Separation
Person
Reliability
Person
Separation
I5
Attribute 1

O6

Physical Ability
1.10

Attribute 2

Attribute 3

1.19

0.81

O6

Physical Ability
& Energy Level

1.52

1.07

1.10

Relationships

1.08

1.02

1.07

1.08

Mood &
Feelings
1.09

Enjoyment
of Diet
0.97

Freedom
Living Life
0.58

Total N

Physical Ability
& Energy Level

I5

Relationships

0.99
Attribute 5

O6

Relationships

1.16
Attribute 4

I5

0.59
52

0.95

Mood &
Feelings
1.01

0.88

Enjoyment
of Diet

0.58

0.83

0.91

0.92

Satisfaction with
Managing
Diabetes

0.48

1.02

65

0.94

1.05

0.90

0.86

1.02

0.12

0.85

-0.51

Enjoyment
of Diet
1.06

1.06

0.09

Satisfaction
with Managing Diabetes
1.11

1. Pilot data from the testing of Version One. See Appendix 4 to view this version.
2. Pilot data from the testing of Version Two. See Appendix 6 to view this version.
3. Pilot data from the testing of Final Version. See Appendix 7 to view this version.
4. Data from the Validation Survey using the Final Version.
5. Infit Mean Squares
6. Outfit Mean Squares
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0.77

Mood &
Feelings
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7. Item Difficulty in logits

Difficulty 7

Relationships

Enjoyment
of Diet

1.15

Lifestyle
Freedoms

0.96

O6

Physical Ability & Energy
Level

Mood &
Feelings

0.99

1.37

1.02

I5

1.07
396

-0.57
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4.1.3.2 Rating Scale Diagnostics Using Rasch Analysis
The performance of the rating scales (severity levels) of the DUI were judged on
the basis of their Average measures, Step calibrations, and Infit and Outfit MNSQs. The
Average measures for each rating category were required to advance evenly up the
severity level, and be reasonably close to their expected values. The Step calibrations
were required to advance in an orderly manner such that the distance between adjacent
categories was between 1.5 logits and 5.0 logits. Outfit MNSQs for category levels were
required to be < 2.0, indicating less randomness and unexpected use of category levels.
While interpreting the results of the Rasch rating scale diagnostics (Tables 9 and
10) , one needs to bear in mind that the results are often unstable under smaller sample
sizes of the kind encountered in the pilot testing of the DUI (Linacre, 2007, personal
communication), chiefly in Pilots 1 and 2. The results may also be unstable in the event
of poor endorsement of certain levels of the rating scale because of the small sample size
overall or because of poor construction that may leave certain levels un-endorsed in spite
of a reasonable sample size. Those results in Tables 9 and 10 that are not in conformance
to the desired norms listed in the previous paragraph have been italicized.
The rating scales saw a major change between the versions tested in Pilots 1 and
2. The rating scale tested in Pilot 1 was directly influenced by suggestions from the
clinical expert panel and was more subjective as compared to the scale employed in later
versions. Results of the scale diagnostics were largely acceptable. However, a decision
was made to adopt a reasonably standardized rating scale across attributes and to test it in
the next pilot. The virtues expected from this change were:
1. less ambiguity in interpreting the meaning of the scale levels;
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2. ease of identification of the differences between scale levels; and
3. less respondent burden from faster completion times because of familiar rating
scale construction across attributes.
An added, though comparatively less important, benefit of the new rating scale
construction was seen in the reduced size of the instrument. The scale levels performed
satisfactorily across the DUI attributes; the result was confirmed from the Rasch rating
scale diagnostics conducted on the data from the Validation Survey, as can be seen in
Tables 9 and 10. In the final version of the DUI, the attributes ‘Physical Ability &
Energy Level’, ‘Relationships’, ‘Mood & Feelings’, and ‘Enjoyment of Diet’ contained
four levels of severity each while the fifth attribute ‘Satisfaction with the Management of
Diabetes’ contained three levels. This classification system can describe a total of 768
(4x4x4x4x3=768) unique health states.
Overall, the Rasch rating scale diagnostic tests of data obtained on the final
validation survey indicated that the severity levels of the DUI attributes performed well.
The average measures were found to increase with the severity levels of each DUI
attribute (Table 10). The probability are presented in Figure 6 for each attribute, with
Level 1 representing the best level and Level 4 (Level 3 in attribute #5) representing the
lowest (or most severe) level. The curves show distinct peaks indicating that each
category (severity level) is the most probable response category for some level on that
attribute. These results indicated that the rating scale statements were satisfactorily
understood and differentiable. Excluding Level 2 on “Mood & Feelings” which spanned
a relatively greater distance on the attribute, the step calibrations for the severity levels of
other attributes were within expectations.
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Table 9: Rating Scale Diagnostics for Versions of the Diabetes Utility Index (1)

Pilot 1 1
I4

O5

Attribute 1

AM 6

SC 7

I4

Physical Ability

Level 1
Level 2
Level 3
Level 4

0.76
0.89
0.84
2.37

Attribute 2
Level 1
Level 2
Level 3
Level 4

0.75
0.85
1.63
1.35

Attribute 3
Level 1
Level 2
Level 3
Level 4

2.19
0.59
0.71
1.15

0.74
0.88
0.83
3.66

O5

0.79
0.76
1.85
1.30

-3.07
-1.20
0.79
-0.18

none
-3.28
0.87
2.41

1.32
0.61
0.45
0.66

1.40
0.82
0.83
0.81

none
-2.62
-0.04
2.67

1.64
0.79
0.74
0.65

Attribute 5
Level 1
Level 2
Level 3
Level 4

0.66
0.73
0.45
0.39

-1.99
-2.01
0.33
1.14

none
-3.09
0.38
2.71

0.92
1.18
1.00
0.82

1.03
2.68
0.37
0.59

-2.52
-1.69
0.35
1.69

52

-2.76
-1.05
0.51
1.91

none
-3.28
0.79
2.50

1.46
0.71
0.70
0.58

-3.34
-1.28
1.51
3.13

none
-3.68
0.87
2.82

0.77
1.19
1.03
0.78

-5.69
-2.33
0.35
2.44

none
-5.61
0.93
4.68

Enjoyment of Diet
none
-3.21
0.34
2.87

2.22
0.96
1.26
1.22

none
-2.19
0.93
1.27

0.77
0.51
0.49
0.64

Freedom living Life
0.77
0.67
0.31
0.36

-3.28
-0.99
1.83
3.13

Mood & Feelings

Enjoyment of Diet
1.26
0.91
0.82
0.77

SC 7

Relationships

-2.65
-.69
0.31
0.98

Mood & Feelings
1.88
0.64
0.67
1.11

AM 6

Physical Ability
& Energy Level

Relationships

Attribute 4
Level 1
Level 2
Level 3
Level 4

Total N

Pilot 2 2

1.61
0.88
0.99
1.10

-3.86
-1.81
0.74
1.89

none
-4.41
0.90
3.51

Lifestyle Freedoms

100%

0.58
0.56
0.32
0.59

-5.07
-1.74
1.56
3.13

65

1. Pilot data from the testing of Version One. See Appendix 4 to view this version.
2. Pilot data from the testing of Version Two. See Appendix 6 to view this version.
4. Infit Mean Squares
5. Outfit Mean Squares
6. Average Measure
7. Step Calibration
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1.14
3.75
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Table 10: Rating Scale Diagnostics for Versions of the Diabetes Utility Index (2)
Pilot3 1
I3
Attribute 1

O4

AM 5

SC 6

Physical Ability & Energy
Level

Level 1
Level 2
Level 3
Level 4

0.93
1.03
0.74
1.89

Attribute 2
Level 1
Level 2
Level 3
Level 4

1.11
.82
.80
4.53

Attribute 3
Level 1
Level 2
Level 3
Level 4

1.14
.82
.79
.90

0.96
1.05
0.68
2.56

-2.65
-0.88
1.05
1.53

I3

O4

1.09
.71
.79
5.02

-3.13
-1.47
0.84
-1.72*

none
-2.40
0.97
1.14

0.89
0.75
0.75
0.99

none
-3.71
.02
3.70

1.15
0.89
0.94
1.27

1.04
.90
.64
1.01

1.03
.98
.59
1.07

Attribute 5
Level 1
Level 2
Level 3
Level 4

.84
1.00
1.24
-

.84
.85
1.20
-

-3.48
-2.08
.43
2.75

none
-5.41
1.21
4.20

1.30
0.74
0.77
1.09

0.90
0.64
0.69
1.07
1.10
0.87
0.91
1.39
1.10
0.77
0.71
1.03

111

none
-2.99
0.83
2.15

1.25
0.93
0.85
1.24

1.13
1.03
0.80
1.37

none
-1.41
1.41
-

1.17
0.99
1.14
-

1.16
0.93
1.12
-

-2.76
-1.19
0.52
1.74

none
-2.54
0.33
2.22

-2.88
-1.86
0.68
1.87

none
-4.68
0.76
3.92

-2.77
-1.28
0.69
1.73

none
-2.88
0.65
2.23

Satisfaction

100%

396

1. Pilot data from the testing of Final Version. See Appendix 7 to view this version.
2. Data from the Validation Survey using the Final Version.
3. Infit Mean Squares
4. Outfit Mean Squares
5. Average Measure
6. Step Calibration
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none
-2.28
0.39
1.90

Enjoyment of Diet

Satisfaction
-2.98
-1.16
0.46
-

-2.53
-0.62
1.14
2.23

Mood & Feelings

Enjoyment of Diet
-3.14
-1.64
.49
1.90

SC 6

Relationships

Mood & Feelings
1.46
.87
.74
.8

AM 5

Physical Ability & Energy
Level

Relationships

Attribute 4
Level 1
Level 2
Level 3
Level 4

Total N

Validation Survey 2

-2.70
-0.88
0.94
-

None
-1.95
1.95
-

100%
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Figure 6: Rasch Category Probability Curves (Validation Survey)

Physical Ability & Energy Level *

Level 1
Level 4

Level 2
Level 3

Relationships *

Level 2
Level 4

Level 1
Level 3

* See footnote presented after the Rasch probability curves for the ‘Satisfaction’ attribute
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Mood & Feelings *

Level 4
Level 3
Level 2

Level 1

Enjoyment of Diet *

Level 2
Level 4
Level 1
Level 3

* See footnote presented after the Rasch probability curves for the ‘Satisfaction’ attribute
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Satisfaction with Management of Diabetes

Level 2
Level 1

Level 3

1. For each DUI attribute, Level 1 represents the best level and Level 4 (Level 3 in attribute #5) represents
the lowest (or most severe) level.
2. The x-axis (Category Probability) represents the probability of responding to a particular level on an
attribute. The y-axis (Measure relative to item difficulty) represents the difference in a person’s ability
(severity on an attribute) and item (attribute) difficulty in logits. For example, individuals with greater
abilities (higher level of severity) on attributes relative to the difficulty of the attribute (for example, +4
on the x-axis) have a higher probability of responding to levels 3 or 4 on the attribute.
3. The intersections of rating scale curves represent step calibrations. Step calibrations between adjacent
severity levels in the range of 1.5 and 5.0 logits indicate that the severity levels are neither too narrow
nor too broad.
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4.2

Objective Two

4.2.1

Overview
A total of 100 persons with diabetes participated in the utility elicitation

interviews, all conducted by a single interviewer. The demographic profile of the
participants is described in Table 11. The interviews took 64 (±17.5) minutes to
complete on an average, with the lengthiest interview lasting 135 minutes. The average
number of minutes the participants took to complete the Feeling Thermometer (FT) and
Chance Board (CB) tasks were 37 (±14.9) and 16 (±8.5) respectively, with the most
amount of time being 85 minutes for the FT and 40 minutes for the CB. While 4% of the
participants found the FT tasks to be either difficult or very difficult, 74% found the tasks
to be either easy or very easy. A similar proportion (70%) found the CB tasks to be
either easy or very easy while 10% rated them to be difficult or very difficult. Almost
94% of the interviews were rated by the interviewer to be either good or very good
overall, with 91% of the participants understanding the questions asked to them either
totally or for the most part.
Towards the beginning of the interview, 31 participants found Pits to be the least
desirable condition while the remaining 69 regarded Dead as least desirable. All the
participants were consistent in their choice of the least desirable state between the FT and
CB stages of the interview, and hence Group A and Group B respondents, respectively,
formed 31% and 69% of the sample interviewed. The data were analyzed as delineated
in the methods section, the basic approach being to calculate aggregated Person-Means of
the scale anchors, marker states and single-attribute utility states for the two groups. The
results of these analyses are summarized in Tables 12 and 13.
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Table 11: Demographic Summary of Interview Participants

n

%

Gender
Male 32
Female 68

32%
68%

White 92
Black 6
Other 2

92%
6%
2%

Race

Marital Status
Single
Married
Divorced/ Separated
Widowed
Not married/ living with partner

7
69
11
10
3

7%
69%
11%
10%
3%

5
23
27
22
23

5%
23%
27%
22%
23%

Employed
Retired
Home-maker
Student
Seeking work
Other

50
30
12
2
3
3

50%
30%
12%
2%
3%
3%

$25,000 or less
$25,001 - $50,000
$50,001 - $75,000
More than $75,000
Refused

19
31
28
16
6

19%
31%
28%
16%
6%

100

100%

Education
High school or less
High school graduate/ GED
Some college/ vocational college
College degree
Graduate / professional degree
Employment

Household income

Total N
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4.2.2

Transformation of Measured Preferences
The following calculations were performed separately for Groups A and B for all

the health states described:
The ten percent trimmed means were calculated from the raw FT values of the
scale anchors, marker states and single-attribute utility states as well as the CB utilities
for marker states and anchors, and are depicted in Columns 2 and 3 of Tables 12 and 13.
No further adjustments were made to the CB utilities obtained separately from the two
groups.
An end-of-scale bias adjustment (EOSBA) was applied to those FT values of
marker states and single-attribute level states greater than 75. Only Marker State A and
second-ranked single-attribute health states (i.e. those immediately below PH in a set of
single-attribute level states for one attribute) needed this adjustment; the adjusted values
are depicted in Column 4.
This sort of adjustment (that changes the FT value of only one health state in a
set) necessitates that the original spacing between health states in a set be restored. This
was accomplished for single-attribute level states by rescaling the FT values between the
EOSBA-adjusted value and the value of the lowest single-attribute level state (i.e. the
corner state, using positive linear transformations). The resultant rescaled FT values are
depicted in Column 5.
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Table 12: Measured and Calculated Preference Scores - Group A

State
Physical Ability&
Energy Level

10% Trimmed
Mean Value 1

EOSBAAdjusted
Value 1

n

Re-scaled
Value 1

Calculated
Utility 2

2
3
4

31
31
31

92.5
75.5
45.0

95.8
75.5
45.0

95.8
77.6
45.0

0.914
0.728
0.395

Relationships

2
3
4

31
31
31

95.0
77.1
54.0

97.2
77.1
54.0

97.2
78.3
54.0

0.929
0.735
0.487

Mood & Feelings

2
3
4

31
31
31

92.0
72.0
47.0

95.5
72.0
47.0

95.5
74.0
47.0

0.911
0.691
0.415

Enjoyment of Diet

2
3
4

31
31
31

95.0
75.0
60.0

97.2
75.0
60.0

97.2
75.9
60.0

0.928
0.711
0.549

Satisfaction

2
3

31
31

95.0
65.0

97.2
65.0

97.2
65.0

0.929
0.600

31
31

6.5
0.0

6.5
0.0

6.5
0.0

0.001
0.000

Dead
Pits

1. Person-Mean(A) Values on a Perfect Health=100 / Pits=0 scale, measured on Visual Analog Scale tasks
using a Feeling Thermometer.
2. Person-Mean(A) Utilities on a Perfect Health=1.00 / Pits=0.00 scale, calculated using a Group A-specific
value to utility conversion algorithm.
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Table 13: Measured and Calculated Preference Scores – Group B

Calculated
Utility 2

Calculated
Re-scaled
Utility 3

96.2
74.7
48.0

0.911
0.715
0.473

0.901
0.684
0.415

97.2
78.0
55.1

97.2
79.3
55.1

0.920
0.757
0.537

0.911
0.730
0.486

95.0
75.0
45.0

97.2
75.0
45.0

97.2
76.3
45.0

0.920
0.730
0.446

0.911
0.700
0.384

2 69
3 69
4 69

96.0
77.0
62.0

97.8
77.0
62.0

97.8
77.8
62.0

0.925
0.743
0.600

0.917
0.715
0.556

2 69
3 69

96.0
70.1

97.8
70.1

97.8
70.1

0.925
0.674

0.917
0.637

69
69

0.0
11.4

0.0
11.4

0.0
11.4

0.000
0.280

-0.111
0.000

EOSBAAdjusted
Value 1

n

10%
Trimmed
Mean
Value 1

2 69
3 69
4 69

93.3
73.1
48.0

96.2
73.1
48.0

Relationships

2 69
3 69
4 69

95.0
78.0
55.1

Mood & Feelings

2 69
3 69
4 69

Enjoyment of Diet

Satisfaction

State
Physical Ability&
Energy Level

Dead
Pits

Re-scaled
Value 1

1. Person-Mean(B) Values on a Perfect Health=100 / Dead=0 scale, measured on Visual Analog Scale tasks
using a Feeling Thermometer.
2. Person-Mean(B) Utilities on a Perfect Health=1.00 / Dead=0.00 scale, calculated using a Group Bspecific value to utility conversion algorithm.
3. Person-Mean(B) Utilities on a Perfect Health=1.00 / Pits=0.00 scale.
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4.2.3 Fitting Value-Utility Conversion Functions
The next set of calculations performed separately for Groups A and B involved
estimating value to utility conversion functions that would enable the conversion of FT
values for single-attribute utility states into Standard Gamble utilities (that were not
directly obtained from the CB for those states). In order to calculate these two
conversion functions, 10% trimmed means of FT values and CB utilities of the three
marker states from the two groups were used separately (For Marker state MA, the
EOSBA-adjusted 10% trimmed means were used). Additionally, the 10% trimmed
means of CB utilities of Dead and Pits were respectively used in the calculation of
conversion functions for Groups A and B, respectively.
The calculation of a conversion function was relatively simple to accomplish with
Group A data where both the FT values and the CB utilities were obtained on a PH-Pits
scale. While Group B FT values were obtained on a PH-Dead scale, CB utilities for the
group were obtained on a PH-Pits scale. However, the proposed conversion function
emanating from this sub-exercise would be applied to Group B FT values calculated for
single-attribute level states for a PH-Dead scale. Hence, the CB utilities for Marker
States obtained for this group had to be rescaled from the PH-Pits scale in which they
were measured to a PH-Dead scale by using the CB utility for Pits obtained on a PHDead scale from Group B respondents. This calculation is described in Table 14.
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Table 14: Linear Rescaling of Values from Pits/PH Scale to Dead/PH Scale for
Group B Respondents
Marker
State MA

Marker
State MB

Marker
State MC

Utility on Pits/PH scale

0.90

0.43

0.14

Disutility on Pits/PH scale

0.10

0.57

0.86

Range of Pits/PH utility scale

1.00

1.00

1.00

Utility of Pits on Dead/PH scale

0.10

0.10

0.10

Range of Pits/PH utility scores
on Dead/PH scale

0.90

0.90

0.90

Disutility on Dead/PH scale

0.09

0.51

0.77

Utility on Dead/PH scale

0.91

0.49

0.23
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Two simple linear regression models, one each for Group A and Group B,
employing EOSBA-adjusted FT values as the predictor variable and the 10% trimmedCB utilities as the dependent variable, were tested on data from the three marker states
(n=4). With adjusted R2s of 0.969 and 0.947 respectively, the simple linear regression
models employed with Group A and Group B data were found to predict the required
utility estimates in their respective groups adequately. The data used in the regression
models as well as the parameters used to calculate the value-to-utility conversion
functions for the two groups are described in Table 15.

4.2.4 Calculation of Overall Person-Mean Utilities
The value-to-utility conversion functions were used to calculate Person-Mean(A)
and Person-Mean(B) utility scores from the EOSBA-adjusted and rescaled FT values for
the single-attribute level states and corner states of the respective groups. The calculated
Person-Mean(A) and Person-Mean(B) utilities are represented in Column 6 of Tables 12
and 13. In order to combine these utilities into one aggregated variable on a common
scale, Person(B) utilities were rescaled to a PH-Pits scale by positive linear
transformation. The rescaled Person(B) utilities are represented in Column 7 of Table 13.
This facilitated the calculation of overall aggregated Person-Mean utility scores
using the respective prevalence proportion of each Groups A and B as weighting factors.
The weights employed for Groups A and B were 0.31 and 0.69 respectively (based on
group sizes of 31 and 69 out of a total N of 100 participants). The overall aggregated
Person-Mean utility scores are represented in Column 2 of Table 16.
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Table 15: Data Used to Estimate Value to Utility Conversion Models

Group A (PH-Pits Scale)
Marker
State

10% Trimmed
Mean Value 1

EOSBAAdjusted Value

10% Trimmed
Mean Utility 2

MA

91.5

95.2

0.93

MB

58.6

51.1

0.43

MC

22.9

23.3

0.13

Dead

9.1

6.5

0.05

Model Fit Statistics: Adj. R2 =0.9828; F(1,3)=172.87; p=0.005
Utility Conversion Function for Group A is represented as follows:
Predicted utility of health state = 0.01022159 * FT value of health state -0.0650056.

Group B (PH-Dead Scale)
Marker
State

10% Trimmed
Mean Value 3

EOSBAAdjusted Value

10% Trimmed
Mean Utility 4

MA

90.5

94.7

0.91

MB

57.9

50.0

0.49

MC

30.3

28.0

0.23

Pits

11.4

11.4

0.19

Model Fit Statistics: Adj. R2 =0.971; F(1,3)=103.52; p=0.009
Utility Conversion Function for Group B is represented as follows:
Predicted utility of health state = 0.0090883 * FT value of health state + 0.03666548.
1. Person-Mean(A) Values on a Perfect Health=100 / Pits=0 scale, measured on Visual Analog Scale tasks
using a Feeling Thermometer.
2. Person-Mean(A) Utilities on a Perfect Health=1.00 / Pits=0.00 scale, measured on Standard Gamble
tasks using a Chance Board.
3. Person-Mean(B) Values on a Perfect Health=100 / Dead=0 scale, measured on Visual Analog Scale tasks
using a Feeling Thermometer.
4. Person-Mean(B) Utilities on a Perfect Health=1.00 / Dead=0.00 scale, calculated from positive linear
transformation of Standard Gamble tasks performed using a Chance Board originally obtained on a
Perfect Health=1.00 / Pits=0.00 scale.
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Table 16: Aggregated Utility Scores and MAUT Parameters
Weighted
Person-Mean
Utility1

State
Physical Ability&
Energy Level

Person-Mean
Disutility2

Rescaled
Person-Mean
Utility3

Rescaled
Person-Mean
Disutility4

2
3
4

0.905
0.697
0.408

0.095
0.303
0.592

0.840
0.489
0.000

0.160
0.511
1.000

Relationships

2
3
4

0.917
0.732
0.486

0.083
0.268
0.514

0.838
0.478
0.000

0.162
0.522
1.000

Mood & Feelings

2
3
4

0.911
0.697
0.394

0.089
0.303
0.606

0.854
0.501
0.000

0.146
0.499
1.000

Enjoyment of Diet 2
3
4

0.920
0.714
0.554

0.080
0.286
0.446

0.822
0.359
0.000

0.178
0.641
1.000

Satisfaction

0.920
0.626

0.080
0.374

0.788
0.000

0.212
1.000

2
3

1. Overall Person-Mean Utility on a Perfect Health=1.00 / Pits=0.00 scale were calculated as
[0.31 * Person-Mean(A) utility + 0.69 * Person-Mean(B) rescaled utility].
2. Overall Person-Mean Disutility (Disutility = 1 – Utility) on a Pits=1.00 / Perfect Health=0.00 scale.
Bolded numbers represent the disutilities for the corner states (i.e. cjs).
3. Rescaled Overall Person-Mean Utility on a scale where the highest level on the attribute=1.00 and the
lowest level on the attribute=0.00.
4. Rescaled Overall Person-Mean Disutility on a scale where the lowest level on the attribute=1.00 and the
highest level on the attribute=0.00. These numbers represent the single-attribute level disutility scores,
(i.e. u`js), that are used to calculate overall the DUI disutility score depending on the attribute level
selected.
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4.2.5 Calculation of MAUT Parameters
The parameters required to develop a utility scoring function for the DUI using
the MAUT framework were obtained using a disutility approach, as discussed earlier.
These parameters were five ‘cj’s’ (overall Person-Mean disutility scores for corner states
of the five attributes of the DUI), a scaling parameter ‘c’, and a 15 ‘u`js’ (single-attribute
level disutility scores for every level of the five attributes of the DUI). The value of the
cj’s would also determine the type of model to be employed within the MAUT
framework, specifically whether a simple additive model would be adequate to develop
the scoring function for the DUI.
The overall Person-Mean utility scores were converted to disutility scores. The
disutilities for the five corner states were designated as cj’s (where j=1 through 5); these
are represented in Column 3 of Table 16. Borrowing from Equation 3, the additive
model would hold if the sum of the cj’s were equal to 1. Since the sum of the cj’s was
2.532, the additive model was rejected and the multiplicative model was chosen to
describe the interaction between the five attributes of the DUI, and thereby calculate a
utility scoring function for the DUI. A general multiplicative MADUF that provides
disutilities on a Pits=1.00/ Perfect Health=0.00 scale was represented in Equation 4.
Towards fitting the MADUF, the value of the scaling parameter ‘c’ was
calculated, by iteratively solving Equation 5, to be equal to -0.966. Additionally, the
‘uj`s’ were to be calculated on a scale where the lowest level of an attribute had a
disutility of 1.00 and the highest level of an attribute had a disutility of 0.00. The first
step in this calculation was to convert the Person-Mean single-attribute level utility
scores for each attribute from a Pits=0.00/ Perfect Health=1.00 scale into a scale where
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the lowest level of a given attribute=0.00 and the highest level of the attribute=1.00, as
depicted in Column 4 of Table 16. These were converted to disutility scores (Column 5
of Table 16) on the desired scale, and were designated as uj`s (where j=1 through 5).

4.2.6 Obtaining Utility Scores from DUI Responses
Overall Utility Function
Substituting the values of ‘c’, c1, c2, c3, c4, and c5 discussed in the previous section
into the general multiplicative MADUF illustrated in Equation 4, we get
Disutility = (1 / - 0.966) * ((1 + (-0.966) * 0.592 * uattribute1) *
(1 + (-0.966) * 0.514 * uattribute2) *
(1 + (-0.966) * 0.606 * uattribute3) *
(1 + (-0.966) * 0.446 * uattribute4) *
(1 + (-0.966) * 0.374 * uattribute5) -1).
Thus, an overall disutility (on a scale where PH=0.00 / Pits=1.00) can be
calculated by substituting the appropriate values of uattribute1 through uattribute5 in the
equation above, obtained from the uj`s for each attribute (presented in Column 5 of Table
16), depending on the severity level for each attribute on the DUI. This disutility score,
when subtracted from 1.00, yields the required overall utility score (on a scale where
PH=1.00 / Pits=0.00). For example, the disutility for a health state represented as
(3,3,4,3,2) can be calculated as:
Disutility PH=1.00 / Pits=0.00 = (1 / - 0.966) * ((1 + (-0.966) * 0.592 * 0.511) *
(1 + (-0.966) * 0.514 * 0.522) *
(1 + (-0.966) * 0.606 * 1.000) *
(1 + (-0.966) * 0.446 * 0.641) *
(1 + (-0.966) * 0.374 * 0.212) -1)
= 0.88; and
Utility PH=1.00 / Pits=0.00 = (1 – 0.88) = 0.12
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Single-Attribute Utility Functions
In addition to an overall function, the DUI provides single-attribute functions that
indicate the preference associated with being on specific levels within an attribute. In
disutility terms, they are the uj`s (presented in Column 5 of Table 16), depending on the
severity level for the DUI attribute considered, on a scale where the lowest level on an
attribute has a disutility=1.00 and the highest level has a disutility=0.00. These disutility
scores, when subtracted from 1.00, yield the required single-attribute utility scores (on a
scale where the highest level=1.00 / lowest level=0.00). The five single-attribute
functions, one for each DUI attribute, are summarized in Table 17.
MAUF on a PH-Dead Scale
Conventionally, utility scores are based on a scale where PH=1.00 and
Dead=0.00. In order to transform the MAUF from the DUI-specific PH=1.00/Pits=0.00
scale into a conventional PH=1.00 / Dead=0.00 scale, the SG utility for Dead on a
PH=1.00/Pits=0.00 scale was needed (Furlong et al., 1998). This was obtained by
aggregating:
a. the 10% trimmed mean of directly measured SG utility for Dead (equal to 0.05,
on a PH=1.00 / Pits=0.00 scale) from Group A respondents (n=31); and
b. the derived SG utility of Dead (equal to -0.11, on a PH=1.00 / Pits=0.00 scale)
from Group B respondents (n=69), by linear transformation of the 10% trimmed
mean of directly measured SG utility of Pits (equal to 0.10, on a PH=1.00 /
Dead=0.00 scale).
The weighted average utility for Dead on a PH=1.00 / Pits=0.00 scale was calculated as
0.31 * (0.05) + 0.69 * (-0.11), and was found to be equal to -0.06, indicating that for the
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sample interviewed, overall, Dead was less preferable compared to Pits. An overall
disutility score for a health state (on a scale where PH=0.00 / Dead=1.00) can be
calculated as:
Disutility PH=1.00 / Dead=0.00 = Disutility PH=1.00 / Pits=0.00 / (1 – Utility of Dead PH=1.00 / Pits=0.00); and
Utility PH=1.00 / Dead=0.00 = 1 - Disutility PH=1.00 / Dead=0.00
For example, the disutility for a health state represented earlier as (3,3,4,3,2) can
be calculated as:
Disutility PH=1.00 / Dead=0.00 = 0.88 / 1 - (-0.06) = 0.83; and
Utility PH=1.00 / Dead=0.00 = 1 – 0.83 = 0.17.
The calculations necessary to calculate the utility scores based on the DUI MAUF are
summarized in Table 17.
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Table 17: DUI Multi-Attribute Utility Function
Physical Health
& Energy Level

Relationships

Mood &
Feelings

Enjoyment
of Diet

Level

u1

u2

u3

u4

Satisfaction
with
Management
U5

1

0.00

0.00

0.00

0.00

0.00

2

0.160

0.162

0.146

0.178

0.212

3

0.511

0.522

0.499

0.641

1.000

4

1.000

1.000

1.000

1.000

NA

MADUF: Formula for Disutility (PH=0.00 / Pits=1.00)
Disutility(PH=0.00 / Pits=1.00) = (1 / - 0.966) * ((1 + (-0.966) * 0.592 * u1) *
(1 + (-0.966) * 0.514 * u2) *
(1 + (-0.966) * 0.606 * u3) *
(1 + (-0.966) * 0.446 * u4) *
(1 + (-0.966) * 0.374 * u5) -1)
MAUF: Formula for Utility (PH=1.00 / Pits=0.00)
Utility(PH=1.00 / Pits=0.00) = 1 - Disutility(PH=0.00 / Pits=1.00)
Formula for Disutility (PH=0.00 / Dead=1.00)
Disutility(PH=0.00 / Dead=1.00) = Disutility(PH=0.00 / Pits=1.00) / 1 - (- 0.06)
Formula for Utility (PH=1.00 / Dead=0.00)
Utility(PH=1.00 / Dead=0.00) = 1- Disutility(PH=0.00 / Dead=1.00)
= 1- (Disutility(PH=0.00 / Pits=1.00) / 1 - (- 0.06))
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4.3

Objective Three: Validating the DUI

4.3.1

Overview
A total of 396 usable responses were obtained to the Validation Survey, with a

response rate of about 33%. About 52% of the respondents were female, over one-third
were 65 years or older, while just under two-thirds did not have a college degree. The
demographic profile of the respondents is summarized in Table 18.
The average age of respondents and duration of diabetes were 59 (±13.9) years
and 12 (±11.5) years, respectively. About 80% of the respondents reported being Type 2,
while 15% reported being Type 1. About 43% of the respondents reported currently
using insulin overall; 36% of the respondents with Type 2 diabetes reported using insulin.
The mean of average A1Cs in the past year for respondents was 7.5 (±1.6), and more than
70% had at least one diabetes-related complication in the past year, from analysis of their
ICD-9 diagnosis codes. About 91% of the respondents self-reported that they did not
have either an ER visit or hospitalization related to diabetes during the previous year,
with the mean number of physician-office visits related to diabetes being 3 (±2.1) visits
during the previous year. The average BMI was 32.4 (±7.7), with about 80% of the
respondents being either overweight or obese.
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Table 18: Socio-demographic Profile of the Validation Survey Respondents
n

%

Male
Female

191
204

48.2%
51.5%

White
Black
Other

380
9
5

96.0%
2.3%
1.3%

Single
Married
Divorced/ Separated
Widowed
Not married/ living with partner

42
263
30
43
14

10.6%
66.4%
7.6%
10.9%
3.5%

47
125
84
69
70

11.9%
31.6%
21.2%
17.4%
17.7%

Employed
Retired
Retired – Disability
Home-maker
Student
Other

163
158
14
38
9
13

41.2%
39.9%
3.5%
9.6%
2.3%
3.3%

Household income
$25,000 or less
$25,001 - $50,000
$50,001 - $75,000
More than $75,000
Refused

128
105
77
55
31

32.3%
26.5%
19.4%
13.9%
7.8%

Total N

396

100%

Gender

Race

Marital Status

Education
High school or less
High school graduate/ GED
Some college/ vocational college
College degree
Graduate / professional degree
Employment
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4.3.2 Distribution of DUI Scores
The scores reported for the DUI are on the PH=1.00 / Dead=0.00 scale. The DUI
scores calculated from the validation survey responses ranged from 0.00 to 1.00. The
mean DUI score was 0.61 (±0.24) and the median score was 0.66. The histogram of DUI
scores (Figure 7a) indicates a relatively flat distribution that is skewed to the left
(skewness and kurtosis were calculated to be -0.42 and -0.79 respectively). From the
Normal Q-Q and box plots (Figures 7b and 7c), it can be inferred that the distribution is
light-tailed, indicating less severe deviation from normality.
Rasch analysis conducted on data obtained on the endorsement of DUI severity
levels from the Validation Survey indicated a Person-reliability, an equivalent of the
classical ‘test’ reliability, of 0.71 (n=396). This statistic provides information on the
number of levels to which the DUI is able to discriminate the sample into levels on a
linear continuum of HRQoL, which would be about two to three for the DUI based on a
person reliability of 0.71. Another Rasch reliability statistic, the ‘item-reliability’ (no
equivalent in Classical Theory) was calculated to be 0.96 for the DUI (n=396). The fit of
individual attributes (items) of the DUI to the Rasch model and the Rasch rating scale
diagnostics have been discussed in an earlier section.

145

Chapter Four

Figure 7: Distribution of DUI Scores
Figure 7a: Histogram

Figure 7b: Normal Q-Q Plot
This Q-Q normality plot of DUI scores
shows no outliers and an S-shaped curve,
with the upper end bending above a
hypothetical straight line passing through
the main body of the X-Y values of the
plot, and the lower end bending below
the line. This suggests a light-(left) tailed
distribution.

Figure 7c: Box Plot
This box plot of DUI scores shows no
outliers, with the tails of the box short
relative to the height of the box. The
mean value is below the median (the
center line in the box), the median line
does not evenly divide the box, and the
lower tail of the box plot is longer than
the upper tail. This suggests a light-tailed
distribution.
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4.3.3

Examination of DUI Severity Categories and Attribute-level Scores
Scores on relevant patient-reported outcomes measures were compared across the

severity categories of the DUI attributes and with its single-attribute utility scores. The
SF-12 Physical Component Summary (PCS-12) scores were significantly lower within
higher severity groups on the Physical Ability & Energy level attribute, F(3,392)=111.75,
p<0.001. The correlation between the single-attribute utility scores for this attribute and
PCS-12 scores was 0.65 (p<0.001). Those reporting higher severity groups on the Mood
& Feelings attribute had significantly lower SF-12 Mental Component Summary (MCS12) scores, F(3,392)=82.1, p<0.001, and total Well-Being Questionnaire (WB-Q12) scores,
F(3,392)=95.3, p<0.001. The correlations for the single-attribute scores for this attribute
were: 0.59 (p<0.001) with MCS-12 scores, 0.61 (p<0.001) with Total W-BQ12 scores,
0.48 (p<0.001) with the Positive well-being subscale scores, 0.52 (p<0.001) with the
energy subscale scores, and -0.572 (p<0.001) with the negative well-being subscale
scores. The Diabetes Empowerment Scale Short-Form (DES) scores were significantly
lower within higher severity groups on the ‘Satisfaction with managing changes’
attribute, F(2,392)=45.25, p<0.001. The correlation between the single-attribute scores for
this attribute and DES scores was 0.38 (p<0.001).
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4.3.4

Construct, Concurrent, and Predictive Validation of the DUI Utilities
The concurrent validity of the DUI was evaluated by examining the relationship

between the DUI and other generic PBMH. The correlations of the DUI scores with
generic PBMH were moderate: 0.62 (p<0.001) with SF-6D scores, 0.60 (p<0.001) with
EQ-5D scores and 0.66 (p<0.001) with the derived HUI-3 scores. The correlations are
summarized in Table 19.
As evidence of the construct validity of the DUI, its scores were examined against
indicators of disease severity. The correlation between DUI utilities and the average of
A1Cs in the past one year was small, but significant (r=-0.30, p<0.001). The correlations
with the Diabetes Symptoms Checklist-Revised (DSC-R) subscale scores (see Table 19)
were as follows: hyperglycemic -0.47; hypoglycemic -0.55; psychological -0.64;
cardiovascular -0.47; neurological -0.58; and ophthalmologic -0.51; all statistically
significant (p<0.001). The negative sign of these correlations indicate that lower DUI
utilities are associated with higher diabetes symptom scores.
The DUI scores significantly differed between categories based on the number of
diabetes-related complications, calculated on the basis of prevalent ICD-9 diagnosis
codes in the last one year, F(2, 389)=9.682 (p<0.001). Specifically those with two or more
complications had significantly lower DUI scores as compared to those with none
(p<0.001) or one complication (p=0.015). Table 20 reports the DUI scores observed
within sub-categories based on clinical and medical history variables.
The DUI scores predicted by the MAUF were compared with the SG scores
directly obtained for the three marker states. The MAUF underestimated SG utilities, on
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an average by 0.05, with the closest prediction observed for the more severe state. These
differences are represented in Table 21.
There was only a small relationship between the DUI scores and age (r=0.14), and
there was no significant difference in scores between men and women. Those without a
college degree, however, had significantly lower DUI scores than those with a college
degree or beyond (t=-3.76, p<0.001). Further analysis revealed that those without a
college degree also had significantly higher diabetes symptom burden, as evidenced from
higher scores on the DSC-R (t=5.53, p<0.001). The relationship between DUI scores and
education was found to be not significant when controlled for by DSC-R scores,
F(2,392)=0.232, p=0.630.
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Table 19: Correlations with the DUI Utilities
Correlations 1
DUI 2

Single-Attribute Utility Scores
Physical
Ability &
Energy
Level

Relationships

Mood &
Feelings

Enjoyment
of Diet

Satisfaction
with
Managing
Changes

Total DSC-R 3

-0.670

-0.649

-0.490

-0.553

-0.530

-0.358

Hyperglycemic

-0.468

-0.412

-0.308

-0.339

-0.411

-0.274

Hypoglycemic

-0.550

-0.384

-0.336

-0.561

-0.432

-0.303

Psychological

-0.643

-0.602

-0.434

-0.568

-0.475

-0.330

Cardiovascular

-0.472

-0.469

-0.346

-0.371

-0.428

-0.237

Neurological

-0.582

-0.614

-0.449

-0.445

-0.458

-0.324

Ophthalmologic

-0.509

-0.564

-0.475

-0.424

-0.380

-0.250

0.596

0.666

0.465

0.521

0.381

0.231

0.623

0.608

0.456

0.550

0.381

0.275

0.660

0.670

0.475

0.568

0.424

0.311

0.571

0.653

0.461

0.395

0.354

0.240

0.574

0.456

0.350

0.589

0.401

0.312

0.470

0.281

0.268

0.354

0.305

0.384

0.641

0.521

0.371

0.614

0.449

0.373

Positive Well-Being

0.522

0.420

0.274

0.481

0.356

0.305

Energy

0.592

0.522

0.377

0.519

0.417

0.342

Negative Well-Being

- 0.530

- 0.396

- 0.302

- 0.572

- 0.378

- 0.309

EQ-5D
SF-6D
HUI-3 Derived
SF PCS-12
SF MCS-12
DES
Total W-BQ12

4
5
6
7
8
9

10

1. All figures reported here are Pearson’s correlations. The correlations were all found to be significant (p<0.001).
2. DUI = Diabetes Utility Index scores on a PH=1.00/Dead=0.00 scale.
3. DSC-R = Diabetes Symptoms Checklist – Revised total scores followed by subscale scores standardized on a 1-100
scale.
4. EQ-5D = EuroQoL EQ-5D index scores.
5. SF-6D = Short-Form 6D scores.
6. HUI-3 Derived = Health Utilities Index (HUI) Mark 3 scores derived from SF-12 items.
7. SF PCS-12 = SF-12 Physical Component Summary scores on a 1-100 scale
8. SF MCS-12 = SF-12 Mental Component Summary scores on a 1-100 scale
9. DES = Diabetes Empowerment Scale Short Form scores.
10.W-BQ12 = Well-Being Questionnaire (12-item) total scores followed by subscale scores.
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Table 20: Construct Validation of the DUI Utilities

Variable

Physical
Ability
&
Energy
Level 1

Relationships 1

Mood &
Feelings

Enjoyment
of Diet 1

Satisfactio
n with
Managing
Changes 1

DUI 2

0.79

0.69

0.71

0.71

0.72

0.54

1

Insulin Use
1. Insulin user
2. Insulin non-user

0.87

0.83

0.78

0.77

0.74

0.65

p=0.114

p=0.002

p=0.025

p=0.058

p=0.004

p<0.001

1. A1C < 7.0

0.86

0.83

0.78

0.77

0.79

0.66

2. A1C ≥ 7.0

0.81

0.73

0.73

0.71

0.68

0.56

p<0.001

p<0.001

p=0.001

p=0.034

p=0.529

p<0.001

1. None

0.90

0.82

0.80

0.80

0.77

0.67

2. One complication

0.86

0.80

0.77

0.75

0.73

0.63

3. Two or more

0.76

0.71

0.71

0.70

0.72

0.54

p<0.001
(1 Vs 3)
p=0.001
(2Vs3)

p=0.003
(1 Vs 3)
p=0.023
(2Vs3)

p=0.001
(1 Vs 3)

p=0.018
(1 Vs 3)

-

p<0.001
(1 Vs 3)
p=0.015
(2Vs3)

p-value

3

Glycemic Control

p-value 3
Diabetes
Complications

p-value 4

1. Single attribute utility scores are calculated on a scale where the lowest level on this attribute has a utility of 0.00 and
the highest level has a utility of 1.00.
2. DUI utility scores are calculated on a scale where the Perfect Health has a utility of 1.00 and Dead has a utility of
0.00.
3. p-value for t-test (for variables with two categories)
4. p-value for post-hoc ANOVA test (for variables with more than two categories). Non-significant differences between
sub-groups are not reported.
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Table 21: Predicted Validity of the DUI MAUF

Marker State A

Marker State B

DUI Disutility 1

0.16

0.63

0.88

-

DUI Utility

0.84

0.37

0.12

-

2

0.93

0.43

0.13

-

SG Utility(B) 3

0.90

0.43

0.14

-

SG Utility 4

0.91

0.43

0.14

-

Difference

-0.07

-0.06

-0.02

SG Utility(A)

Marker State C Average

1. DUI MAUF predicted utility on a PH=1.00/Pits=0.00 scale.
2. Group A Standard Gamble 10% trimmed mean utility on a PH=1.00/Pits=0.00 scale.
3. Group B Standard Gamble 10% trimmed mean utility on a PH=1.00/Pits=0.00 scale.
4. Overall weighted average Standard Gamble 10% trimmed mean utility on a PH=1.00/Pits=0.00 scale.
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A hierarchical regression model was constructed in order to explain the
relationship between DUI utilities and the various demographic, clinical, and medical
history predictors. The model was checked for violations of regression assumptions,
including for the presence of multi-collinearity that was expected in view of the multiple
indicators of disease severity and co-morbidity that were available from the validation
survey component of this study. During this process of diagnostic checks, the variables
representing ‘index of complications’ and ‘BMI’ had to excluded in order to avoid multicollinearity. The remaining variables were entered sequentially into the model in the
following order:
Block 1: Average A1C, Insulin use (categorical), Duration of diabetes, Diabetes symptom
burden (i.e. DSC-R total score);
Block 2: Index of co-morbidity (i.e. Charlson co-morbidity score); and
Block 3: Demographic variables: Age, Gender and Education (all categorical).
Wherever indicated, the categories were designated as indicated in Table 3. Since
indicators of co-morbidity and diabetes severity were retained in the model, the exclusion
of the two variables was not expected to lead to a loss in model specification. Although
‘average A1C’ was retained, ‘insulin use’ was included since the variable was expected
to additionally represent the expected burden resulting from the administration of
injectible insulin. The resultant model had an adjusted R2 of 49% (F(8,291) = 36.8;
p<0.001). Those with a greater burden of diabetes symptoms (p<0.001), indicated by
higher DSC-R scores, those with higher A1C levels (p=0.041), and those using insulin
(p=0.05) were found to have significantly lower DUI utility scores, as summarized in
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Table 22. This indicates that insulin use had an effect on DUI utility scores independent
of the effect of diabetes symptoms and glycemic control.

Table 22: Results of the Hierarchical Regression Model Predicting DUI Utilities
Predictor

Beta

Variable

Std.

Test

Sig.

Error

statistic (t)

p

1.

Insulin Use

0.048*

0.025

1.97

0.050

2.

Diabetes duration

0.000

0.001

0.15

0.882

3.

Average A1C

-0.014*

0.007

-2.05

0.041

4.

Diabetes Symptoms Burden

-0.008*

0.001

-13.63

< 0.001

5.

Index of Co-morbidity

0.000

0.004

0.09

0.926

6.

Age in years

0.000

0.001

0.44

0.660

7.

Gender

-0.031

0.021

-1.49

0.137

8.

Education

0.020

0.022

0.89

0.374

* significant at 0.05 level
Model fit statistics:
R2 = 0.71, adjusted R2 = 0.49, F(8, 291) = 36.8, p < 0.001
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CHAPTER FIVE: DISCUSSION AND CONCLUSIONS

5.1

Objective One
The health state classification system of the DUI represents an effort in the

development of a diabetes-specific PBMH involving inputs from theory, an existing
diabetes-specific measure of quality of life, a clinical expert panel, primary data
collection, and statistical analyses. Obtaining input from the descriptive system offered
by an existing valid and reliable measure avoided the need to perform extensive research
on content identification and item pool composition. In addition to the classical approach
to reviewing the item content of the existing measure, the study incorporated techniques
based on the Modern Test Theory as well as subjective approaches based on expert
review.
In order to develop a disease-specific measure, it is necessary to build a pool of
items that reflect the areas of impairment caused by the disease. Type 1 and Type 2
diabetes are chronic illnesses that can influence QoL because the treatments are
burdensome and the complications can be debilitating and/or life-threatening. Patients
have to deal with their diabetes almost every instant of their life and have to make
continuous decisions that interfere with living a normal life. Patients with diabetes may
feel overwhelmed by the management of the disease that requires them to make diet and
lifestyle changes as well as taking medications (oral, injectible, or both). Apart from the
emotional and social burdens this may cause, patients with diabetes face the acute
physical distresses of hypoglycemia or hyperglycemia and chronic physical distress of
diabetes-related complications.
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At the outset, it was decided that the DUI was not intended specifically for either
Type 1 or Type 2 diabetes patients, and that the out-of-skin focus would be adopted to
ascertain items for the DUI given the broad range of impairments in life due to the nature
of diabetes and its management. Also, this implies that the scope of the DUI would be
beyond the ‘within the skin’ approach of a generic PBMH (that omits social interaction)
like the HUI-3 (Feeny et al., 2002) , and would not limit its focus to the measurement of
distresses due to disease (diabetes)-related symptoms. The latter approach was adopted
with disease specific PBMH like the ASUI (Revicki et al., 1998a) and the RSUI (Revicki
et al., 1998b) whose scores were not suitable for calculating QALYs. Polonsky’s (2000)
guidance in this regard was a starting point in the identification of relevant constructs that
ought to be measured using the out-of-skin focus in the assessment of the impact of
diabetes. Keeping in mind the nature of diabetes and its management, it was important to
build context-specificity to the DUI in order to estimate the true impact of the disease.
The next step involved the identification of an item pool in order to measure these
constructs. Structurally, profile-based measures are similar to PBMH, in that they
contain items representing various domains that are important in the measurement of the
overall construct they measure. Responses of patients with Type 2 Diabetes to the Audit
of Diabetes Dependent Quality of Life (ADDQoL), available from our previous research
(Sundaram et al., 2006), were explored as a first step towards identifying items. The
study utilized a dataset containing responses to the ADDQoL, a profile-based diabetesspecific QoL measure. In addition to the favorable psychometric properties of the
measure, the instrument was considered because of its applicability to both Type 1 and
Type 2 diabetes patients, as well as because a dataset with previously collected responses
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to this measure was readily available. In the process of developing the item pool, input
from both statistical analysis as well as a diabetes clinical expert panel was obtained.
Thus, the diabetes classification system borrowed from subjective input as well and was
not based on the content of the ADDQoL alone.
The purpose of using Classical Methods, (including used of Exploratory Factor
Analysis) was not limited to selecting (or excluding) ADDQoL items. The intention was
to rather explore the possibility of measuring the constructs described by Polonsky in a
dataset consisting of responses of patients with diabetes to items that can be relatable to
those constructs. The Classical statistical criteria we employed involved item exclusion
and forced three factor solution in order to gain a better understanding of the relationships
between ADDQoL items and not to propose an alternate structure for the instrument.
Two main DUI attributes could be ascertained in the process – ‘Relationships’ and
‘Enjoyment of Diet’, with other items potentially describing broad functioning- related
aspects in the lives of patients with diabetes.
The Diabetes Clinical Expert Panel was diverse in the area of expertise of its
members. Subjective input obtained from the panel helped better understand the nature
of the impact of diabetes on aspects of functioning, relationships, and enjoyment of diet,
and provided additional areas to consider in the measurement of the impact of diabetes.
The attributes of ‘Physical Ability & Energy Level’, ‘Mood & Feelings’, and
‘Satisfaction with the Management of Diabetes’ were identified in the process. The
subjective input gathered from the panel formed the basis of explaining the scope of the
DUI attributes in the form of actual easy to understand descriptions so as to avoid
ambiguity in the minds of the respondents. It was hoped that including these
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explanations in the DUI would enhance the validity of assessments. Additionally, input
from the panel provided initial suggestions on the rating scale for each selected attribute.
The intended approach was to avoid generic rating scales with ambiguous interpretation
that may be subject to biases.
The five selected attributes were tested in three successive pilot rounds for fit to
the Rasch model. The technique is robust to missing data, in comparison to CTT where
data have to either be discarded or imputation employed. This held special promise
because of the smaller sample sizes expected in the pilot rounds of testing the DUI.
Limiting the number of attributes to five helped in the design of health states that could
be feasibly presented to the interview participants in Objective Two of this research. In
general, people are said to be able to process a limited number of concepts at a time
(seven, plus or minus two) and therefore, parsimony in health state classifications
systems is desirable (Feeny, 2002a). Fewer attributes also perhaps works well with the
over-the-skin nature of an instrument’s content since the chances of overlap, and
consequentially, the risk of dependence between attributes, is lower.
Indeed, an important consideration in the development of the DUI was the
independence between its attributes. The decomposed approach to estimating a
preference scoring function essentially stipulates the measurement of the preference of
individual attributes of a classifications system and provides a framework for estimating
the overall preference of a health state in terms of the preferences of its constituent
attributes. Hence, it is important to be able to measure the unique contribution of
individual attributes to the overall preferences of health states (Feeny, 2002a). As can be
understood from the experience of the development of the HUI-2, dependent attributes
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complicate the process of preference elicitation when the decomposed approach is the
approach chosen (Torrance et al., 1996).
Dependence between items of an instrument can be ascertained by simply
understanding the nature of the items, from knowledge of theory, as well as from
statistical input. Rasch Analysis fit statistics employed on data from pilot versions of the
DUI indicated the problem of overfit of the attribute ‘freedom living life’ because of its
dependence on the ‘physical ability’ attribute, which in retrospect could be naturally
expected. The attribute was replaced with a related concept of ‘lifestyle freedoms’ in
order to tap patients’ perception of the impact diabetes has on account of the major
lifestyle changes that the condition imposes, but the problem of dependence persisted.
This problem could have potentially led to difficultly in having the interview respondents
view a corner state describing full ‘lifestyle freedom’ in the face of severely impaired
physical health. While the final set of DUI attributes did not theoretically indicate a
definitive threat of dependence, Rasch fit statistics obtained from Pilot 3 as well as the
Validation Survey do not suggest otherwise.

Potential Limitations and Sample Size Considerations
While the initial pool of items considered for the description of DUI attributes
were based on the structure of existing PBMH, theory on PRO evaluations in diabetes,
and an existing diabetes-specific measure of QoL, the diabetes clinical expert panel
additionally provided a qualitative and critical review of this pool as well as suggested
additional items that were not represented in the pool. This sought to minimize any bias
that may have been introduced by the exclusion of relevant and important items. The
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sample size of the dataset used in the determination of the initial plausible attributes was
adequate for performing factor analyses, with more than the suggested 15 subjects per
factor. The Rasch pilot samples were smaller in relation to those conventionally reported
as required to obtain stable parameters. Due to time and resource constraints, we were
unable to pursue larger samples in the pilot rounds, but we were successful in obtaining
data on pilot versions of the DUI and in diagnosing issues with the structure of the DUI
on the basis of the Rasch model parameters. Our final validation survey had a sufficient
sample size to interpret the Rasch output with confidence, and confirmed some of the
decisions that were taken by interpreting the output from the pilot rounds. Since Rasch
Analysis is considered to be free of sample effects, the results discussed here can be
considered to be mostly free of the biases that would normally be associated with the
usage of samples that were not geographically diverse- in our case, the use of samples
located for the most part in N-Central WV.

5.2

Objective Two
There is no consensus on which approach to choose for the purpose of modeling

health state valuations because each has a number of advantages and disadvantages. The
scoring function for the DUI was based on the principles of a well-established theory, the
MAUT, which permits certain assumptions to be made regarding the relationship
between the DUI attributes. The ability of the technique to enable the determination of a
scoring function for the DUI using fewer valuations was an important determinant of the
choice of the MAUT. The adopted Person-mean approach to summarizing the valuations
obtained in the interviews allows the estimation of a MAUF that provides utility
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estimates for the general diabetes population. The MAUT approach also afforded the
ability to estimate single-attribute functions for the five attributes of the DUI.
The preference-elicitation interviews were expected to be a subjective and
challenging exercise, given the length of the interviews and the nature of the tasks
involved. The participant reward, among others, was designed to evoke a satisfactory
level of interest from the participants in completing the interviews in a satisfactory
manner. All the interviews were conducted by one trained person who was also
technically aware of the principles of preference elicitation and the MAUT. While the
possibility of interviewer bias due to the selection of one interviewer alone is not ruled
out, the qualifications of the lone interviewer as well as participant feedback seems to
allay these concerns - about three-fourths found the FT tasks and the CB tasks to be either
easy or very easy to understand. While more participants found the CB to be difficult
than those feeling the same about the FT, this was anticipated given the comparatively
added cognitive burden of the CB. On the other hand, the interviewer reported that only
four percent of the respondents had a great deal of trouble in answering the questions.
The structure of the interview and the interview props were based on detailed
technical reports published by the HUI group (Furlong et al., 1990; Furlong et al., 1998),
with added consultations available from the group via phone and email. The HUI group
is reputed to be one of the pioneers in the design and development of modern health state
preference instrumentation techniques. The interview props, including the FT, CB and
health state cards were produced by a professional graphic design team using the design
suggested in the HUI manuals but making agreeable improvisations to the colors and
materials used. The interviews began with the administration of the DUI survey and a
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prior verbal explanation of the DUI attributes supplemented with a pictorially referenced
attribute sheet. This was intended to help reinforce the idea of the constituents of each
attribute in the minds of the respondents, and it is expected that this step in the interview
process aided the participants in taking part in the FT and CB tasks. Also, completing the
survey made participants familiar with the DUI classification system, especially the
sentences used to describe the severity levels of the five attributes, as well as provided
them an internal reference with which to compare other health states introduced during
the course of the interview.
In the interest of reducing the cognitive burden of the interviews, SG tasks were
performed only for the Marker States, while all health states including the Marker States
were valued on the FT. Though not the best possible approach, this method has been
considered to be reasonable, practical (Torrance et al., 2001), and has been used in the
determination of preference-scoring functions of other PBMH using the MAUT approach
(Torrance et al., 1996; Feeny et al., 2002; Revicki et al., 1998a; Revicki et al., 1998b).
Using a combination of VAS and SG tasks in the manner described above, however,
necessitates the use of a value-to-utility conversion function. A study-specific conversion
function was used, derived separately for the two sub-groups considered for the purpose
of analysis, rather than use the functions reported in the literature for generic populations.
With adjusted R2s in excess of 90%, the regression-based conversion functions for both
groups showed good ability to predict SG cardinal utilities from the values obtained in
FT-based tasks. The conversion functions thus allowed the calculation of SG utilities for
all the health states required for the estimation of a MAUF for the DUI, thereby imparting
interval properties to the DUI utilities. The study-specific maker states described in order
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to obtain data for the conversion also functioned as a set of internal references, never
removed from the FT board, against which participants could rate the other health states
included in the interview.
From the value of the sum of the disutilities of the corner states obtained during
the preference interviewers, it was determined that the DUI attributes were complements,
exhibiting an antagonistic disutility (or a synergistic utility) interaction, as has been
reported with the HUI-1 and HUI-2 (Furlong et al., 1998; Feeny et al., 2002). This
means that the disutility of disabilities in two DUI attributes together is less than the sum
of the disutility of disability in the two DUI attributes separately. Also, the sum of the
utility added by restoring ability in two DUI attributes will be less than the utility added
by restoring the abilities in both. Since the DUI attributes are preference complements,
they work in tandem; either one alone is not that valuable, but together they are very
valuable. This type of preference structure is indicative of multi-attribute risk-seeking
(MARS) (Furlong et al., 1998).
There was no strong a priori expectation that the DUI attributes would be better
suited to be fitted using multi-linear MAUF models, in which case an econometric
approach would be a better modeling approach than the MAUT (Feeny, 2002b). From
the data gathered during the preference elicitation interviews, a multiplicative MAUF was
fitted for the DUI because the additive model had to be rejected. This result was
expected since healthcare applications of the MAUF have seldom found the additive
model to be appropriate. This indicates that in process of calculating the utility for a DUI
health state, the preference interactions between attributes cannot be ignored. Although
the multiplicative model chosen to fit the MAUF allows for interactions between the DUI

163

Chapter Five

attributes, it places restrictions in that it only allows for a certain type of preference
interaction between all the attributes. While multi-linear MAUF models do not place this
restriction, comparative studies show that the multiplicative models not only capture the
important interactions, but also fare better in predicting utilities for health states using the
directly-measured SG utilities for those heath states as a benchmark (Furlong et al.,
1998).
The majority of the interview respondents indicated ‘Dead’ to be their worst state.
This choice is generally study-specific and should hence should be understood in relation
to the description of the DUI-defined ‘Pits’ state. Evidently, most respondents found the
DUI Pits state to be preferable to Death when asked to make a choice. Although the
respondents were classified into groups based on their choice of the worst health state
during both the conduct of the interviews as well as the analysis of the interview data, the
data were aggregated on the PH-Pits scale for the purpose of calculating the necessary
metrics to fit a MAUF.
The DUI MAUF is capable of predicting utilities for all the health states defined
in the geometric space bound by its five attributes. Dead is undefined in the DUI system
as is the case with other PBMH, while the ‘Pits’ states defined by PBMH are not
standardized but are specific to classification systems. The aggregated SG utility for
Dead, obtained directly for Group A respondents and calculated for Group B respondents
facilitated the calculation of the DUI utilities in the more traditional PH-Dead scale, such
that these utilities could be used to calculate QALYs. Since the majority of the
respondents found Dead to be the worst state, the modified DUI MAUF on a
PH=1.00/Dead=0.00 scale calculates the utility of the Pits state to be greater than zero.
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The utility scores provided by the DUI thus meet the three criteria – they convey
preferences of users of healthcare, they are measured on an interval scale, and are
calculated on a PH=1.00/Dead=0.00 scale.
The results of the preference interviews indicate the feasibility of conducting
preference interviews for health states composed of ‘out-of-skin’ aspects of life that are
influenced by diabetes and its treatments. Additionally, these results suggest the
practicality of the decomposed approach in formulating a scoring function for a diseasespecific PBMH not based entirely on disease-related symptoms. The degree of cooperation provided by the respondents indicates that the health states, described in
accordance with the requirements of fitting a MAUF based on the MAUT, were
reasonably conceivable and that it was possible to elicit both VAS values and SG utilities
for these health states.
Sample Size Considerations
While it would be preferable to calculate a MAUF from a larger sample, the
respondent pool of 100 persons with diabetes seems adequate in relation to other studies
reporting the development of PBMH using the MAUT approach. More importantly, all
the valuations tasks required under MAUT were conducted for all the participants, rather
than allocating a sample of the total number of tasks to each participant. Hence, every
health state had 100 valuations, although the valuations were categorized into Groups A
and B in the ratio of 31:69 for calculation purposes. This categorization could not be
ascertained beforehand since it is dependant on participants’ responses during the
interview. At final count, it was not feasible to conduct any further number of interviews
to boost the sample size of Group A, if at all the increase was warranted for any reason.
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Given the non-acute nature of the description of the Pits health state, it can be reasonably
expected that the proportion of participants indicating Death to be a worse outcome in
comparison to Pits would always be more.
Potential Limitations
Preferences are considered to be heterogeneous. Hence, a potential limitation of
the MAUF derived in the study is its generalizability to populations in other geographical
regions and cultures. The recruitment efforts were concentrated more at outpatient
settings than community settings, though it is expected that a reasonable number of the
100 participants were people with diabetes who came to know about the interviews
through our dissemination efforts in the general community. While the sample was more
or less balanced across age-groups, more than half of the participants lacked a college
degree or came from households earning less than $50,000 a year, and more than twothirds were women. No clinical information could be collected during the course of the
interview to be able to compare with the answers to the interview questions, but it is
reported that lower income and less educated populations tend to exhibit poorer control
of their diabetes, leading to worse health outcomes.

5.3

Objective Three
Rasch analysis conducted on data from the Validation Survey indicated a lower

than expected Person-Separation of 1.55. However, the Person-Reliability, an equivalent
of the classical ‘test’ reliability, for this brief five-item measure was acceptable at 0.71.
Larger Rasch Person reliabilities result from respondent samples with a greater range in
abilities on the construct being measured, better test targeting, greater number of items on
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the instrument and longer rating scales. For reasons of maintaining parsimony as
discussed earlier, the number of attributes selected for inclusion in the DUI seems
adequate. Further increases in the length of the DUI severity rating scales also seem
unnecessary at this point since doing so may result in the inclusion of levels that lie
insufficiently endorsed or are not sufficiently differentiable by respondents, leading to
arbitrary levels being chosen. Even the three severity categories for the Satisfaction
attribute seem to provide a theoretically reasonable range of measurement. With the
severity levels presented in the form of statements, it was expected that there would be
less ambiguity in the minds of respondents when choosing one statement for each
attribute. Rasch rating-scale diagnostics indicated that these statements were indeed
reasonably well-functioning.
Within the constraints of the number of attributes and severity levels for the
attributes discussed above, a higher Person reliability for the DUI may be obtained if it
were administered to a diabetes population widely varying in the extent of the severity of
diabetes and its complications. While one-third of the respondents to the survey had no
complications, another third had only one diabetes-related complication with the mean
DSC-R standardized score across all the respondents being 20.7. Another Rasch
reliability, the ‘item reliability’ is independent of the length of the instrument and was
calculated to be 0.96 for the DUI. While high Item reliabilities can be obtained in larger
sample sizes, they are also indicative of a larger range of item difficulty. The ItemSeparation and Item-Reliability values together indicated that the five-item DUI covered
a satisfactory range in the measurement of the impact of diabetes.
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The scores on relevant patient-reported outcomes measures like the SF-12, WBQ12, DSC-R and DES were different across the severity categories of the DUI
attributes. The results indicate that the rating scale statements were differentiable and
also represented validated increases (or decreases) in the abilities on the construct (the
attribute) they represent. The DUI utility scores showed moderate correlations with other
generic PBMH scores (r=0.6) like the EQ-5D, the SF-6D, and the derived HUI-3 that, in
turn, showed moderate to high correlations among themselves. While this indicates the
concurrent validity of the DUI, the lack of large correlations with generic PBMH can be
expected due to the differences in content arising out of the disease specificity of the
DUI.
The DUI scores were largely free of socio-demographic effects since they were
not influenced by gender and age. The lower DUI scores among respondents with lower
education levels can be explained by the greater diabetes symptom burden observed in
this group, as seen from the DSC-R scores. The instrument also performed well in
relation to disease severity indicators – the number of complications and DSC-R scores.
Differences were observed in DUI scores between those with two or more complications
and those with either no or one complication. The differences in DUI utilities between
those with none and one complication were non-significant, as was the case with DSC-R
scores, leading to the reasonable conclusion that those with one diabetes-related
complication were relatively asymptomatic and hence did not report significantly
different scores from those with none. While the correlation with average A1C levels in
the past one year was higher and significant with the DUI utility scores than with generic
PBMH, the magnitude of this correlation itself was small and can be interpreted in light
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of the suggested small magnitude of association between a biomedical marker such as
A1C and humanistic outcome such as QoL (Lau, Qureshi, & Scott, 2004; Sundaram et
al., 2006). On the other hand, those respondents with A1Cs below the American
Diabetes Association-suggested level of 7.0 were found to have significantly higher DUI
utility scores.
The DUI MAUF was used to determine the utility scores for respondents to the
Validation Survey, in which a large population of people with diabetes answered the DUI
questions. Not all the health states that can be described on the DUI were directly valued
using the SG technique, which can be considered to be the closest there is to any
available gold-standard for comparison with the MAUF predicted utilities. Since the
DUI MAUF will be frequently used to generate utilities for health states that were not
directly measured, an assessment of this out-of-sample prediction will influence the
degree of confidence placed in the scores calculated from the function. The scores
predicted by the DUI MAUF for the three Marker States were compared to the 10%
trimmed means of the directly derived SG scores for the respective states. The results of
this internal validity check show that while the MAUF slightly under-estimates SG
utilities for mild and moderate health states, the differences are very small for relatively
severe health states. The mean absolute difference from SG utilities was 0.05, which was
equal to the mean differences in scores and is hence not misleading as would be the case
due to possible offsets of under-estimated utilities by over-estimated utilities.
Unfortunately, only three health states provided data for this comparison.
While interpreting this difference, it is important to understand that the DUI
MAUF was derived from Person-Mean preferences and that it was designed to provide
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utility scores for a broad range of health states that can be defined from its classification
system. These preferences were obtained from individuals with diabetes rather than from
a general population because of the need to build context specificity within the preference
scores. While members of the general population can be considered to provide more
objective evaluations without any bias, their preferences, however, may not be able to
adequately reflect the unique decisions that patients with diabetes have to permanently
make in their every day lives in managing diabetes.
Sample Size Considerations & Potential Limitations
The sample sizes that were available to conduct the various validation analyses
were adequate. The validation results presented here are based on the analysis of
responses obtained from a diabetes outpatient population in N-Central WV, and hence
may not be generalizable. The survey respondents had a relatively good level of
glycemic control overall, with an average of A1C in the past year equal to 7.5 (±1.6) and
more than 90% self-reporting not having either an ER visit or hospitalization related to
diabetes during the previous year. While more than 70% had at least one ICD-9 diagnosis
code related to a diabetes complication, the mean DSC-R score (standardized to a high
score of 100 that corresponds to the greatest burden of the symptoms of diabetes) was 21,
indicating that the respondents of the validation survey had a low diabetes burden overall.
On the other hand, about 80% were either overweight or obese. Our respondents were
overwhelmingly white, with more than two-thirds not having a college degree. The
performance of the DUI in populations with a more diverse racial mix that has better
education and greater burden of diabetes symptoms needs to be assessed. Such samples
may exhibit a higher probability of selecting the lowest (highest severity) level on the
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attributes, providing an instructional discussion on the floor and ceiling effects observed
with the use of the DUI.
Suggestions for Future Research
Additional validation testing using the DUI in more diverse populations will
enhance confidence in the applicability of the DUI to other research settings. Further
research is also needed to evaluate the responsiveness of the DUI. Since the DUI was
able to discriminate between groups based on disease severity, it can be expected to be
clinically responsive, which will enable its use in the assessment of changes in the
detection of the effects of disease progression and due to clinical interventions like the
Staged Diabetes Management program (Mazze et al., 1994; Mazze, Bergenstal, &
Ginsberg, 1995). Also, evaluation of the Minimally Important Difference on the DUI
alongside indicators of disease severity will be needed to ascertain the smallest change in
DUI utility score associated with a clinically meaningful change in health status. With
diabetes being a relatively asymptomatic and chronic disease, these changes will need to
be explored at longer time intervals.
Potential Application of the Diabetes Utility Index
The utility scores provided by the DUI MAUF can be useful in summarizing the
health of diabetes populations. Hence the DUI will be an appropriate tool to obtain
preference-weights to calculate Quality-Adjusted Life Years for use in Cost-Utility
Analyses. The DUI also finds application in comparing outcomes between groups of
patients with diabetes in clinical trials and clinical studies. Both overall outcomes and
attribute-specific outcomes can be compared between groups using the general MAUF
and single-attribute functions of the DUI respectively. At the same time, the DUI MAUF
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utilities should not be used to make clinical decisions for individual patients since
preferences for health states are not homogenous. Direct elicitation of utilities, using the
SG, is the most appropriate technique in this regard, to use with decision trees and other
types of decision analysis.
The content of the DUI also makes it appropriate for use in diabetes intervention
and educational programs in which patients’ satisfaction with the management of the
disease and its treatments and patients’ initiative and control with dietary regulation are
key goals. The diet-related attribute of the DUI describes the level of burden required for
adaptation to and enjoyment of food and drink despite the limitations often imposed by
diabetes. Diabetes Intervention Programs are typically designed to lead to a decreased
sense of burden and an increased sense of enjoyment of diet that may result from more
frequent appropriate food and drink choices. The fifth DUI attribute describes the
satisfaction felt with individuals’ management of diabetes. The more individuals feel
confident to do what is needed to take care of their diabetes and that they are taking the
necessary steps in that direction, the more satisfaction should be present. Through the
inclusion of these attributes, the DUI not only reflects attitude but confidence or ability as
well.
From the above discussion, it can be understood that in addition to being able to
evaluate the impact of diabetes on aspects of functioning, the DUI will be able to measure
the degree of burden or difficulty associated with prescribed behaviors as perceived by
the patient. The adjustments needed to be made in the management of diabetes as
discussed above are permanent and can be interpreted as constituting separate domains
that independently influence diabetes patients’ standing on the construct of QoL. The
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DUI single-attribute scores, and hence overall DUI utility scores, can be expected to be
positively associated with improved diabetes management. It would seem that the
outcomes might be dependent upon the method, content and duration of instruction.
Longitudinal research designs involving Diabetes Intervention Programs with known
efficacy, like the Staged Diabetes Management program (Philis-Tsimikas & Walker,
2001; Zanetti et al., 2007) and the Chronic Disease Model that incorporates the American
Association of Diabetes Educators’ 7 Self-Care Behaviors, can also be used to evaluate
the responsiveness of the DUI to these outcomes.
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CONCLUSIONS

Patient assessed measures of health outcomes are increasingly being used
alongside traditional biomedical measures for the evaluation of treatments and the
management of diabetes. The Diabetes Utility Index provides this assessment by
providing a preference-weighted score that can be used to calculate QALYs. The
diabetes health state classification system of the DUI exhibited satisfactory fit to the
Rasch uni-dimensional model. The preference scoring function was derived from a wellestablished theory, the Multi-attribute Utility Theory, and provided utility scores that
compared adequately with cardinal Standard Gamble utilites. Results of the concurrent
validation, with existing established preference-based measures of health, and construct
validation, with indicators of diabetes severity, were both encouraging. The DUI will be
appropriate for use in both clinical interventions as well as disease management programs
for patients with diabetes.
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Appendix 1: Expectations from Expert Panel
Dear member of my expert panel,
Thank you for agreeing to be a part of my PhD dissertation project. From my
discussions with you in the past, you may remember that the purpose of my project is to
develop a questionnaire that will ultimately enable the calculation of a score that
describes the ‘utility’ that a patient with diabetes places on his or her present heath
condition.
In case you may want to refresh your memory on the concept of ‘utility’, I have
provided you with links to two websites:
1. http://www.bjmath.com/faq/utility/faqmanager.cgi?file=utility&toc=faq
This link offers a general overview of the theory of utility, by using a simple economic
example.
2. http://symptomresearch.nih.gov/chapter_24/sec4/cmgs4pg1.htm
This link offers a healthcare perspective to measuring utility, or health state utility.
I’m requesting your input in two main areas:
1. Selecting attributes that influence health state utility in people with diabetes, and
2. Describing the selected attributes and designating attribute levels.
1. Selecting attributes that influence health state utility in people with diabetes:
One of the major selection criteria will be the importance that is accorded to
attributes in terms of how they affect utility. This exercise ideally involves an extensive
amount of primary research on these attributes in subjects with diabetes. Researchers
have suggested that this step can be supplemented by the use of previously designed
questionnaires that measure a similar concept and that have been validated in similar
populations.
In my Master’s thesis, I collected data on the quality of life of people with Type 2
diabetes using an instrument called the ‘Audit of Diabetes Dependent Quality of Life’, or
ADDQoL. The ADDQoL asks respondents to rate how the following aspects of life
would be influenced if that individual did not have diabetes:
1. Working life
2. Family life
3. Social life
4. Sex life
5. Physical Appearance
6. Physical activities
7. Holidays/ leisure
8. Travel
9. Confidence in ability
10. Motivation

11. Society reaction
12. Worries about the future
13. Finances
14. Dependence
15. Living Conditions
16. Freedom to eat
17. Enjoyment of food
18. Freedom to drink
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A copy of the ADDQoL is attached towards the end of this document (Appendix
A). I will be using statistical analyses (using ADDQoL scores from a dataset I compiled
previously in my Master’s research) to guide in the selection of 5 broad attributes from
the 18 issues addressed in the ADDQoL. While this method does use indirect patient
input, I’ve been advised by my dissertation committee to take a more balanced approach
by obtaining the input of an expert panel as well.
1. Please advise if these attributes in all, in your opinion, provide
adequate coverage of the MAIN areas that would influence the utility
that a person with diabetes would place on his or her current condition.
Please keep in mind that there may be several issues to consider, but
the goal is to conceive broad areas or attributes (4-5 in number) that
may be representative of those issues.
2. Please do not feel limited by the items in the ADDQoL on which the
statistical analyses are based. Based on your experience in this
clinical field, you may be aware of important areas not represented in
the instrument that you think patients may consider very important, or
that, according to you, is important in the assessment of utility.
For example, the instrument does not provide coverage on symptoms of the condition
(perhaps because primary research preceding the development of the instrument noted that
there was lack of overall significantly distressing symptoms in diabetes that impaired
patients’ QoL; you may or may not agree to this). If you have in mind attributes that you
think are crucial to patients’ utility but are unrepresented in the list of items from the
ADDQoL, please feel free to indicate those.

The underlying approach is to develop a brief questionnaire that does not severely
compromise on the coverage of issues necessary to capture patient’s health state utility.
Let me provide you with some examples of attributes included in instruments that assess
health state utility. You may notice that these instruments differ in the nature of attributes
included. While the Health Utilities Index Mark 3 (HUI-3) and the Short Form 6-D (SF6D) are instruments that offer a generic perspective to the measurement of health state
utility, the menopause health state classification system focuses on aspects unique to the
condition.
The attributes included in the HUI-3 are:
1. Vision
2. Hearing
3. Speech
4. Ambulation
5. Dexterity
6. Emotion
7. Cognition
8. Pain
You may notice that this instrument employs an ‘under the skin’ approach in choosing
attributes.
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The attributes included in the SF-6D are:
1. Physical functioning
2. Role Limitations
3. Social Functioning
4. Pain
5. Mental Health, and
6. Vitality
You may notice that this instrument incorporates aspects of life and existence beyond
those related to the state of the body.
The attributes included in the menopause health state classification system are:
1. hot flushes
2. aching joints or muscles
3. anxious or frightened feelings
4. breast tenderness
5. bleeding
6. undesirable cosmetic signs (facial or body hair growth, greasy skin or acne)
7. vaginal dryness
You may notice that this classification system focuses on symptoms.
For our own purpose, it is useful to consider the broad areas listed above. I gave you
these examples to provide you with a glimpse into the state of the art in the development
of an instrument assessing health state utility.
2. Describing the selected attributes and designating attribute levels
Attribute levels need to be defined to cover the full range of possible
abilities/disabilities and to be clearly distinguishable from one another. I will attempt to
provide initial thought on the desirable range on the basis of statistical input, which you
may or may not agree to.
3. Please suggest a one line description of the attribute; this will be a way
to guide the respondent to provide an answer about the attribute with
better clarity. This may be contrasted with the use of words or phrases
to describe attributes in the examples provided above.
4. Please suggest descriptions for the attribute levels. We may consider
avoiding designating attribute levels such as ‘highly affected,
moderately affected’, and so on. While these types of scales have
been used widely, the interpretation of the relative differences between
adjoining scale levels is left to the respondent. We should address that
by describing attribute levels briefly, and if at all possible, keeping in
mind scenarios that are more reflective of what a person with diabetes
may undergo with regards to that particular attribute.
Again, I’ve provided you with examples of the way attribute levels have been described
for the instruments discussed before, in Appendices B, C, and D.
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Where do we go from here?
I will be collating input from a panel of experts, of which you are a part, using the
Delphi technique. I will soon be emailing you a document with a summary of the results
of the statistical analyses. I will make an attempt to suggest 4-5 attributes from available
ADDQoL data as well as their severity levels. I will request you to make your own
individual assessments, using the suggestions in this document as a guideline if you agree
to them in principle, and return them in 10-15 days. This will be Delphi Component One.
I will then compile individual contributions and email a document which, this
time, contains a draft of the questionnaire that may be influenced by the opinions of
several panel members. The expert panel will be approached again - this time to finetune the questionnaire with regards to the wording, and if necessary, to alter the item
content, and return it to me by email in 7-10 days. This will be Delphi Component Two.
At this point I should have enough input from the panel to be able to finalize the
instrument. I will have a better idea as to the scheduling of these components once the
statistical analyses are ready. Component Two would depend on the timeliness of
completion of Component One.
Thank you for going through this document. I look forward to working with you.
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Appendix A: The ADDQoL Questionnaire
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Appendix B: The Menopause health state classification
Please consult the following paper for more details on this instrument and for potential use:
Brazier JE, Roberts J, Platts M, Zoellner YF. Estimating a preference-based index for a menopause specific
health quality of life questionnaire. Health Qual Life Outcomes. 2005 Mar 15;3:13.

1. Hot flushes
1) You have no hot flushes
2) You get 1–3 hot flushes per day
3) You get 4 or more hot flushes per day
2. Aching joints or muscles
1) You have no aching joints or muscles at all.
2) You have 1–3 episodes of aching joints or muscles per week.
3) You have 4 or more episodes of aching joints or muscles per week.
4) You have mild to moderate constant pain in your joints or muscles.
5) You have severe constant pain in your joints or muscles.
3. Anxious or frightened feelings
1) You do not have anxious or frightened feelings.
2) You have anxious or frightened feelings 1–3 times per week.
3) You have anxious or frightened feelings 4 or more times per week.
4. Breast tenderness
1) You have no breast tenderness.
2) You have mild to moderate breast tenderness.
3) You have severe breast tenderness
5. Bleeding
1) You have no bleeding
2) You have mild regular (monthly) bleeding
3) You have mild irregular bleeding
4) You have intense regular (monthly) bleeding
5) You have intense irregular bleeding
6. Undesirable cosmetic signs (facial or body hair growth, greasy skin or acne)
1) You have no undesirable cosmetic signs.
2) You have mild to moderate undesirable cosmetic signs
3) You have severe undesirable cosmetic signs.
7. Vaginal dryness
1) You have no vaginal dryness.
2) You have mild to moderate vaginal dryness.
3) You have severe vaginal dryness.
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Appendix C: The HUI-3 Classification System
The Health Utilities Index (Mark 3) is copyrighted. Please contact Bill Furlong for enquiries.
E-mail: furlongb@mcmaster.ca

1. Vision
1) Able to see well enough to read ordinary newsprint and recognize a friend on the other
side of the street, without glasses or contact lenses.
2) Able to see well enough to read ordinary newsprint and recognize a friend on the other
side of the street, but with glasses.
3) Able to read ordinary newsprint with or without glasses but unable to recognize a friend
on the other side of the street, even with glasses.
4) Able to recognize a friend on the other side of the street with or without glasses but
unable to read ordinary newsprint, even with glasses.
5) Unable to read ordinary newsprint and unable to recognize a friend on the other side of
the street, even with glasses.
6) Unable to see at all.
2. Hearing
1) Able to hear what is said in a group conversation with at least three other people, without
a hearing aid.
2) Able to hear what is said in a conversation with one other person in a quiet room without
a hearing aid, but requires a hearing aid to hear what is said in a group conversation with
at least three other people.
3) Able to hear what is said in a conversation with one other person in a quiet room with a
hearing aid, and able to hear what is said in a group conversation with at least three other
people, with a hearing aid.
4) Able to hear what is said in a conversation with one other person in a quiet room, without
a hearing aid, but unable to hear what is said in a group conversation with at least three
other people even with a hearing aid.
5) Able to hear what is said in a conversation with one other person in a quiet room with a
hearing aid, but unable to hear what is said in a group conversation with at least three
other people even with a hearing aid.
6) Unable to hear at all.
3. Speech
1) Able to be understood completely when speaking with strangers or friends.
2) Able to be understood partially when speaking with strangers but able to be understood
completely when speaking with people who know me well.
3) Able to be understood partially when speaking with strangers or people who know me
well.
4) Unable to be understood when speaking with strangers but able to be understood partially
by people who know me well.
5) Unable to be understood when speaking to other people (or unable to speak at all).

The Health Utilities Index (Mark 3) is copyrighted. Please contact Bill Furlong for enquiries.
E-mail: furlongb@mcmaster.ca
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4. Ambulation
1) Able to walk around the neighbourhood without difficulty, and without walking
equipment.
2) Able to walk around the neighbourhood with difficulty; but does not require walking
equipment or the help of another person.
3) Able to walk around the neighbourhood with walking equipment, but without the help of
another person.
4) Able to walk only short distances with walking equipment, and requires a wheelchair to
get around the neighbourhood.
5) Unable to walk alone, even with walking equipment. Able to walk short distances with
the help of another person, and requires a wheelchair to get around the neighbourhood.
6) Cannot walk at all.
5. Dexterity
1) Full use of two hands and ten fingers.
2) Limitations in the use of hands or fingers, but does not require special tools or help of
another person.
3) Limitations in the use of hands or fingers, is independent with use of special tools (does
not require the help of another person).
4) Limitations in the use of hands or fingers, requires the help of another person for some
tasks (not independent even with use of special tools).
5) Limitations in use of hands or fingers, requires the help of another person for most tasks
(not independent even with use of special tools).
6) Limitations in use of hands or fingers, requires the help of another person for all tasks
(not independent even with use of special tools).
6. Emotion
1)
2)
3)
4)
5)

Happy and interested in life.
Somewhat happy.
Somewhat unhappy.
Very unhappy.
So unhappy that life is not worthwhile.

7. Cognition
1) Able to remember most things, think clearly and solve day to day problems.
2) Able to remember most things, but have a little difficulty when trying to think and solve
day to day problems.
3) Somewhat forgetful, but able to think clearly and solve day to day problems.
4) Somewhat forgetful, and have a little difficulty when trying to think or solve day to day
problems.
5) Very forgetful, and have great difficulty when trying to think or solve day to day
problems.
6) Unable to remember anything at all, and unable to think or solve day to day problems.

The Health Utilities Index (Mark 3) is copyrighted. Please contact Bill Furlong for enquiries.
E-mail: furlongb@mcmaster.ca
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8. Pain
1)
2)
3)
4)
5)

Free of pain and discomfort.
Mild to moderate pain that prevents no activities.
Moderate pain that prevents a few activities.
Moderate to severe pain that prevents some activities.
Severe pain that prevents most activities.

The Health Utilities Index (Mark 3) is copyrighted.
Please contact Bill Furlong for enquiries.
William (Bill) Furlong, MSc
Department of Clinical Epidemiology & Biostatistics
Faculty of Health Sciences, McMaster University
Health Utilities Inc.
88 Sydenham Street
Dundas, ON, Canada L9H 2V3
Telephone: (905) 525-9140 extension 22389
FAX: (905) 627-7914
E-mail: furlongb@mcmaster.ca

201

Appendix D: The SF-6D Classification System
Appendices
The SF-6D is protected by copyright.
Please visit www.qualitymetric.com for further details and for potential use
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Appendix 2: Expert Panel Input
Dear member of my expert panel,
Some days ago, I sent you a document explaining the specific inputs I will be
requesting from you as a member of an expert panel on issues perceived as important to
the health state utility of persons with diabetes.
This document contains my initial suggestions pertaining to the important
attributes that may influence the health state utility of persons with diabetes. Your inputs
will constitute the first round of inquiry of what is known as the Delphi technique on this
topic. As a follow up to this round I will compile each panel member’s inputs, at the end
of which I will email you a draft of the questionnaire (the health-state utility
questionnaire, also called the ‘diabetes health-state classification system’) that
incorporates the opinions of all the participating panel members.
This will initiate another round of inputs from the panel members with the
objective of fine-tuning the questionnaire with regards to its wording, or even making
modifications to the attributes listed. This will constitute the second round of inquiry of
the Delphi technique, following which I will further refine the instrument based on each
panel member’s responses.
A final round will involve panel members receiving a draft of the revised
questionnaire utilizing the inputs obtained in the first two rounds of the Delphi, and will
be finalized upon receiving consent from each member.
Thank you for going through this document. I look forward to receiving your
responses BY APRIL 9th, 2007. If you have any questions, please do not hesitate to
contact me.
Sincerely,

Murali Sundaram
PhD Candidate
PSP Dept., WVU School of Pharmacy
P.O. Box 9510
Morgantown, WV - 26506-9510
muralisundaram@hsc.wvu.edu
(304) 685 3106

Michael J Smith
Assistant Professor & PhD Advisor
PSP Dept., WVU School of Pharmacy
P.O. Box 9510
Morgantown, WV - 26506-9510
msmith2@hsc.wvu.edu
(304) 293 1832
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A. INFORMATION SOURCE
My input comes from a statistical analysis of items in the Audit of Diabetes
Dependent Quality of Life (ADDQoL), an existing instrument assessing the impact of
diabetes on quality of life of people with the condition. The ADDQoL asks respondents
to rate how the following aspects of life would be influenced if that individual did not
have diabetes:

1. Working life

10. Motivation

2. Family life

11. Way society reacts

3. Friendship & Social life

12. Worries about the future

4. Sex life

13. Finances

5. Physical appearance

14. Dependence

6. Physical activities

15. Living conditions

7. Vacations & leisure activities

16. Freedom to eat

8. Ease of travel

17. Enjoyment of food

9. Confidence in ability to do things

18. Freedom to drink

Please consult the document ‘Expert panel role.doc’ (sent to you in my previous
email) for a copy of the instrument and for the exact wording of the above items.
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B. PROPOSED ARRANGEMENT OF THE ABOVE ITEMS INTO BROAD
ATTRIBUTES
In interpreting the results of the statistical analysis of the ADDQoL items, I also
employed my own logic regarding the attributes these items represent, as well as
consulted the components of existing instruments assessing health-state utility. Please
bear in mind that
• the attributes suggested below are plausible,
• the phrases describing them are my interpretation, and
• the arrangement of items to plausible attributes is not indisputable.
Items

Plausible attribute

Freedom to eat
Diet-related

Enjoyment of food
Freedom to drink

Items

Plausible attribute

Work life
Family life

Relationships

Friendship & social life
Sex Life

Items

Plausible attribute

Living conditions
Finances

Life

Way society reacts

situations

Dependence
Appearance
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Items

Plausible attribute

Ease of travel
Physical activities

Physical & Mental

Holidays & leisure activities

Functioning *

Confidence in ability to do things
Motivation
Worries about the future

* Statistical analysis of the ADDQoL items in my dataset did not strongly support separating
these set of five items into individual attributes of Physical and Mental Functioning. Theory,
however, strongly supports such a separation. In such a case, the two items below the jagged
line in the box to the left would intuitively be regarded as describing mental functioning, while
the three items on top of the jagged line would be regarded as describing physical functioning.

In summary, the initial plausible attributes based on statistical
analysis and my own interpretation and intuition are:

Diet-related
Social functioning
Life situations
Physical & Mental functioning
Are there other important BROAD attributes NOT
REPRESENTED?

Please continue reading
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C. EXPERT’S RECOMMENDATION ON COVERAGE OF INITIAL
ATTRIBUTES – TASK 1
TASK 1. The purpose of this task is to ascertain your opinion about whether the
attributes listed on page 3 provide adequate coverage of the MAIN
areas that would influence the utility that a person with diabetes would
place on his or her current health condition. Towards that end, please
revisit the items and assess how they are influenced by diabetes, using
the format provided.
NOTES:
You are requested to provide your answers in three steps:
• First, rate how important you think each aspect of life, represented by that item,
may influence the utility that a person with diabetes places on his or her health
condition.
• Second, briefly describe how, in your experience dealing with persons with
diabetes, this aspect of life may be influenced.
• Third, please suggest an attribute, from the list on page 3 OR any another that you
may think of as appropriate, that the item under consideration best fits under.
Item: Working life and work-related opportunities
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced by diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
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Item: Family life
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)

Item: Friendships and social life
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
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Item: Physical appearance
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)

Item: Physical activities
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
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Item: Vacations or leisure activities
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)

Item: Ease of travel (local or long distance)
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
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Item: Confidence in ability to do things
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)

Item: Motivation to achieve things
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
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Item: The way society at large reacts
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)

Item: Finances
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
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Item: Dependence on others
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)

Item: Living conditions
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
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Item: Freedom to eat
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)

Item: Enjoyment of food
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
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Item: Freedom to drink
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)

Item: Sex life
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
215

Appendices

Item: Worries about the future
a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
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C. EXPERT’S RECOMMENDATION ON COVERAGE OF INITIAL
ATTRIBUTES (contd.) – TASK 2
TASK 2. Based on your clinical experience with this disease, you may be aware
of important areas not represented in the ADDQoL that you feel
persons with diabetes may consider very important, or that, according
to you, is important in the assessment of the utility that persons with
diabetes place on their health condition.
NOTES:

•

•
•

For example, the items you have considered up until this point do not provide
coverage on symptoms of the condition (perhaps because primary research
preceding the development of the instrument noted that overall, there aren’t
distressing symptoms of diabetes that significantly impair patients’ QoL; you may
or may not agree with this).
If you have in mind attributes that you think are important but are unrepresented
in the list of items from the ADDQoL, please feel free to indicate those.
Please indicate AS MANY ITEMS as you think represent aspects that are
presently not covered in the items listed in Task 1, and that would impact the
utility that persons with diabetes place on their health condition.

PLEASE LIST THE ITEM HERE: (

)

a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition?
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)
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PLEASE LIST THE ITEM HERE: (

)

a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)

PLEASE LIST THE ITEM HERE: (

)

a. Using the scale below, rate how important you think this may influence the utility
that a person with diabetes places on his or her health condition.
(Please bold the appropriate option)
0
Not at all important

1
Somewhat important

2
Important

3
Very important

b. Please briefly describe how this aspect of life may be influenced in diabetes.

c. Which attribute do you think this item best fits under?
(Please suggest one or more from the list on page 3 OR suggest another attribute)

Add more items if necessary, ‘copy-pasting’ the above format
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C. EXPERT’S RECOMMENDATION ON COVERAGE OF INITIAL
ATTRIBUTES (contd.) – TASK 3
TASK 3: Now, based on your recommendations of the items completed in Task 1
and Task 2, please UPDATE or MODIFY the initial list of attributes
indicated on page 3.

In summary, the attributes I consider important in influencing
the perceived utility of a person’s health condition are:
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D. EXPERT’S RECOMMENDATION ON DESCRIPTION OF ATTRIBUTES –
TASK 4
TASK 4. Please suggest a description for each attribute that you listed on the
previous page. This could be a phrase, a sentence, or a short
paragraph. This description will be directly incorporated into the
questionnaire being developed.
NOTES:
•

Each attribute can be said to represent an underlying common thread among
items. In Task 1 and Task 2, you indicated the impact of diabetes on aspects of
life represented by individual ADDQoL items as well as those you additionally
listed. You may consider these items in generating your description for each
attribute.

•

Please use a common format (a phrase, a sentence, or a short paragraph) for the
descriptions of all attributes.

•

You can modify the following table to suitably meet your needs.

Please go to the next page
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Name of Attribute

Description of Attribute

Add more rows if necessary
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E. EXPERT’S RECOMMENDATION ON RATING SCALE FOR ATTRIBUTES
– TASK 5
TASK 5. Designate SEPARATE CUSTOMIZED rating scales for the attributes
that you listed and described in Task 4. These scales will be reflective
of the levels of impairment on each attribute. Please suggest FOUR
LEVELS FOR EACH ATTRIBUTE. These rating scales will be
directly incorporated into the questionnaire being developed.
NOTES:
•

The type of rating scale to be used for this task is a ‘severity scale’ where the
scale levels for an attribute represent a varying level of impairment on that
particular attribute.

•

Please avoid designating each attribute with generic severity levels such as
‘Highly Affected, Moderately Affected, Slightly Affected and Not at all Affected’.
While these types of rating scales have been used widely, the interpretation of the
relative differences between adjoining scale levels is left to the discretion of the
respondent.

•

Please design a separate 4-level rating scale for each attribute. Please consider
using diabetes-specific scenarios (as far as possible) representative of the
respective rating scale level rather than using generic severity levels.

•

To aid you in this task, use your responses in Task 1 and Task 2 and also consult
the examples (of the HUI-3, the SF-6D, or the Menopause classification system)
provided in the document, ‘Expert panel role.doc’, emailed or sent to you earlier.

Please go to the next page
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Attribute 1 & Description of Attribute 1:
(Copy and paste Attribute 1 from Task 4)

Rating Scale for Attribute 1:
(Please modify the following table as necessary)
Severity
Level*

Description of Rating Scale Level

1

2

3

4

* 1 (no impairment) to 4 (highest level of impairment)
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Attribute 2 & Description of Attribute 2:
(Copy and paste Attribute 2 from Task 4)

Rating Scale for Attribute 2:
(Please modify the following table as necessary)
Severity
Level*

Description of Rating Scale Level

1

2

3

4

* 1 (no impairment) to 4 (highest level of impairment)
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Attribute 3 & Description of Attribute 3:
(Copy and paste Attribute 3 from Task 4)

Rating Scale for Attribute 3:
(Please modify the following table as necessary)
Severity
Level*

Description of Rating Scale Level

1

2

3

4

* 1 (no impairment) to 4 (highest level of impairment)
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Attribute 4 & Description of Attribute 4:
(Copy and paste Attribute 4 from Task 4)

Rating Scale for Attribute 4:
(Please modify the following table as necessary)
Severity
Level*

Description of Rating Scale Level

1

2

3

4

* 1 (no impairment) to 4 (highest level of impairment)
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Attribute 5 & Description of Attribute 5:
(Copy and paste Attribute 5 from Task 4)

Rating Scale for Attribute 5:
(Please modify the following table as necessary)
Severity
Level*

Description of Rating Scale Level

1

2

3

4

* 1 (no impairment) to 4 (highest level of impairment)
Please add more tables if necessary

END OF DOCUMENT
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Appendix 3: Suggested Version 1
The Current State of Your Health and Well-being
The following five questions assess how diabetes may influence the quality of your health and
well-being. There are no correct or wrong answers to these questions since we know that
your situation is unique. In answering all these questions, please think about your diabetes,
including:
Symptoms

Complications

Treatment

For instance, when your sugar is low, you may feel weak or tired, dizzy,
irritable, sweaty, weak or tired, hungry, have blurry vision or a headache.
On the other hand, when you sugar is high, you may feel tired, have
extreme thirst or hunger, need to urinate often, have dry skin, blurry vision,
or slow-healing wounds.
For instance, you may think about problems connected with your diabetes,
such as, wounds that don’t heal, numbness or tingling in your feet, feeling
tired, or blurry vision.
For instance, you may think about taking medications, checking blood
sugar, and watching what you eat every day.

1. First, please tell us how diabetes depletes your energy or restricts you physical ability to perform
activities of your choice as well as those required towards maintaining your health.
•
•
•
•

For example, you may think about
physical health problems you may experience as a person with diabetes
the pain associated with your diabetes and its treatment
physical activities you need to do on a daily basis, your mobility, and travel needs
activities you need to do to take care of your health, like exercising and seeking medical care

Please read all these statements below and check ONE box that most closely describes you:
I have no problems with my physical health nor do I face any difficulty in doing
activities as a result of my diabetes.
I have no no problems with my physical health but I accomplish less in physical
activities because of the fatigue that is a result of my diabetes.
I am quite limited in physical activities because of problems with my physical health
and lack of energy due to my diabetes.
I am unable to perform most of the physical activities I would like to as a result of my
diabetes.
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2. Next, please share with us your ability to function and enjoy various interpersonal roles
to the extent that you would like to, while you manage your diabetes.
•
•
•

For example, you may think about whether your diabetes
interferes with you family life and your duties towards your family
limits your social relationships
allows you to manage your responsibilities and relationships at work

Please read all these statements below and check ONE box that most closely describes you:
I manage my diabetes everyday, and yet am always able to perform and enjoy
interpersonal roles to my satisfaction.
I am not always able to perform and enjoy interpersonal roles to my satisfaction
as I manage my diabetes.
I am quite limited in the extent to which I can participate and enjoy
interpersonal roles to my satisfaction because of the demands of my diabetes.
I am unable to perform and enjoy interpersonal roles to my satisfaction because
of the demands of my diabetes.

3. Living with your diabetes may require you to make some changes to your lifestyle.
•
•
•
•

For example, you may think about
your ability to undertake and enjoy leisure time activities
your ability to perform acts of self-care
your dependence on others for your every day and diabetes management needs
your need to balance your finances and living conditions to meet the needs of your
situation

Please read all these statements below and check ONE box that most closely describes you:
I have complete freedom in living my life just the way I want to even though I
have diabetes.
I am not always able to live my life on my terms because of the need to manage
my diabetes on an everyday basis.
I am quite limited in my ability to live my life the way I would like to because of
my diabetes, and it makes me dependent on others.
I find it very difficult to live my life the way I would like to because of my
diabetes, and it makes me very dependent on others.
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4.

Now, please tell us about your ability to enjoy food and drink while adapting to different
social settings.
For example, you may think about
the restrictions imposed your diet, the need for you to follow meal plans
situations when you to make educated food choices

•
•

Please read all these statements below and check ONE box that most closely describes you:
I always make smart food choices, quantity adjustments, or medication
adjustment and always enjoy what I eat and drink anywhere.
I do not always make educated choices or stick to meal plans but I manage to
enjoy food and drink without worrying too much.
I frequently worry about what the food and drink I consume will do to me but am
unsure of what to do to make my food intake better.
I never enjoy food and drink in all situations.. (need to expand this?)

5. Finally, we’d like to understand how the burden/stress of daily living combined with
managing your diabetes influences your emotions and health behavior.
•
•
•
•

For example, you may think about whether you
feel anxious about the symptoms and management of your diabetes
worry that you will pass out, or get complications, or in general about the future
have trouble sleeping, lack in concentration
feel confident or motivated in doing necessary acts of self-care

Please read all these statements below and check ONE box that most closely describes you:
I know that managing my diabetes is a life-long effort. I work on it myself daily,
and am pleased to see the progress I have made.
I know that I can take care of my diabetes, but just need something to jumpstart me. I plan ahead and ask for help when I need it.
I am usually worried that I don’t pay attention to my health care behaviors, but I
just don’t feel confident in putting all the effort that is required.
I feel very overwhelmed with all the things I need to do to manage my diabetes
and worry a lot. Sometimes, I just take a vacation from diabetes.

Thank you for your participation. Your response is highly appreciated!
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Appendix 4: Version One
The Current State of Your Health and Well-being
The following five questions assess how diabetes may influence the quality of your health and well-being.
There are no right or wrong answers to these questions since everyone’s experience is different. When
answering these questions, please think about your diabetes, including:
Symptoms

For instance, what you go through when your blood sugar is low and when your sugar is high.

Complications

For instance, you may think about health problems that are connected with your
diabetes.

Treatment

For instance, you may think about taking medications, checking blood sugar, and
watching what you eat every day.

we would like to ask you if diabetes affects your energy or restricts your physical ability to
1. First,
perform everyday activities.
•
•

•

For example, you may think about
everyday activities like your ability to move around, your travel needs, bathing and dressing
activities you need to do to take care of your diabetes, like exercising and seeking medical care
any pain you may have due to your diabetes and in managing it, when you use finger-sticks, or insulin.

Please read all these statements below and check ONE box that most closely describes you:

□
□

I don’t feel tired nor do I have difficulty doing everyday activities even though I have diabetes.
I feel tired some of the time and am able to do some everyday activities even though I have
diabetes.

□

I feel tired most of the time and am quite limited in everyday activities due to my diabetes.

□

I feel tired all the time and am unable to perform most everyday activities due to my diabetes.

please share with us whether diabetes interferes with your participation in and enjoyment
2. Next,
of social activities and relationships.
•
•
•

•

For example, you may think about whether your diabetes
interferes with you family life and your role within your family
limits your social relationships
allows you to manage your responsibilities and relationships at work
affects your ability to be intimate with your partner

Please read all these statements below and check ONE box that most closely describes you:

□
□
□
□

I am always able to participate in and enjoy social activities and relationships even though I
have diabetes.
I am able to participate in and enjoy social activities and relationships some of time even though
I have diabetes.
I am quite limited in the extent to which I can participate in and enjoy social activities and
relationships due to my diabetes.
I am very limited in the extent to which I can participate in and enjoy social activities and
relationships due to my diabetes.
Please turn to the back of this page
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3.

Please tell us about your ability to enjoy food and drink.
•
•

For example, you may think about the need to
make food choices at home, at parties, during the holidays, or at work
take or adjust your diabetes medication at meal times

Please read all these statements below and check ONE box that most closely describes you:

□

I always enjoy what I eat and drink.

□

I enjoy food and drink some of the time without worrying too much about what I consume will
do to me.

□

I am quite limited in my enjoyment of food and drink and frequently worry about what I
consume will do to me.

□

I have lost the ability to enjoy food and drink.

4.

Now, kindly share with us about your freedom to live life the way you would like to.
•

•

For example, you may think about
your dependence on others for your every day and diabetes management needs
your need to balance your finances and living conditions to meet the needs of your situation

Please read all these statements below and check ONE box that most closely describes you:

□

I have complete freedom in living my life just the way I want to even though I have diabetes.

□

I am able to live my life the way I want to some of the time even though I have diabetes.

□
□

I am quite limited in my ability to live my life the way I want to to because of the need to manage
my diabetes on an everyday basis.
I find it very difficult to live my life the way I want to because of the need to manage my diabetes
on an everyday basis.

5. Finally, we’d like to understand how the demands of daily living combined with managing your
diabetes influences your mood and feelings.

For example, you may think about whether you
•

feel confident and motivated or tensed and anxious about managing your diabetes

•

feel generally low, have trouble sleeping, lack in concentration

•

worry that you will pass out or get complications or worry in general about the future

Please read all these statements below and check ONE box that most closely describes you:

□
□
□
□

I feel confident all of the time and never worry about what will happen to me even though I have
diabetes.
I feel confident some of the time but do not worry too much about about what will happen to me
even though I have diabetes.
I just don’t feel confident most of the time and am frequently worried about what will happen to
me due to my diabetes.
I never feel confident, feel very overwhelmed and worry a lot.

Thank you for your participation. Your response is highly appreciated!
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Appendix 5: Suggested Version Two
The Current State of Your Health and Well-being
These five questions ask you how diabetes may affect the quality of your health and well-being. Since
everyone experiences diabetes in their own way, there are no right or wrong answers to these questions.
When you answer these questions, please think about your diabetes and how it affects your health, including:
Symptoms

-

Complications -

for example, what you may feel when your blood sugar is low or high.
for example, the health problems you may have that are connected with your diabetes,
whether it is with your eyes, your hands, your feet, your heart, or your kidneys.

Treatment

-

for example, taking medicines (including insulin), checking blood sugar (including finger
sticks), checking your feet, and watching what you eat every day.

Answer the five questions after reading the examples provided below:

we would like to ask you if diabetes has limited your physical ability or caused changes in
1. First,
your energy level to do everyday tasks.
•
•
•
•

For example, you may think about:
how able you are to do things around the house, move about or travel
how able you are to take part in relaxing activities, hobbies or exercise
how much energy you have to do normal everyday tasks
how any pain you have due to your diabetes affects what you can do

Please read all these statements below and then check ONE box that most closely describes you:

□

I am always able to do my everyday tasks even though I have diabetes.

□

I am usually able to do my everyday tasks even though I have diabetes.

□

I usually find it hard to do my everyday tasks because I have diabetes.

□

I always find it hard to do my everyday tasks because I have diabetes.

please tell us whether diabetes gets in the way of your taking part in and enjoying social
2. Next,
activities and relationships.
•
•

•
•

For example, you may think about:
your family life and being able to play your role within the family
your relationships at work and being able to do your job
your friendships and being able to socialize
your sex life and being able to be intimate with your partner

Please read all these statements below and then check ONE box that most closely describes you:

□
□
□
□

I am always able to take part in and enjoy social activities and relationships even though I have
diabetes.
I am usually able to take part in and enjoy social activities and relationships even though I have
diabetes.
I usually find it hard to take part in and enjoy social activities and relationships because I have
diabetes.
I always find it hard to take part in and enjoy social activities and relationships because I have
diabetes.
Please turn to the back of this page
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3.

Please tell us about your ability to enjoy food and drink.
•
•

For example, you may think about:
making food and drink choices at home, at parties, during the holidays, or at work
taking or adjusting your diabetes medicines at meal times

Please read all these statements below and then check ONE box that most closely describes you:

□

I am always able to enjoy what I eat and drink even though I have diabetes.

□

I am usually able to enjoy what I eat and drink even though I have diabetes.

□

I usually find it hard to enjoy what I eat and drink because I have diabetes.

□

I always find it hard to enjoy what I eat and drink because I have diabetes.

4.

Now, tell us how the way you live your life has been affected by your diabetes.
For example, you may think about:
•

how able you are to take care of yourself, like bathe, dress or feed yourself

•

how able you are to do things to care for your diabetes on a daily basis

•

Any other things I should mention to clarify the concept? (It is anchored by how life changes due to
diabetes)

Please read all these statements below and check ONE box that most closely describes you:

□

I am always able to live my life just the way I want to even though I have diabetes.

□

I am usually able to live my life the way I want to even though I have diabetes.

□

I usually find it hard to live my life the way I want to because I have diabetes.

□

I always find it hard to live my life the way I want to because I have diabetes.

5.

Finally, we’d like to understand how living with diabetes influences your mood and feelings.
For example, you may think about:
•

how happy or how sad you feel in general, and if you are moody or irritable at times

•

whether you find to hard to pay attention

•

whether you feel confident about yourself or worry about what will happen because of your diabetes

Please read all the statements below and then check ONE box that most closely describes you:

□
□
□
□

I always feel confident about myself and never worry about what will happen to me even though
I have diabetes.
I usually feel confident about myself and worry little about what will happen to me even though I
have diabetes.
I usually don’t feel confident about myself and often worry about what will happen to me
because I have diabetes.
I never feel confident about myself and always worry about what will happen to me because I
have diabetes.

Thank you for your participation. We appreciate your time and efforts!
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Appendix 6: Version Two
The Current State of Your Health and Well-being
These five questions ask you how diabetes may affect the quality of your health and well-being. Since everyone
experiences diabetes in their own way, there are no right or wrong answers to these questions. When you
answer these questions, please think about your diabetes, including:

Symptoms

-

Complications -

for example, what you may feel when your blood sugar is low or high.
for example, the health problems you may have that are connected with your diabetes,
whether it is with your eyes, your hands, your feet, your heart, or your kidneys.

Treatment

-

for example, taking medicines (including insulin), checking blood sugar (including finger
sticks), checking your feet, and watching what you eat every day.

Answer the five questions after reading the examples provided below:

1.

First, we would like to ask you if diabetes has limited your physical ability or caused changes
in your energy level to do everyday tasks.
•
•
•
•

For example, you may think about:
how able you are to do things around the house, move about or travel
how able you are to take part in relaxing activities, hobbies or exercise
how much energy you have to do these normal everyday tasks
how any pain you have due to your diabetes affects what you can do

Think of these examples and then check ONE box below that most closely describes your physical ability and
energy level:

□

I am always able to do my everyday tasks even though I have diabetes.

□

I am usually able to do my everyday tasks even though I have diabetes.

□

I usually find it hard to do my everyday tasks because I have diabetes.

□

I always find it hard to do my everyday tasks because I have diabetes.

2.

Next, please tell us whether diabetes gets in the way of your taking part in and enjoying social
activities and relationships.
•
•

•
•

For example, you may think about:
your family life and being able to play your role within the family
your relationships at work and being able to do your job
your friendships and being able to socialize
your sex life and being able to be intimate with your partner

Think of these examples and then check ONE box below that most closely describes your relationships:

□
□
□
□

I am always able to take part in and enjoy social activities and relationships even though I have
diabetes.
I am usually able to take part in and enjoy social activities and relationships even though I have
diabetes.
I usually find it hard to take part in and enjoy social activities and relationships because I have
diabetes.
I always find it hard to take part in and enjoy social activities and relationships because I have
diabetes.
Please turn to the back of this page
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3.

Please tell us about your ability to enjoy food and drink.
•
•

For example, you may think about:
making food and drink choices at home, at parties, during the holidays, or at work
taking or adjusting your diabetes medicines at meal times

Think of these examples and then check ONE box below that most closely describes how you enjoy food and
drink:

□

I am always able to enjoy what I eat and drink even though I have diabetes.

□

I am usually able to enjoy what I eat and drink even though I have diabetes.

□

I usually find it hard to enjoy what I eat and drink because I have diabetes.

□

I always find it hard to enjoy what I eat and drink because I have diabetes.

4.

Now, tell us how your freedom to live life the way you like to has been affected by your
diabetes.
For example, you may think about:
•

how able you are to take care of yourself, like bathe, dress or feed yourself

•

how able you are to do things to care for your diabetes on your own everyday

Think of these examples and then check ONE box below that most closely describes you:

□

I am always able to live my life just the way I want to even though I have diabetes.

□

I am usually able to live my life the way I want to even though I have diabetes.

□

I usually find it hard to live my life the way I want to because I have diabetes.

□

I always find it hard to live my life the way I want to because I have diabetes.

5.

Finally, we’d like to understand how living with diabetes influences your mood and feelings.
•

For example, you may think about:
how happy and calm, or how low and depressed you feel

•

whether you feel moody or irritable, find it hard to pay attention to what you do

•

whether you feel confident in general or worry about what will happen because of your diabetes

Think of these examples and then check ONE box below that most closely describes your feelings:

□
□
□
□

I always feel confident about myself and never worry about what will happen even though I have
diabetes.
I usually feel confident about myself and worry little about what will happen even though I have
diabetes.
I usually don’t feel confident about myself and often worry about what will happen because I
have diabetes.
I never feel confident about myself and always worry about what will happen because I have
diabetes.

Thank you for your participation. We appreciate your time and efforts!
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Appendix 7: Final Version:
The Current State of Your Health and Well-being
These five questions ask you about how diabetes may affect the quality of your health and well-being.
There are no right or wrong answers to these questions.
When you answer these questions, please think about your diabetes, in terms of:
Symptoms

-

Complications -

for example, what you may feel when your blood sugar is low or high
for example, the health problems (such as with your eyes, hands, feet, heart, or kidneys) and
pain you may have because of your diabetes

Daily care

-

for example, taking medicines (including insulin), checking blood sugar (including doing finger
sticks), checking your feet, and watching what you eat every day.

1. First, we would like to ask you if diabetes has limited your physical ability or caused changes in your
energy level to do everyday tasks.
•
•

•
•

Think of the following as they apply to you:
how able you are to move about, do things around the house, take part in hobbies, exercise, and travel
how able you are to take care of yourself, like bathe, dress or feed yourself
how much energy you have to do these normal everyday tasks
how any pain you may have due to your diabetes affects what you physically can do

Think
about

Based on the above, check ONE box below that most closely describes your physical ability and energy level:

I am always able to do my everyday tasks even though I have diabetes.
I am usually able to do my everyday tasks even though I have diabetes.
I usually find it hard to do my everyday tasks because I have diabetes.
I always find it hard to do my everyday tasks because I have diabetes.

2. Next, please tell us whether diabetes gets in the way of your social interactions or relationships.
•
•

•

•

Think of the following as they apply to you:
your family life and being able to play your role within the family
your relationships with co-workers and your roles in the workplace
your friendships and being able to socialize with friends and other people
your sex life and being able to be intimate with your partner

Think

about

Based on the above, check ONE box below that most closely describes your social interactions or
relationships with family, friends and co-workers:

My social interactions or relationships are never affected even though I have diabetes.
My social interactions or relationships are usually not affected even though I have diabetes.
My social interactions or relationships are usually affected because I have diabetes.
My social interactions or relationships are always affected because I have diabetes.
Please turn to the next page
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3.

We’d like to know whether living with diabetes affects your mood and feelings.
•

Think of the following as they apply to you:
how happy or how sad you feel in general, and how moody you may be

•

whether you feel calm in general or feel irritable at times

•

how much you worry about what will happen to your health and future because of your diabetes

Think
about

Based on the above, check ONE box below that most closely describes your feelings:

I always feel happy in general and never worry about what will happen to my health and
future even though I have diabetes.
I usually feel happy in general and worry little about what will happen to my health and future
even though I have diabetes.
I usually don’t feel happy in general and often worry about what will happen to my health
and future because I have diabetes.
I never feel happy in general and always worry about what will happen to my health and
future because I have diabetes.

4.

Now, tell us whether diabetes affects your ability to enjoy food and drink.
•
•

Think of the following as they apply to you:
having to make food and drink choices at home, at parties, at restaurants, during the holidays,
or at work
taking or adjusting your diabetes medicines at meal times

Think

about

Based on the above, check ONE box below that most closely describes your enjoyment of food and drink:

I am always able to enjoy what I eat and drink even though diabetes limits my choices.
I am usually able to enjoy what I eat and drink even though diabetes limits my choices.
I usually find it hard to enjoy what I eat and drink because diabetes limits my choices.
I always find it hard to enjoy what I eat and drink because diabetes limits my choices.

5.

Finally, tell us how satisfied you are with how you manage the changes in your life because
of your diabetes.
Think of the following as they apply to you:

Think

•

how much you have accepted the changes in your life because of your diabetes

•

how much you do what is necessary and important to care for your diabetes

•

how confident and satisfied you are in your ability to care for your diabetes on a daily basis

about

Based on the above, check ONE box below that most closely describes how satisfied you are with how you
manage your diabetes:

I am very satisfied with what I do in order to take care of my diabetes the way I am supposed
to.
I am somewhat satisfied with what I do in order to take care of my diabetes the way I am
supposed to.
I am not satisfied with what I do in order to take care of my diabetes the way I am supposed to.
Thank you for your participation. We appreciate your time and efforts!
© 2008 Murali Sundaram

This Questionnaire is protected by Copyright.
For further enquiries and use, please contact
Murali Sundaram at doctormurali@gmail.com
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Appendix 8: Preference Elicitation Interview Booklet

Living With Diabetes
RESPONDENT I.D.

MALE /

Group

FEMALE

A

/ B

INTERVIEWER

START TIME: _________ a.m. / p.m.
INTERVIEW DATE:
END TIME: _________ a.m. / p.m.
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SECTION 1: The Current State of Your Health and Well-being
These five questions ask you about how diabetes may affect the quality of your health and well-being.
There are no right or wrong answers to these questions.
When you answer these questions, please think about your diabetes, in terms of:
Symptoms

-

Complications -

for example, what you may feel when your blood sugar is low or high
for example, the health problems (such as with your eyes, hands, feet, heart, or kidneys) and
pain you may have because of your diabetes

Daily care

-

for example, taking medicines (including insulin), checking blood sugar (including doing finger
sticks), checking your feet, and watching what you eat every day.

1. First, we would like to ask you if diabetes has limited your physical ability or caused changes in your
energy level to do everyday tasks.
•
•

•
•

Think of the following as they apply to you:
how able you are to move about, do things around the house, take part in hobbies, exercise, and travel
how able you are to take care of yourself, like bathe, dress or feed yourself
how much energy you have to do these normal everyday tasks
how any pain you may have due to your diabetes affects what you physically can do

Think
about

Based on the above, check ONE box below that most closely describes your physical ability and energy level:

I am always able to do my everyday tasks even though I have diabetes.
I am usually able to do my everyday tasks even though I have diabetes.
I usually find it hard to do my everyday tasks because I have diabetes.
I always find it hard to do my everyday tasks because I have diabetes.

2. Next, please tell us whether diabetes gets in the way of your social interactions or relationships.
•
•

•

•

Think of the following as they apply to you:
your family life and being able to play your role within the family
your relationships with co-workers and your roles in the workplace
your friendships and being able to socialize with friends and other people
your sex life and being able to be intimate with your partner

Think

about

Based on the above, check ONE box below that most closely describes your social interactions or
relationships with family, friends and co-workers:

My social interactions or relationships are never affected even though I have diabetes.
My social interactions or relationships are usually not affected even though I have diabetes.
My social interactions or relationships are usually affected because I have diabetes.
My social interactions or relationships are always affected because I have diabetes.
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3.

We’d like to know whether living with diabetes affects your mood and feelings.
Think of the following as they apply to you:

Think

•
•

how happy or how sad you feel in general, and how moody you may be
whether you feel calm in general or feel irritable at times

•

how much you worry about what will happen to your health and future because of your diabetes

about

Based on the above, check ONE box below that most closely describes your feelings:

I always feel happy in general and never worry about what will happen to my health and
future even though I have diabetes.
I usually feel happy in general and worry little about what will happen to my health and future
even though I have diabetes.
I usually don’t feel happy in general and often worry about what will happen to my health
and future because I have diabetes.
I never feel happy in general and always worry about what will happen to my health and
future because I have diabetes.

4.

Now, tell us whether diabetes affects your ability to enjoy food and drink.
•
•

Think of the following as they apply to you:
having to make food and drink choices at home, at parties, at restaurants, during the holidays,
or at work
taking or adjusting your diabetes medicines at meal times

Think

about

Based on the above, check ONE box below that most closely describes your enjoyment of food and drink:

I am always able to enjoy what I eat and drink even though diabetes limits my choices.
I am usually able to enjoy what I eat and drink even though diabetes limits my choices.
I usually find it hard to enjoy what I eat and drink because diabetes limits my choices.
I always find it hard to enjoy what I eat and drink because diabetes limits my choices.

5.

Finally, tell us how satisfied you are with how you manage the changes in your life because
of your diabetes.
Think of the following as they apply to you:

Think

•

how much you have accepted the changes in your life because of your diabetes

•
•

how much you do what is necessary and important to care for your diabetes
how confident and satisfied you are in your ability to care for your diabetes on a daily basis

about

Based on the above, check ONE box below that most closely describes how satisfied you are with how you
manage your diabetes:

I am very satisfied with what I do in order to take care of my diabetes the way I am supposed
to.
I am somewhat satisfied with what I do in order to take care of my diabetes the way I am
supposed to.
I am not satisfied with what I do in order to take care of my diabetes the way I am supposed to.
© 2008 Murali Sundaram

This Questionnaire is protected by Copyright.
For further enquiries and use, please contact
Murali Sundaram at doctormurali@gmail.com
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SECTION 2: Table 1
Card
#
1

Section
VI

Card
Code
PH

Card Technical Name

2

VI

PIT

3

VI

D

4

VII

MA

Marker State 1

5

VII

MB

Marker State 2

6

VII

MC

Marker State 3

7

I

SPC

Physical Corner State

8

I

SP2

Physical Single-Attribute Level State 2

9

I

SP3

Physical Single-Attribute Level State 3

10

II

SSC

Social Corner State

11

II

SS2

Social Single-Attribute Level State 2

12

II

SS3

Social Single-Attribute Level State 3

13

III

SFC

Feelings Corner State

14

III

SF2

Feelings Single-Attribute Level State 2

15

III

SF3

Feelings Single-Attribute Level State 3

16

IV

SDC

Diet Corner State

17

IV

SD2

Diet Single-Attribute Level State 2

18

IV

SD3

Diet Single-Attribute Level State 3

19

V

SMC

Satisfaction-Management Corner State

20

V

SM2

Satisfaction-Management SingleAttribute Level State 2

Perfect Health
Pits
Death

Table 1 finished at _____ a.m. / p.m.
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SECTION 2: Table 2
Card MA
RECORD SCORE INDICATED ON BOARD = __.__ __
? – PROMPT “Why did you choose a 100% chance of health B rather than a
100% chance of perfect health?
RECORD VERBATIM RESPONSE:

?? –

B more preferable than Death

- 0.05

B less preferable than Death

- less than 0.00

B and Death equally preferable - 0.00

________________________________________________________________

Card MB
RECORD SCORE INDICATED ON BOARD = __.__ __
? – PROMPT “Why did you choose a 100% chance of health B rather than a
100% chance of perfect health?
RECORD VERBATIM RESPONSE:

?? –

B more preferable than Death

- 0.05

B less preferable than Death

- less than 0.00

B and Death equally preferable - 0.00
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Card MC
RECORD SCORE INDICATED ON BOARD = __.__ __
? – PROMPT “Why did you choose a 100% chance of health B rather than a
100% chance of perfect health?
RECORD VERBATIM RESPONSE:

?? –

B more preferable than Death

- 0.05

B less preferable than Death

- less than 0.00

B and Death equally preferable - 0.00

________________________________________________________________

Card Death / Pits (circle appropriate option)
RECORD SCORE INDICATED ON BOARD = __.__ __
? – PROMPT “Why did you choose a 100% chance of health B rather than a
100% chance of perfect health?
RECORD VERBATIM RESPONSE:

?? –

B more preferable than Death

- 0.05

B less preferable than Death

- less than 0.00

B and Death equally preferable - 0.00

________________________________________________________________
Table 2 finished at _____ a.m. / p.m.
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SECTION 3: About You and About the Study
In the next stage of the interview, I will collect demographic information
and your opinions on the interview.
Socio-demographics:
1. Gender: CHECK Male or Female
( ) Male 1
( ) Female 2
2. How old are you? ____________
3. Which of the following would you say is your race?
(
(
(
(
(
(
(
(

) White/ Caucasian 1
) Black/African American 2
) Hispanic/Latino 3
) Pacific Islander 4
) Asian 5
) American Indian/ Native Indian/ Alaskan Native 6
) Other (please specify) _______________ 7
) Refused 0

4. What is your current marital status?
(
(
(
(
(
(
(

) Single 1
) Married 2
) Divorced or Separated 3
) Widowed 4
) Not married, living with partner 5
) Other (please specify) _________________ 6
) Refused 0

5. What is the highest level of education you have completed?
(
(
(
(
(
(
(

) Some high school or less 1
) High school graduate or GED 2
) Vocational college or some college 3
) College degree 4
) Professional or graduate degree 5
) Other (please specify) ___________________ 6
) Refused 0
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6. Which of the following best describes your main activity?
(
(
(
(
(
(
(
(

) Employed (including self employment) 1
) Employed part-time 2
) Retired 3
) Keeping house/ home-maker 4
) Student 5
) Seeking work 6
) Other (please specify) ________________ 7
) Refused 0

7. What is your annual household income from all sources? (Please check one)
(
(
(
(
(
(

) $25,000 or less 1
) $25,001 - $50,000 2
) $50,001 - $75,000 3
) More than $75,000 4
) Refused 0
) Don't know --- PROBE: If you had to guess, what would you say?

Opinions about the interview:
The final questions ask for your opinions of this interview. We constantly try to
improve our method of collecting information. Any assistance you may provide
would be appreciated.
8. How would you rate the Feeling Thermometer and questions?
(
(
(
(
(
(
(

) Very easy to understand 1
) Easy to understand 2
) Neither easy nor difficult 3
) Difficult 4
) Very difficult 5
) Refused 0
) Don't Know 99

9. How would you rate the Chance Board and its questions?
(
(
(
(
(
(
(

) Very easy to understand 1
) Easy to understand 2
) Neither easy nor difficult 3
) Difficult 4
) Very difficult 5
) Refused 0
) Don't Know 99
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10. Thank you very much. Is there anything else you would like· to say or add
about the interview?

THIS PART BELOW TO BE COMPLETED BY INTERVIEWER
11. Did anyone other than the respondent contribute information?
Please explain
( ) 1. YES
( ) 2. NO
12. Rate degree of co-operation from the respondent in the following categories:
( ) 1. Complete co-operation
( ) 2. General co-operation – not fully open on all questions
( ) 3. Substantial lack of co-operation
13. How much thought did the respondent put into his/ her answers?
(
(
(
(

) 1.
) 2.
) 3.
) 4.

A great deal
Some
Very little
None at all

14. How well did the respondent understand the questions?
(
(
(
(
(

) 1.
) 2.
) 3.
) 4.
) 5.

Totally
For the most part
Somewhat
Only a little
Not at all

15. How much trouble did the respondent have in answering these questions?
(
(
(
(

) 1.
) 2.
) 3.
) 4.

A great deal
Some
Very little
None at all

16. Record impression of the interview (i.e., the quality of response):
(
(
(
(
(

) 1.
) 2.
) 3.
) 4.
) 5.

Very good
Good
Average
Poor
Very Poor
Comments
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